WO2017018370A1 - Mixed injection assistance system - Google Patents

Mixed injection assistance system Download PDF

Info

Publication number
WO2017018370A1
WO2017018370A1 PCT/JP2016/071692 JP2016071692W WO2017018370A1 WO 2017018370 A1 WO2017018370 A1 WO 2017018370A1 JP 2016071692 W JP2016071692 W JP 2016071692W WO 2017018370 A1 WO2017018370 A1 WO 2017018370A1
Authority
WO
WIPO (PCT)
Prior art keywords
work
information
mixed injection
unit
medicine
Prior art date
Application number
PCT/JP2016/071692
Other languages
French (fr)
Japanese (ja)
Inventor
真希 松永
Original Assignee
株式会社湯山製作所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社湯山製作所 filed Critical 株式会社湯山製作所
Priority to JP2017530852A priority Critical patent/JP6809460B2/en
Priority to KR1020177037191A priority patent/KR20180035738A/en
Priority to CN201680043975.XA priority patent/CN107920955B/en
Publication of WO2017018370A1 publication Critical patent/WO2017018370A1/en

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
    • G06K7/00—Methods or arrangements for sensing record carriers, e.g. for reading patterns
    • G06K7/10—Methods or arrangements for sensing record carriers, e.g. for reading patterns by electromagnetic radiation, e.g. optical sensing; by corpuscular radiation
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10L—SPEECH ANALYSIS OR SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING; SPEECH OR AUDIO CODING OR DECODING
    • G10L13/00—Speech synthesis; Text to speech systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Definitions

  • the present invention relates to a mixed injection support system that supports mixed injection work of drugs such as anticancer agents.
  • a pharmacist performs a mixed injection operation in which a drug such as an anticancer drug is mixed with a solution such as physiological saline.
  • a mixed injection support system that supports a pharmacist performing the mixed injection work by displaying information necessary for the mixed injection work on a display device may be used (for example, see Patent Document 1).
  • An object of the present invention is to provide a mixed injection support system capable of improving the work efficiency of mixed injection work.
  • the co-infusion support system includes a display unit and a control unit that sequentially displays information on each work process included in the co-infusion operation of medicine on the display unit.
  • the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are used as the information on the specific work process. Display on the display.
  • a mixed injection support system includes a display unit and a control unit that sequentially displays information on each work process included in the mixed injection operation of the medicine on the display unit.
  • the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are used as the information on the specific work process.
  • region which shows the color previously matched with the said specific said work process is displayed on the said display part.
  • a mixed injection support system includes a display unit and a control unit that sequentially displays information on each work process included in the mixed injection operation of the medicine on the display unit.
  • the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are used as the information on the specific work process.
  • the medicine number display area indicating the number of scheduled executions and the number of completed same specific work processes is displayed on the display unit.
  • a mixed injection support system includes a display unit and a control unit that sequentially displays information on each work process included in the mixed injection operation of the medicine on the display unit.
  • the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are used as the information on the specific work process.
  • region for operating at least progress or reverse about the said specific work process is displayed on the said display part.
  • the content of the work process is a pictogram set in advance corresponding to the content of the work process.
  • the mixed injection support system may further include a second display unit having the display unit as a first display unit and a screen size larger than that of the first display unit.
  • the control unit causes the second display unit to display information on the work process, and the information amount of the work process information displayed on the first display unit is the second display. It is conceivable that the amount of information of the work process displayed on the section is smaller.
  • the mixed injection support system further includes a wearable terminal that can be worn by an operator of the mixed injection operation, and the first display unit is provided in the wearable terminal.
  • the mixed injection support system may further include a reading processing unit that reads out the information of the work process by voice.
  • the said control part displays the medicine name in the display unit without omitting the medicine name in the medicine authentication process for authenticating the medicine in the work process, and the other work process after the medicine authentication process is finished.
  • the medicine name it is conceivable to display the abbreviation of the medicine name on the display unit.
  • the said control part can display a chemical
  • the said control part can switch and display the state where the content of the said work process, the said work amount, and the said work object are displayed, and the state where the said chemical
  • the mixed injection support system includes a medicine update processing unit that updates the medicine image based on a medicine database set in advance.
  • the mixed injection support system is a wearable terminal that can be worn by an operator of the mixed injection work and includes the display unit and the imaging unit, a reading processing unit that reads information from code information captured by the imaging unit, It is conceivable to include a setting processing unit that sets the contents of the setting items related to the wearable terminal based on information read by the reading processing unit.
  • the setting processing unit transitions the reading processing unit to a standby state in which the information can be read with activation of the wearable terminal, and then before the elapse of a preset first upper limit time.
  • the reading processing unit When information is read by the reading processing unit, the contents of the setting items related to the wearable terminal are set based on the information, and when the information is not read by the reading processing unit before the first upper limit time elapses It is conceivable to cancel the standby state.
  • the mixed injection support system includes a wearable terminal that can be worn by a chemical mixed injection worker and includes a display unit and a photographing unit, and information on each work process included in the mixed injection operation.
  • a reading processing unit that reads information from code information captured by the photographing unit, and a standby that enables the reading processing unit to read the information when the wearable terminal is activated.
  • the reading processing unit After the transition to the state, when information is read by the reading processing unit before the elapse of a preset first upper limit time, the contents of the setting items related to the wearable terminal are set based on the information, and the first And a setting processing unit for canceling the standby state when information is not read by the reading processing unit before the elapse of one upper limit time.
  • the setting processing unit maintains the standby state after setting the setting item based on the information read by the reading processing unit within the first upper limit time, and then a preset second upper limit time. If the information is read by the reading processing unit at an interval of within, the content of the setting item is set based on the information to maintain the standby state, and the reading processing unit is set before the second upper limit time has elapsed. If the information is not read by this, it is possible to cancel the standby state.
  • One of the setting items may include one or both of a display mode by the display unit and a connection destination of the wearable terminal.
  • the display modes may include a right eye mode in which the worker views the display unit with a right eye and a left eye mode in which the worker views the display unit with a left eye.
  • one piece of code information includes information about the setting contents of a plurality of setting items, and the setting processing unit adds a plurality of the setting items at a time based on information read by the reading processing unit. It is conceivable that it can be set.
  • the mixed injection support system includes a storage unit that stores a history of the setting items set by the setting processing unit, and the setting processing unit reads the setting items in the standby state by the reading processing unit. It is conceivable that an unset item that has not been set based on the information to be set is set based on the history stored in the storage unit.
  • the mixed injection support system includes a storage unit that stores the setting item corresponding to each worker, and the setting processing unit assigns the worker to information read by the reading processing unit in the standby state.
  • the setting item corresponding to the worker may be read from the storage unit and set.
  • the mixed injection assistance system which can improve the work efficiency of mixed injection work is provided.
  • FIG. 1 is a block diagram showing an example of a mixed injection support system according to an embodiment of the present invention.
  • FIG. 2 is a schematic external view showing an example of the mixed injection support system according to the embodiment of the present invention.
  • FIG. 3 is a diagram illustrating a usage state of the safety cabinet used in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 4 is a schematic external view illustrating an example of a wearable terminal of the mixed injection support system according to the embodiment of the present invention.
  • FIG. 5 is a flowchart for explaining an example of the procedure of the mixed injection support process executed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 6A is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 6B is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 7 is a flowchart for explaining an example of the procedure of the display control process executed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 8 is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 9 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 10 is a diagram illustrating an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 11 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 12 is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 13 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 14 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 15 is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 16 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 17 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 18 is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 19A is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 19B is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 19C is a diagram illustrating an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 20 is a diagram illustrating an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 21 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 22 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 23 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 24 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 25A is a diagram illustrating an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 25B is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 25C is an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 26 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 27 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 28 is a flowchart illustrating an example of a medicine image update process executed by the mixed injection support system according to the embodiment of the present invention.
  • FIG. 29 is a flowchart showing an example of setting processing executed in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 30A is a diagram illustrating an example of a display screen displayed on the wearable terminal in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 30B is a diagram showing an example of a display screen displayed on the wearable terminal in the mixed injection support system according to the embodiment of the present invention.
  • FIG. 30C is a diagram showing an example of a display screen displayed on the wearable terminal in the mixed injection support system according to the embodiment of the present invention.
  • the mixed injection support system 1 includes a mixed injection control unit 11, an operation display unit 12, a first reading unit 13, a printer 14, a foot switch unit 15, and a wearable terminal. 16, a second reading unit 21, a weighing unit 22, and the like.
  • the mixed injection support system 1 is used to increase the efficiency of the mixed injection work of medicines performed by an operator such as a doctor or a pharmacist.
  • an operator may perform an operation of sucking a drug solution from a drug container with a syringe and injecting the solution into an infusion bag containing a solution such as physiological saline. Further, in the mixed injection work, an operator sucks a solution such as a physiological saline solution from an infusion bag with a syringe, and injects the solution into a medicine container in which the powder is contained, dissolves the powder, and after the dissolution In some cases, the chemical solution is sucked with a syringe and injected into an infusion bag.
  • the second reading unit 21 and the weighing unit 22 are arranged in a work chamber 101 of a safety cabinet 100 where an operator performs a mixed injection operation.
  • the mixed injection control unit 11, the operation display unit 12, the first reading unit 13, the printer 14, the foot switch unit 15, and the wearable terminal 16 are disposed outside a work room of the safety cabinet 100.
  • the safety cabinet 100 includes a work chamber 101 partitioned by a glass door 102 having a transparent front surface.
  • the glass door 102 is supported at a position where an opening 103 is formed below, and an operator can access the work chamber 101 from the opening 103.
  • the safety cabinet 100 is also provided with an air cleaning device 104 having a HEPA filter for purifying and exhausting the air in the work chamber 101.
  • the operator inserts both hands into the work chamber 101 from the opening 103 and performs a chemical injection operation while visually observing the inside of the work chamber 101.
  • a non-toxic chemical such as a high calorie infusion
  • a clean bench or the like may be used instead of the safety cabinet 100.
  • the second reading unit 21 provided in the safety cabinet 100 is a code reading device capable of reading code information such as a one-dimensional code or a two-dimensional code attached to a medicine container for a medicine used in the mixed injection operation. is there.
  • the two-dimensional code is, for example, a QR code (registered trademark).
  • the code information includes identification information for specifying the type of the medicine.
  • the code information read by the second reading unit 21 is input to the mixed injection control unit 11.
  • the weighing unit 22 provided in the safety cabinet 100 is an electronic balance used for various types of weighing in the mixed injection work.
  • the measurement result by the weighing unit 22 is input to the mixed injection control unit 11 in real time. Further, the weighing unit 22 inputs stability information indicating whether or not the measurement result is stable to the mixed injection control unit 11.
  • the mixed injection control unit 11 can acquire information such as the measurement result by the weighing unit 22 and the presence or absence of stability.
  • the mixed injection control unit 11 may be configured to actively read information such as the measurement result by the weighing unit 22 and the presence or absence of stability.
  • the mixed injection control unit 11 is communicably connected to a host system wirelessly or via a communication network such as a LAN, WAN, Internet, or intranet.
  • the host system is an electronic medical record system, an ordering system, a receipt system, or the like, and the mixed injection control unit 11 acquires preparation data (prescription data) indicating the contents of mixed injection work performed by an operator from the upper system. Is possible.
  • the preparation data includes patient information (patient ID, patient name, height, weight, body surface area, etc.), preparation date, drug information (drug code, drug name, etc.), dose, regimen identification information, and the like.
  • the regimen identification information is information that can identify regimen information such as a therapy name (regimen name), a therapy ID, or a regimen ID.
  • the preparation data includes doctor information, types of chemical containers (such as ampoules with chemicals, vials with chemicals, vials with powders, or infusion bags), preparation information (chemical containers, syringes, Information such as type and number of injection needles) and preparation procedure information (work contents, dissolved drug, solvent, dissolved drug volume, solvent volume, sampling volume), medication date, prescription classification, clinical department, ward, etc. May be.
  • the mixed injection control unit 11 is a computer having a CPU 111, a RAM 112, a storage unit 113, and the like.
  • the CPU 111 is a processor that executes various arithmetic processes.
  • the RAM 112 is a volatile storage unit, and is used as a temporary storage memory (working area) for various processes executed by the CPU.
  • the storage unit 113 is a non-volatile storage unit such as an HDD or an SSD that stores information such as a control program for causing the CPU 111 to execute various processes.
  • the mixed injection control unit 11 uses the CPU 111 and the RAM 112 to execute various processes according to various control programs stored in the storage unit 113 in advance.
  • the storage unit 113 includes storage areas such as a data area, a program area, and a master area.
  • the storage unit 113 may include a plurality of storage media such as an HDD and a semiconductor memory, and the data area, the program area, and the master area may be distributed over a plurality of storage media. .
  • the preparation data acquired from the host system is accumulated and stored.
  • the mixed injection control unit 11 can also newly register or edit the preparation data in accordance with a user operation.
  • history data indicating the contents of mixed injection work performed by an operator according to the preparation data is stored in association with the preparation data.
  • the history data includes a worker of the mixed injection work, a work start time, a work end time, and a photographed image taken during the mixed injection work.
  • the program area stores a control program for causing the mixed injection control unit 11 to execute a mixed injection support process (see FIG. 5) described later.
  • an application program such as an operating system (OS) and browser software is also stored in the program area.
  • the master area stores various types of master information such as a medicine master, patient master, ward master, doctor master, and pharmacist master.
  • the medicine master includes a medicine ID, a medicine name, a medicine code, a medicine bottle code, a classification (dosage form: powder, tablet, liquid medicine, topical medicine, etc.), specific gravity, medicine type (ordinary medicine, anticancer agent). , Poisonous drugs, narcotics, powerful drugs, antipsychotics, therapeutic drugs, etc.), formulation changes, excipients, precautions, types of drug containers (ampoules, vials), drug capacity per drug container (predetermined amount), And information such as the weight of the chemical container.
  • the medicine ID is an identification code such as a YJ code, JAN code, or RSS code.
  • the operation display unit 12 includes a display unit such as a liquid crystal display or an organic EL display that displays various information in accordance with a control instruction from the mixed injection control unit 11, and a user for inputting various information to the mixed injection control unit 11. It is an example of a 2nd display part provided with the operation part operated by. When viewed from the operator, the size of the display screen of the display unit of the operation display unit 12 is larger than the size of the display screen of the terminal display unit 162 of the wearable terminal 16 described later.
  • the operation unit of the operation display unit 12 is a touch panel that receives touch operations on various operation screens displayed on the display unit.
  • the operation display unit 12 may be a tablet terminal.
  • the operation unit may include a keyboard and a mouse (pointing device) that accept input operations on various operation screens displayed on the display unit.
  • the operation unit may include a voice input device that receives input of various types of information by voice recognition.
  • the first reading unit 13 is a code reading device capable of reading code information such as a one-dimensional code or a two-dimensional code printed on a preparation note corresponding to the preparation data.
  • the code information includes identification information for identifying the preparation data.
  • the code information read by the first reading unit 13 is input to the mixed injection control unit 11.
  • the said mixed injection control part 11 specifies the said preparation data used as the object of this mixed injection operation
  • the mixed injection control unit 11 may acquire the preparation data from the code information.
  • the printer 14 is used by the mixed injection control unit 11 to print various information. For example, it is used for printing the preparation note corresponding to the preparation data executed by the mixed injection control unit 11 or printing the history of the mixed injection work executed according to the preparation data.
  • the foot switch unit 15 is an operation unit for an operator to input an operation to the mixed injection control unit 11 during execution of the mixed injection operation.
  • the foot switch unit 15 includes a first foot switch 151, a second foot switch 152, and a third foot switch 153.
  • the first foot switch 151 and the second foot switch 152 are used for selecting an operation target item, and the third foot switch 153 is used for determining an operation target item.
  • the wearable terminal 16 includes a terminal control unit 161, a terminal display unit 162, a photographing unit 163, operation buttons 164, a speaker 165, a microphone 166, and the like.
  • the wearable terminal 16 is a wearable glass having a product name “InfoLinker (registered trademark)” and a model number “WUZ-01A-NB01” manufactured by West Unitis Co., Ltd.
  • the wearable terminal 16 can communicate with the mixed injection control unit 11 according to a wireless LAN standard such as Wi-Fi (registered trademark) or a short-range wireless communication standard such as Bluetooth (registered trademark).
  • the wearable terminal 16 is provided with a rechargeable secondary battery that can be attached to and detached from the wearable terminal 16, and the wearable terminal 16 is operated by power supplied from the secondary battery.
  • the wearable terminal 16 is a terminal that can be worn by an operator. Specifically, as shown in FIG. 4, the wearable terminal 16 can be attached to and detached from glasses worn by an operator by a detachable member (not shown), and is a one-eye type that the worker can visually recognize with one eye. Smart glasses. Note that the wearable terminal 16 may be configured to be directly attached to the operator's head via an attachment (not shown). Further, the wearable terminal 16 may be a so-called head mounted display or the like integrally configured with glasses. Furthermore, the wearable terminal 16 may be any device that can be easily carried by an operator, such as a smart watch or a smartphone, and that allows the operator to check display information as necessary.
  • the terminal control unit 161 includes a CPU 171, a RAM 172, a storage unit 173, and the like.
  • the CPU 171 is a processor that executes various arithmetic processes.
  • the RAM 172 is a volatile storage unit, and is used as a temporary storage memory (working area) for various processes executed by the CPU.
  • the storage unit 173 is a nonvolatile storage unit such as an EEPROM (registered trademark) in which information such as a control program for causing the CPU 171 to execute various processes is stored.
  • the terminal control unit 161 executes various processes according to various control programs stored in advance in the storage unit 173 using the CPU 171 and the RAM 172.
  • the storage unit 173 stores layout information and image data of various display screens displayed on the terminal display unit 162 in a display control process (see FIG. 7) described later.
  • the terminal display unit 162 is an example of a first display unit including a small display capable of displaying various types of information by being controlled by the terminal control unit 161.
  • the operator can view the information displayed on the terminal display unit 162 by looking directly into the terminal display unit 162.
  • the terminal display unit 162 displays information so as to give the operator a feeling that a display screen corresponding to several inches is displayed several tens of centimeters away.
  • the terminal display unit 162 includes a micro display that projects information on a lens or the like of the glasses.
  • the photographing unit 163 is a digital camera capable of photographing a photograph at the same angle of view as the viewpoint of the worker wearing the wearable terminal 16. An image or video imaged by the imaging unit 163 is temporarily stored in the storage unit 173 of the terminal control unit 161 and transmitted to the mixed injection control unit 11.
  • the terminal control unit 161 uses the photographing unit 163 to provide code information such as a medicine container or a preparation note. It is conceivable to have a reading function. Thereby, one or both of the first reading unit 13 and the second reading unit 21 can be omitted.
  • the terminal operation unit 164 includes various operation buttons such as a power button for an operator to directly operate the wearable terminal 16.
  • the speaker 165 is used to reproduce sound based on preset guidance message data.
  • the microphone 166 converts input sound into a sound signal and inputs the sound signal to the terminal control unit 161. It is also conceivable that an earphone or an earphone terminal to which a speaker can be attached is provided instead of the speaker 165, or a microphone terminal to which a microphone can be attached instead of the microphone 166.
  • the mixed injection support system 1 configured as described above, when a lot of information is displayed on the display device such as the operation display unit 12 and the terminal display unit 162 as information necessary for the mixed injection operation, the worker However, for each work process included in the mixed injection work, it is necessary to organize information while selecting necessary information and unnecessary information, which may reduce work efficiency. On the other hand, in the mixed injection support system 1 according to the present embodiment, the work efficiency of the mixed injection work can be improved.
  • a necessary work process is selected from the mixed injection process and the like and sequentially executed.
  • the medicine authentication step is a step for authenticating a medicine used in the mixed injection operation, for example, a step of reading medicine identification information using the second reading unit 21.
  • the taring step is a step for measuring in advance the weight of only the equipment such as a syringe used in the mixed injection operation, for example, a step of placing the syringe on the weighing unit 22.
  • the solution extraction step is a step of extracting a necessary amount of a solution such as physiological saline from an infusion bag with a syringe.
  • the solution measuring step is a step for measuring the weight of the syringe from which the solution is extracted, and is a step of placing the syringe on the weighing unit 22.
  • the mixed injection control device 11 calculates the difference between the weight of the syringe placed on the weighing unit 22 and the weight of the syringe set by the tare, and the weight of the dissolution liquid.
  • the dissolution step is a step for dissolving the drug when the drug is a powder drug, and is a step of injecting the solution extracted with the syringe into the drug container.
  • the solution photographing step is a step for photographing the syringe from which the solution is extracted by the photographing unit 163.
  • medical solution extraction process is a process of extracting a chemical
  • the medicinal solution measuring step is a step for measuring the weight of the syringe from which the medicinal solution has been extracted, and is a step of placing the syringe on the weighing unit 22.
  • the mixed injection control device 11 uses the difference between the weight of the syringe placed on the weighing unit 22 and the weight of the syringe set by the tare as the weight of the medicinal solution. Weigh.
  • the chemical solution photographing step is a step for photographing the syringe from which the chemical solution has been extracted by the photographing unit 163.
  • the mixed injection step is a step of injecting the drug solution in the syringe into the infusion bag.
  • step S11 the mixed injection control unit 11 determines whether or not the preparation data to be subjected to the mixed injection operation has been selected. Specifically, the mixed injection control unit 11 determines that the preparation data corresponding to the identification information is selected when the identification information of the preparation data is read by the first reading unit 13. In the preparation data selection screen displayed on the operation display unit 12, it may be determined that the preparation data is selected when any one of the unadjusted preparation data is selected. If it is determined that the preparation data is selected (S11: Yes), the process proceeds to step S12. If the preparation data is not selected (S11: No), the process waits in step S11. . An error is notified when the preparation data corresponding to the identification information read by the first reading unit 13 is not stored in the storage unit 113 or has already been prepared.
  • step S12 the mixed injection control unit 11 displays the preparation data selected in step S11 on the operation display unit 12 as the target of the mixed injection operation.
  • FIG. 6A is a diagram showing an example of the mixed injection support screen D1 on which the contents of the preparation data are displayed.
  • the mixed injection support screen D1 includes an operator name (pharmacist name), an examiner name, a medical department, a ward, a start date of taking, a doctor name, and a patient name (patient ID) for the preparation data. ), Age, gender, prescription content, etc. are displayed.
  • the measurement result by the weighing unit 22 is displayed.
  • the mixed injection control unit 11 also transmits the measurement result from the weighing unit 22 to the wearable terminal 16, and the measurement result is displayed on the terminal display unit 162 by the terminal control unit 161 as necessary. Is done.
  • step S ⁇ b> 13 the co-infusion control unit 11 causes the operation display unit 12 and the terminal display unit 162 to sequentially display information on each work process included in the co-infusion operation of the medicine to be executed based on the preparation data. Specifically, the mixed injection control unit 11 displays information on the work process on the operation display unit 12 and transmits a display request for the work process to the wearable terminal 16.
  • the work process display request includes information such as the contents of the work process, the work amount, and the work target.
  • the terminal control unit 161 displays the work process information on the terminal display unit 162.
  • the information on the work process sequentially displayed on the terminal display unit 162 by the terminal control unit 161 is the work process to be performed next among the plurality of work processes included in the mixed injection work.
  • This information is necessary only for the above-mentioned, and is information in which the contents of the work process, the work amount, and the work object are simplified.
  • information on the current work process among the mixed injection work may be displayed on the terminal display unit 162.
  • the mixed injection control unit 11 performs the medicine authentication step, the tare step, the solution extraction step, the solution measurement step, the solution photographing step, and the dissolution step.
  • Information on various work processes such as the chemical liquid extraction process, the chemical liquid measurement process, the chemical liquid photographing process, and the mixed injection process are sequentially displayed.
  • the information on the work process includes, for example, the contents of the work process (type of work process), work amount (sampling amount, injection amount), and work target (chemical, solution, syringe identification information).
  • the information on the work process displayed on the terminal display unit 162 is simplified compared to the information on the work process displayed on the operation display unit 12. ing.
  • the mixed injection control unit 11 displays the work process information on the terminal display unit 162 by transmitting a display request to the wearable terminal 16.
  • the mixed injection control unit 11 may directly control the terminal display unit 162 to display the work process information on the terminal display unit 162.
  • FIG. 6B is a diagram showing an example of the main body side display screen D11 displayed on the operation display unit 12 in step S13.
  • the main body side display screen D11 is displayed as a part of the mixed injection support screen D1, or is displayed as a pop-up on the mixed injection support screen D1.
  • a work process area A1 On the main body display screen D11, a work process area A1, a work amount area A2, and a work target area A3 are displayed as areas indicating information of each work process in the mixed injection work.
  • an operation display area A4 in which operation items that can be operated at present are displayed, and a title of the content of the work process displayed on the main body display screen D11 is displayed as a character string.
  • a status area A5 is displayed.
  • the contents of the work process are displayed as character strings indicating the contents of the work process.
  • numerical values and units such as the number of medicines, sampling amount, or injection amount are displayed as work amounts in the work process.
  • identification information such as a name or a code for specifying a work target to be worked in the work process is displayed.
  • patient information, detailed information on the preparation data, and the like are displayed on the mixed injection support screen D1. Therefore, the worker can confirm the details of the mixed injection work by referring to the mixed injection support screen D1 and the main body side display screen D11 of the operation display unit 12.
  • step S14 the mixed injection control unit 11 determines whether or not the current work process is the medicine authentication process.
  • the process proceeds to step S15, and if it is determined that the current work process is not the medicine authentication process (S14). : No), the process proceeds to step S16.
  • step S15 the mixed injection control unit 11 executes a chemical authentication process for determining whether or not the chemical used in the mixed injection work is appropriate. Specifically, the mixed injection control unit 11 waits for reading of the medicine identification information by the second reading unit 21. When the medicine identification information is read, the medicine identification information is displayed as the current medicine identification information. It is verified whether or not it matches the identification information of the medicine in the preparation data to be read in the medicine authentication process. And the said mixed injection control part 11 makes a process transfer to step S16, when the collation result of the identification information of the said medicine is in agreement. In addition, the said mixed injection control part 11 alert
  • step S ⁇ b> 16 the mixed injection control unit 11 determines whether the current work process is the tare process.
  • the process proceeds to step S17, and when it is determined that the current work process is not the taring process (S16). : No), the process proceeds to step S18.
  • step S ⁇ b> 17 the mixed injection control unit 11 performs a taring process for setting the weight of the syringe used in the mixed injection operation. Specifically, the mixed injection control unit 11 waits for placement of the syringe on the weighing unit 22 and stabilization of the measurement value by the weighing unit 22, and when the measurement value is stabilized, the measurement value is The weight is stored in the storage unit 113 as the tare weight of the syringe, and the process proceeds to step S18.
  • step S ⁇ b> the mixed injection control unit 11 determines whether or not the current work process is a measurement process such as the solution measurement process or the chemical measurement process. If it is determined that the current work process is the weighing process (S18: Yes), the process proceeds to step S19, and if it is determined that the current work process is not the weighing process (S18: No). ), The process proceeds to step S19.
  • a measurement process such as the solution measurement process or the chemical measurement process.
  • step S19 the mixed injection control unit 11 executes a process for supporting the measurement process. Specifically, the mixed injection control unit 11 waits for the placement of the weighing object on the weighing unit 22 and the stabilization of the measurement value (hereinafter referred to as “actual measurement value”) by the weighing unit 22, When the measurement value is stable, it is determined whether or not the difference between the actual measurement measurement value and the measurement target value of the measurement object is within a preset error range. When the mixed injection control unit 11 determines that the difference between the measured measurement value and the measurement target value is within the error range, the measured measurement value is stored in the storage unit 113 as a measurement result, and processed. To step S20. If the difference between the measured measurement value and the measurement target value is not within the error range, the mixed injection control unit 11 notifies an error and repeatedly executes step S19.
  • actual measurement value hereinafter referred to as “actual measurement value”
  • step S20 the mixed injection control unit 11 determines whether the current work process is an imaging process such as the solution imaging process or the chemical imaging process. Here, if it is determined that the current work process is the shooting process (S20: Yes), the process proceeds to step S21, and if it is determined that the current work process is not the shooting process (S20: No). ), The process proceeds to step S22.
  • an imaging process such as the solution imaging process or the chemical imaging process.
  • step S ⁇ b> 21 the mixed injection control unit 11 executes a process for causing the photographing unit 163 of the wearable terminal 16 to take a picture. Specifically, the mixed injection control unit 11 waits for a photographing operation by the photographing unit 163 using the foot switch unit 15 and transmits a photographing request to the wearable terminal 16 when the photographing operation is performed. . Thereby, in the wearable terminal 16, the photographing unit 163 is controlled by the terminal control unit 161 to perform photographing by the photographing unit 163, and a photographed image is transmitted to the mixed injection control unit 11. The mixed injection control unit 11 displays the photographed image on the operation display unit 12 and then associates the photographed image with the preparation data when the operator performs a confirmation operation.
  • the mixed injection control unit 11 re-executes photographing by the photographing unit 163 by transmitting the photographing request to the wearable terminal 16 again when a re-photographing operation or the like is performed by an operator. Is also possible.
  • step S22 the mixed injection control unit 11 determines whether the current operation process is another operation process such as the dissolution liquid extraction process, the dissolution process, the chemical extraction process, and the mixed injection process. .
  • the process proceeds to step S23, and it is determined that the current work process is not the other work process. (S22: No), the process proceeds to step S13.
  • step S23 the mixed injection control unit 11 executes a confirmation process for accepting a confirmation operation for information on the other work process. Specifically, the mixed injection control unit 11 waits for a confirmation operation of the work process, and when the confirmation operation is performed, the process shifts to step S24.
  • the confirmation operation is performed by an operator using the operation display unit 12 or the foot switch unit 15.
  • step S24 the co-infusion control unit 11 determines whether or not all work processes of the co-infusion work based on the preparation data have been completed. Here, if it is determined that all the work processes are not completed (S24: No), the process proceeds to step S13, and the same process is executed for the next work process. If it is determined that all the work steps have been completed (S24: Yes), the series of mixed injection support processing for the preparation data is completed, and the processing is returned to step S11.
  • Display control processing Next, a display control process executed by the terminal control unit 161 of the wearable terminal 16 will be described with reference to FIG.
  • the display control process is executed when, for example, the wearable terminal 16 is turned on and the mixed injection control unit 11 is turned on.
  • the display control process may be executed by the mixed injection control unit 11.
  • step S31 the terminal control unit 161 determines whether or not the work process display request (the step S13) from the mixed injection control unit 11 has been made. If it is determined that a display request for the work process has been made (S31: Yes), the process proceeds to step S32, and if it is determined that a display request for the work process has not been made (S31: No). The process proceeds to step S33.
  • step S32 the terminal control unit 161 causes the terminal display unit 162 to sequentially display a terminal display screen D2 indicating information on each work process included in the mixed injection work in response to the work process display request.
  • the work process display request includes information such as the contents of the work process, the work amount, and the work target.
  • the terminal control unit 161 displays information on a specific work process set in advance among the work processes, the content of the work process (type of work process) as the information on the specific work process. ), Only the work amount and the work target are displayed on the terminal display screen D2 of the terminal display unit 162.
  • the specific work steps are the chemical authentication step, the dissolved solution extraction step, the dissolution step, and the chemical solution extraction step.
  • the terminal control unit 161 reads out information on the work process displayed on the terminal display screen D2 by voice.
  • the terminal control unit 161 when executing the reading process is an example of the reading process unit. Thereby, the worker can recognize the information of the work process not only visually but also by hearing, and an artificial mistake in the work process is suppressed.
  • the voice reading of the information on the work process may be any one or more of the contents of the work process, the work amount, and the work target in the information on the work process.
  • voice data that reads out the content of the work process is stored in advance corresponding to the content of the work process, and the terminal control unit 161
  • the audio data corresponding to the content of the work process is reproduced by the speaker 165. It should be noted that the reading of information on the work process by the voice may be omitted.
  • FIG. 8 is a diagram showing an example of the terminal display screen D2 when the work process is the medicine authentication process.
  • authentication process is an example of the specific work process in this invention.
  • only the work process area A11, the work amount area A12, and the work target area A13 are displayed on the terminal display screen D2 as areas indicating information of each work process in the mixed injection work. Yes.
  • an operation display area A14 and a status area A15 are displayed on the terminal display screen D2 separately from the work process information. 6A and 8, the information amount of the work process information displayed on the terminal display unit 162 is larger than the information amount of the work process information displayed on the operation display unit 12. There are few.
  • the work process area A11 and the work amount area A12 are displayed side by side in the upper stage, and the work target area A13 is displayed in the lower stage.
  • the background colors of the work process area A11, the work amount area A12, and the work target area A13 are displayed in different preset colors.
  • the operation display area A14 is displayed in the lower part of the work target area A13, and the status area A15 is displayed on the left side of the work process area A11 and the work target area A13.
  • a pictogram showing the contents of the work process with an illustration or the like is displayed as the contents of the work process.
  • the storage unit 173 of the wearable terminal 16 stores pictogram image data set in advance corresponding to the contents of the work process.
  • the terminal control unit 161 reads the pictogram image data corresponding to the content of the work process from the storage unit 173 in response to the display request of the work process, and displays the pictogram in the work process area A11. .
  • the worker can intuitively recognize the contents of the work process by referring to the work process area A11.
  • the work amount is the number of chemicals that need to be authenticated in the chemical certification process, is a withdrawal quantity in the dissolution liquid extraction process or the chemical extraction process, and is an injection quantity in the dissolution process.
  • identification information such as a name or a code for specifying a work target to be worked in the work process is displayed. More specifically, when the work target is a medicine, the name or abbreviation of the medicine is displayed as the identification information, and when the work target is a syringe, the name or abbreviation of the syringe is the identification. When the work target is a solution, the name or abbreviation of the solution is displayed as the identification information.
  • work target identification information displayed in the work target area A13 is set in advance in a range that is equal to or larger than a preset character size. If the identification information cannot be displayed in the work target area A13 with the character size or larger, the identification information may be scrolled in the work target area A13.
  • operation items that are currently operable are displayed in the operation display area A14.
  • an operation area A141 indicating an operation item accepted by the mixed injection control unit 11 when the third foot switch 153 is operated is displayed.
  • an operation area A142 indicating operation items displayed by moving to the operation area A141 when the first foot switch 151 is operated, and the second foot switch 152 are operated.
  • an operation area A143 indicating operation items displayed in the operation area A141 is displayed.
  • the example shown in FIG. 8 shows a state in which the operation contents “return” to the operation area A142, “skip” to the operation area A143, and “authentication” to the operation area A141 are assigned. .
  • the mixed injection control unit 11 displays “return” in the operation area A141 when the first foot switch 151 is operated, and displays the operation area A141 when the second foot switch 152 is operated. “Skip” is displayed.
  • the mixed injection control unit 11 executes processing corresponding to the operation content of “authentication” displayed in the operation area A141. Specifically, in the case of the medicine authentication process, the medicine authentication process (S15) is started.
  • the color displayed in the status area A15 is not limited to a case where the color is different for each content of the work process, but may be a color which is different for each group set in advance for the content of the work process.
  • the contents of the work process are classified into a group of work processes involving sampling or injection, a group of work processes involving measurement, a group of work processes involving photographing, and the like.
  • step S32 the terminal control unit 161 displays the terminal display screen D2 on the terminal display unit 162 and reads out the information on the work process displayed on the terminal display screen D2 by voice. Good. Thereby, the worker can recognize the information of the work process not only visually but also by hearing, and an artificial mistake in the work process is suppressed.
  • the voice reading of the information on the work process may be any one or more of the contents of the work process, the work amount, and the work target in the information on the work process.
  • voice data that reads out the content of the work process is stored in advance corresponding to the content of the work process, and the terminal control unit 161
  • the audio data corresponding to the content of the work process is reproduced by the speaker 165. It should be noted that the reading of information on the work process by the voice may be omitted.
  • step S ⁇ b> 33 the terminal control unit 161 determines whether a shooting request from the shooting unit 163 has been made. For example, when the third foot switch 153 of the foot switch unit 15 is operated while the “shooting” is displayed in the operation area A 141 of the terminal display screen D2, the mixed injection control unit 11 The imaging request is transmitted to the terminal control unit 161.
  • step S ⁇ b> 34 the terminal control unit 161 executes photographing by the photographing unit 163, and transmits a photographed image photographed by the photographing unit 163 to the mixed injection control unit 11. Accordingly, the mixed injection control unit 11 can store the captured image in the storage unit 113 as history data in association with the preparation data corresponding to the mixed injection operation.
  • the mixed injection support system 1 an operator executes each work process of the mixed injection work by referring to the terminal display screen D ⁇ b> 2 displayed on the terminal display unit 162 of the wearable terminal 16. Is possible. In particular, on the terminal display screen D2, only the contents of the work process, the work amount, and the work object are extracted and displayed as information on each work process of the mixed injection work. Therefore, since it is not necessary for the worker to sort out necessary information and unnecessary information for each work process included in the mixed injection work, the work efficiency of the mixed injection work is improved.
  • FIG. 9 to 24 show a main body display screen D11 pop-up displayed on the mixed injection support screen D1 on the operation display unit 12 when the terminal display screen D2 is displayed on the left side.
  • the size relationship between the main body display screen D11 and the terminal display screen D2 in FIGS. 9 to 24 is not limited to the ratio shown in FIGS.
  • ⁇ Chemical certification process> 9 and 10 are diagrams showing display examples corresponding to the medicine authentication process.
  • a character string “Please authenticate” is displayed as the content of the work process in the work process area A1.
  • a character string of “number: 0/1” is displayed as the work amount.
  • a character string “Alimta (registered trademark)” 500 mg for injection ” is displayed as the work target.
  • the work process area A ⁇ b> 11 is set in advance corresponding to the medicine authentication process, and medicine identification information is displayed using the second reading unit 21.
  • a pictogram suggesting reading from the bar code is displayed.
  • a character string “0/1” is displayed as the work amount.
  • the character string “500 mg alim”, which is an abbreviation for the drug “500 mg for alimta injection” is displayed in the work target area A13.
  • the content of the work process is a medicine authentication process as information of the medicine authentication process for the other medicine
  • the work target is an alimta. The fact that the amount is 100 mg for injection and the work amount is 3 is displayed.
  • FIG. 11 is a diagram showing a display example corresponding to the tare subtraction process.
  • a character string “Please tare an empty syringe” is displayed in the work process area A1 as the contents of the work process.
  • a character string “50 mL syringe-1” is displayed as the work target.
  • a pictogram showing the movement of the needle is displayed.
  • a work target area A131 in which identification information of the work target of the taring process is shown, and a measured value measured by the weighing unit 22 are displayed.
  • a measurement area A130 including the actual measurement area A132 is displayed.
  • a stable display area A16 is displayed in which whether or not the weighing state by the weighing unit 22 is stabilized is displayed. For example, when the weighing state by the weighing unit 22 is not stable, the stable display area A16 is displayed in red, and when stable, the stable display area A16 is displayed in blue.
  • FIG. 12 is a diagram showing a display example corresponding to the solution extraction step.
  • a character string “please remove the solution” is displayed as the content of the work process in the work process area A1.
  • a character string “Dose: 32.6 mL” is displayed as the work amount.
  • a character string “physiological saline 500 ml” is displayed as the work target in the work target area A3.
  • the piston of the syringe set in advance in the work process area A11 corresponding to the solution extraction process and included in the solution extraction process is displayed.
  • a pictogram suggesting an action of pulling out the solution is displayed.
  • a character string “32.6 mL” is displayed as the work amount.
  • a character string “500 ml saline” which is an abbreviation of the drug “physiological saline 500 ml” as the work target is displayed.
  • FIG. 13 is a view showing a display example corresponding to the dissolving liquid measuring step.
  • a character string “Please measure the dissolved solution” is displayed in the work process area A1 as the content of the work process.
  • a character string “Dose: 32.6 mL” is displayed as the work amount.
  • a character string “physiological saline 500 ml” is displayed as the work target in the work target area A3.
  • the work solution area A11 is preset in correspondence with the solution measurement step, and the solution included in the solution measurement step is inhaled.
  • a pictogram indicating the weighing operation of the syringe is displayed.
  • a balance area A121 is displayed in which the target measurement value and the actual measurement value can be visually recognized.
  • a target area A133 where the target measurement value of the work target of the dissolving liquid measuring step is shown, and the actually measured weight value by the weighing unit 22 are displayed.
  • a measurement area A130 including the actual measurement area A132 is displayed.
  • the stable display area A16 is also displayed, which indicates whether or not the weighing state by the weighing unit 22 is stable.
  • the scale corresponding to the target measurement value is displayed so as to be distinguishable from the other scales in a form such as a color different from the other scales.
  • the terminal control unit 161 acquires the actual measurement value obtained by the weighing unit 22 from the mixed injection control unit 11 in real time, and in the balance area A121, the actual measurement value can be identified in a color or the like. Display. Specifically, in the balance area A121, the shorter the left scale, the smaller the measured value, and the longer the right scale, the larger the measured value. Thus, the operator can intuitively recognize whether or not the target measurement value and the actually measured measurement value match in the balance area A121. It is possible to grasp intuitively.
  • the terminal control unit 161 determines whether the difference between the actual measurement value and the target measurement value is within a preset error range in the measurement area A131. It is conceivable to change the display mode. Specifically, when the difference is not within the error range, the terminal control unit 161 displays the background color of the actual measurement area A132 in a first specific color such as red, and the difference is within the error range. In this case, the background color of the actual measurement area A132 is displayed in a second specific color such as white or blue different from the first specific color.
  • a first specific color such as red
  • the background color of the actual measurement area A132 is displayed in a second specific color such as white or blue different from the first specific color.
  • FIG. 14 is a view showing a display example corresponding to the solution photographing step.
  • a character string “Please shoot an image” is displayed as the content of the work process in the work process area A1.
  • a character string “physiological saline 500 ml” is displayed as the work target.
  • the photographing unit 163 is preset in the work process area A ⁇ b> 11 corresponding to the solution photographing process and included in the solution photographing process.
  • a pictogram showing a camera image suggesting a shooting operation is displayed.
  • a character string “500 ml saline” which is an abbreviation of the chemical “physiological saline 500 ml” as the work target is displayed.
  • FIG. 15 to FIG. 18 are diagrams showing display examples corresponding to the melting step.
  • a character string “Please dissolve” is displayed as the content of the work process in the work process area A1.
  • a character string “dissolution amount: 20 mL” is displayed as the work amount.
  • a character string “500 mg for Alimta injection” is displayed as the work target in the work target area A3.
  • the working solution region A ⁇ b> 11 is set in advance corresponding to the dissolving step, and the dissolved solution in the syringe included in the dissolving step is used as the medicine.
  • a pictogram suggesting the action of pouring into the container is displayed.
  • a character string “input 20 mL” is displayed as the work volume.
  • the character string “500 mg alim”, which is an abbreviation for the drug “500 mg for alimta injection” is displayed in the work target area A13.
  • information corresponding to the dissolution process is displayed on the main body display screen D11 and the terminal display screen D2 in the same manner for the other chemicals.
  • the content of the work process is the dissolution process as information on the dissolution process for the other medicine
  • the work target is Alimta injection is 100 mg
  • the work volume is displayed as 4.2 mL.
  • the same terminal display screen is displayed.
  • D2 is continuously displayed a plurality of times.
  • the situation is shown in which 4.2 ml of the solution in the syringe is injected into three drug containers corresponding to “100 mg Alim” and dissolved. .
  • the terminal control unit 161 determines the progress of the work process. Is displayed on the terminal display screen D2.
  • the display mode such as the color of each partial area divided by the number of the work processes repeatedly executed in the longitudinal direction is sequentially changed at the end of the work process. Thereby, the worker can easily recognize the progress status of the current work process for the same work process corresponding to the same medicine by referring to the progress bar A17.
  • the display of the progress bar A17 may be omitted.
  • the terminal control unit 161 specifies each of the partial areas divided by the number of the work steps as shown in FIGS. 19A to 19C, instead of the progress bar A17 shown in FIGS. Can be considered.
  • a line segment is formed at the boundary of each of the partial regions. Thereby, the operator can grasp
  • ⁇ Drug removal process> 20 and 21 are diagrams showing display examples corresponding to the chemical liquid extraction step.
  • a character string “Please extract” is displayed as the content of the work process in the work process area A1.
  • a character string “Dose: 20 mL” is displayed as the work amount.
  • a character string “500 mg for Alimta injection” is displayed as the work target in the work target area A3.
  • the work process area A11 is set in advance corresponding to the chemical solution extraction step, and the piston of the syringe included in the chemical solution extraction step is pulled.
  • a pictogram suggesting the action of extracting the chemical solution from the chemical container is displayed.
  • a character string “20 mL” is displayed as the work volume.
  • the character string “500 mg alim”, which is an abbreviation for the drug “500 mg for alimta injection” is displayed in the work target area A13.
  • the content of the work process is the dissolution process as information on the dissolution process for the other medicine, and the work target is for alimta injection.
  • 100 mg indicating that the working volume is 12 mL.
  • “100 mg for Alimta injection”, which is an object of the chemical extraction process, will be extracted from the three chemical containers, but as shown in FIG.
  • the total amount of the chemical liquid extracted from the three chemical containers is displayed in the work amount area A12.
  • FIG. 22 is a diagram showing a display example corresponding to the chemical liquid measurement step.
  • a character string “Please measure” is displayed as the content of the work process in the work process area A1.
  • a character string “Dose: 32 mL” is displayed as the work amount.
  • a character string “Alimta injection” is displayed as the work target in the work target area A3.
  • the work process area A11 is set in advance corresponding to the chemical liquid measurement process, and the chemical liquid included in the chemical liquid measurement process is inhaled.
  • a pictogram indicating the metering action of the syringe is displayed.
  • the balance area A121 is displayed instead of the work amount area A12, as in the dissolution liquid measuring step.
  • the measurement area A130 is displayed in place of the work target area A13, as in the dissolution liquid measurement step.
  • the stable display area A16 is also displayed, which indicates whether or not the weighing state by the weighing unit 22 is stable.
  • the terminal control unit 161 determines whether the difference between the actual measurement value and the target measurement value is within a preset error range in the measurement area A131. It is conceivable to change the display mode such as the background color of the area A132.
  • FIG. 23 is a diagram showing a display example corresponding to the chemical liquid photographing process.
  • a character string “Please shoot an image” is displayed in the work process area A1 as the content of the work process.
  • a character string “50 mL syringe-1” is displayed as the work target.
  • FIG. 24 is a view showing a display example corresponding to the mixed injection process.
  • a character string “Please mix” is displayed as the content of the work process in the work process area A1.
  • the medicinal solution in the syringe set in advance in the work process area A11 corresponding to the mixed injection process and included in the mixed injection process is transferred to the infusion bag.
  • a pictogram suggesting the action of injecting is displayed.
  • the mixed injection support system 1 As described above, in the mixed injection support system 1 according to the present embodiment, only the information necessary for the mixed injection work is displayed on the terminal display screen D2 of the terminal display unit 162 of the wearable terminal 16 in an aggregated manner. . Therefore, the worker can efficiently proceed with the mixed injection work with reference to the terminal display screen D2.
  • the operation display area A14, the status area A15, and the like are also displayed.
  • the terminal control unit 161 may display the terminal display screen D2 in which one or both of the operation display area A14 and the status area A15 are omitted.
  • Other embodiments are possible. That is, only the work process area A11, the work quantity area A12, and the work target area A13 are displayed on the terminal display screen D2, the work process area A11, the work quantity area A12, and the work target area A13. Only the operation display area A14 is displayed on the terminal display screen D2, and only the work process area A11, the work amount area A12, the work target area A13, and the status area A15 are displayed on the terminal display screen D2. May be displayed.
  • the terminal control unit 161 may cause the terminal display screen D2 to display at least the work process area A11, the work amount area A12, and the work target area A13 individually on the terminal display screen D2 in a predetermined period. Conceivable. Thereby, each of the work process area A11, the work amount area A12, and the work target area A13 can be displayed largely on the terminal display screen D2.
  • the terminal control unit 161 displays the terminal display screen D2
  • the operation display area A14 is omitted, and the mixed injection control unit 11 receives an operation of the foot switch unit 15.
  • the operation display area A14 may be temporarily displayed in accordance with an input signal from the mixed injection control unit 11.
  • the terminal control unit 161 displays the status area A15 only after the preset time has elapsed after displaying the terminal display screen D2, and thereafter omits the display of the status area A15. It is possible to make it.
  • the terminal control unit 161 displays identification information such as a medicine name as the work target in the work target area A13, at least an abbreviated character string from which the standard is removed from the identification information is displayed. Can be considered. For example, when the identification information is “500 mg for Alimta injection”, an abbreviated character string such as “Alimta” or “Alimta injection” may be displayed.
  • the terminal control unit 161 causes the terminal display unit 162 to display the medicine name without omitting the medicine in the medicine authentication process for authenticating the medicine among the work processes. When displaying the medicine name for the work process, it is conceivable to display the abbreviation of the medicine name on the terminal display unit 162.
  • the abbreviated characters are displayed in the work target area A13 only when the terminal display screen D2 in which the work quantity is displayed in the work quantity area A12 is displayed. This prevents erroneous recognition of the numbers included in the identification information as standards and the work amount.
  • the terminal control unit 161 has a medicine image display function for displaying a medicine image P1 such as an appearance photograph or an appearance illustration of the medicine on the terminal display screen D2 as the work target. Conceivable.
  • the medicine image P1 includes at least identification information that can identify the kind of the medicine.
  • a medicine image master including the medicine image P1 corresponding to each medicine displayed on the wearable terminal 16 is stored in the storage unit 173.
  • identification information (medicine name, medicine code, etc.) of each medicine and the medicine image P1 are stored in association with each other.
  • the terminal control unit 161 can specify the medicine image P1 corresponding to the medicine from the medicine image master based on the identification information of the medicine that is the work target.
  • the terminal control unit 161 When the medicine image display function is set to be effective, the terminal control unit 161, when the work target displayed in the work target area A13 is a medicine name, the terminal display screen D2 (for example, FIG. 8), the medicine name and the medicine image P1 are alternately displayed at predetermined time intervals.
  • the terminal control unit 161 is configured to display the entire terminal display screen D2 in a state where the contents of the work process, the work amount, and the work target are displayed, and a state where the medicine image is displayed, and the medicine. It is also conceivable to switch the state in which the image P1 is displayed. That is, it is conceivable that the medicine image P1 is displayed on the entire terminal display screen D2.
  • the terminal control unit 161 may simultaneously display the medicine name and the medicine image P1 on the terminal display screen D2 in the work target area A13.
  • the operator can intuitively recognize the medicine to be worked in the work process by the medicine image P1, and improve the work efficiency of the mixed injection work. It is possible to suppress human errors in the mixed injection work.
  • the mixed injection control unit 11 has a medicine image automatic update function for automatically updating the medicine image P1 based on a medicine database set in advance.
  • the medicine database is stored in advance in a server device or the like that the mixed injection control unit 11 can communicate wirelessly or by wire through the communication network, and the mixed injection control unit 11 acquires the medicine database from the server device.
  • the server device is, for example, a cloud server provided on the Internet.
  • the medicine database may be read from a recording medium such as a CD or a DVD by a reading device (not shown) provided in the mixed injection control unit 11.
  • the mixed injection control part 11 implement
  • the mixed injection control unit 11 when executing the medicine image update process is an example of a medicine update processing part.
  • the medicine update process may be executed by the terminal control unit 161.
  • the mixed injection control unit 11 executes the medicine image update process, for example, when the mixed injection control unit 11 is turned on, when returning from the power saving mode, or when an arbitrary update start operation is performed.
  • an example of the procedure of the medicine image update process will be described with reference to FIG.
  • step S41 the co-infusion control unit 11 sets the medicine image P1 corresponding to each medicine in the medicine database based on the identification information of each medicine contained in the medicine master stored in the storage unit 113. Get the update date and time. For example, the update date / time is included in the data of the medicine image P1 as time stamp information or stored in the medicine database.
  • step S ⁇ b> 42 the mixed injection control unit 11 acquires the update date and time of the medicine image P ⁇ b> 1 corresponding to each medicine in the medicine image master stored in the wearable terminal 16.
  • the update date and time is included in the data of the medicine image P1 as time stamp information or stored in the medicine image master.
  • the medicine image master may be stored in the storage unit 113 of the mixed injection control unit 11.
  • step S43 for each of the medicines included in the medicine master, the mixed injection control unit 11 calculates the update date and time of the medicine image P1 in the medicine database and the update date and time of the medicine image P1 in the medicine image master. The difference is detected by comparison.
  • step S44 the mixed injection control unit 11 updates the medicine image master stored in the storage unit 173 of the wearable terminal 16 based on the difference detected in step S43.
  • the mixed injection control unit 11 acquires the medicine image P1 of the medicine from the medicine database and stores it in the wearable terminal 16. Send. Thereby, in the wearable terminal 16, the terminal control unit 161 registers the medicine identification information and the medicine image P1 in association with the medicine image master of the storage unit 173.
  • the mixed injection control unit 11 may be configured to register the medicine image P1 in the storage unit 173 of the wearable terminal 16. Thereby, in the said mixed injection support system 1, it is possible to respond
  • the mixed injection control unit 11 also includes the medicine when the update date of the medicine image P1 of the medicine existing in the medicine image master is before the update date of the medicine image P1 of the same medicine in the medicine database.
  • the medicine image P1 is acquired from the medicine database and transmitted to the wearable terminal 16.
  • the terminal control unit 161 uses the medicine image P1 transmitted from the mixed injection control unit 11 in the medicine image master of the storage unit 173, and the medicine image P1 corresponding to the medicine. Update as.
  • the said mixed injection control part 11 when the said medicine image P1 is changed about the medicine already registered, it is possible to respond automatically.
  • the mixed injection control unit 11 deletes the medicine image P1 of the medicine from the storage unit 173 of the wearable terminal 16 when the medicine existing in the medicine image master does not exist in the medicine database. Thereby, in the wearable terminal 16, the unnecessary medicine image P1 is automatically deleted, and the compression of the storage capacity is suppressed.
  • the wearable terminal 16 can arbitrarily set one or a plurality of setting items related to the wearable terminal 16.
  • the setting items include, for example, the display mode of the terminal display unit 162 and the connection destination of the wearable terminal 16.
  • Such setting of the various setting items may be performed by an operator according to the operation of the terminal operation unit 164 of the wearable terminal 16, for example. In this case, the operator uses his / her hand. It is necessary to perform an operation.
  • the wearable terminal 16 may have a setting function that allows the operator to set the setting items without using a hand. The setting function will be described below.
  • the wearable terminal 16 can be attached to an operator in a state in which the terminal display unit 162 is visible with only one of the predetermined right eye or left eye. In this case, The operator cannot freely select the right eye or the left eye.
  • the wearable terminal 16 includes a right eye mode in which an operator looks at the terminal display unit 162 with a right eye and a left eye mode in which an operator looks at the terminal display unit 162 with a left eye, and the terminal control unit 161 has It is conceivable that the display mode of the terminal display unit 162 can be arbitrarily switched between the right eye mode and the left eye mode.
  • the terminal control unit 161 inverts the display screen of the terminal display unit 162 in the right eye mode and the left eye mode.
  • a plurality of the mixed injection support systems 1 may be provided in a hospital or pharmacy where the mixed injection support system 1 is used.
  • the mixed injection support system 1 in which the wearable terminal 16 is used is fixed in advance, but the mixed injection support system 1 using the wearable terminal 16 can be arbitrarily switched. It is desirable. Therefore, it is conceivable that the terminal control unit 161 can arbitrarily set the connection destination of the wearable terminal 16.
  • the number corresponding to a plurality of the mixed injection support systems 1 is set in advance, and the connection destination is set by setting the number.
  • the mixed injection control unit 11 may be shared. In this case, for example, instead of the connection destination of the wearable terminal 16, the mixed injection control unit 11 is excluded. Association with components such as the foot switch unit 15, the second reading unit 21, and the weighing unit 22 is set as a setting item.
  • the said terminal control part 161 implement
  • the terminal control unit 161 when executing the setting processing is an example of a setting processing unit.
  • the terminal control unit 161 executes the setting process as the wearable terminal 16 is activated by turning on the power of the wearable terminal 16 or returning from the power saving mode.
  • the mixed injection control unit 11 recognizes activation of the wearable terminal 16 based on an activation signal transmitted from the wearable terminal 16 after the wearable terminal 16 is powered on and activated.
  • Step S51 First, as the wearable terminal 16 is activated, the terminal control unit 161 causes the terminal display unit 161 to display a setting screen D3 used for setting the contents of the setting items in step S51. Note that layout information, image data, and the like of the setting screen D3 are stored in the storage unit 173. 30A to 30C are diagrams showing an example of the setting screen D3.
  • the terminal control unit 161 displays a video captured by the photographing unit 163 on the preview screen P2 in the setting screen D3.
  • the terminal control unit 161 also displays a message on the setting screen D3 prompting to copy code information such as a one-dimensional code or a two-dimensional code on the preview screen P2.
  • the terminal control unit 161 sets the latest setting history to the current setting item setting content. Is displayed on the setting screen D3.
  • the history of the setting items may be stored in the storage unit 113 of the mixed injection control unit 11, and the terminal control unit 161 may read out from the storage unit 113.
  • the setting contents of the current setting item it is displayed that the display mode is the right eye mode and the connection destination is the first machine.
  • step S52 the terminal control unit 161 makes a transition to a standby state in which a reading process of reading information from code information such as a one-dimensional code or a two-dimensional code captured by the photographing unit 163 can be performed.
  • code information such as a one-dimensional code or a two-dimensional code captured by the photographing unit 163 can be performed.
  • the code information may be printed on a paper medium (not shown), affixed to the safety cabinet 100, or displayed on a tablet terminal (not shown).
  • the one-dimensional code is, for example, a bar code
  • the two-dimensional code is, for example, a QR code (registered trademark).
  • the terminal control unit 161 when executing the reading process is an example of a reading processing unit. Specifically, the terminal control unit 161 reads information from the code information when the code information exists within the shooting range of the shooting unit 163. That is, the terminal control unit 161 can read information from the code information without requiring a shooting operation by an operator.
  • step S53 the terminal control unit 161 starts measuring a standby time indicating the duration of the standby state. Specifically, the terminal control unit 161 resets the standby time to 0 at the timing when the step S53 is executed, and starts measuring the standby time.
  • step S54 the terminal control unit 161 determines whether information is read from the code information by the reading process in the standby state. If it is determined that the information has been read from the code information (S54: Yes), the process proceeds to step S541. On the other hand, when it is determined that the information is not read from the code information (S54: No), the process proceeds to step S55.
  • the terminal control unit 161 determines that the information is read only when the information read in the reading process includes predetermined specific information used for setting the setting item, and the specific information If the information is not included, the information read in the reading process may be ignored.
  • step S55 the terminal control unit 161 determines whether or not the standby time from which time measurement was started in step S53 is a preset upper limit time (for example, 5 seconds or 10 seconds).
  • a preset upper limit time for example, 5 seconds or 10 seconds.
  • the process proceeds to step S56.
  • the process returns to step S54.
  • the upper limit time (corresponding to the first upper limit time) used as a determination index in step S55 executed first after the wearable terminal 16 is started, and the step executed after the second time.
  • the case where the upper limit time (corresponding to the second upper limit time) used as a determination index in S55 is the same time will be described, but the upper limit times (first upper limit time and second upper limit time) are different times. Also good.
  • the terminal control unit 161 reads the information by the reading process within the first upper limit time after the wearable terminal 16 is activated, and sets the setting item based on the information. To maintain.
  • the terminal control unit 161 sets the content of the setting item based on the information and waits for the standby Maintain state. That is, when the information is read by the reading process at intervals within the second upper limit time after the wearable terminal 16 is activated not only at the second time but also after the third time, the content of the setting item based on the information is changed. Setting will be executed.
  • the terminal control unit 161 cancels the standby state when information is not read by the reading process before the second upper limit time elapses after the information is read by the previous reading process. For example, if the first upper limit time is set longer than the second upper limit time, an operator can afford to read the first code information after turning on the wearable terminal 16, and thereafter Will reduce wasted waiting time.
  • the terminal control unit 161 sets each of all the setting items that can be set in the wearable terminal 16 even when the standby time does not reach the upper limit time or more in Step S55 (S55: No). In a case where the setting for is completed, it is also conceivable as another embodiment that the process proceeds to step S58.
  • Step S541> On the other hand, if it is determined that the information has been read from the code information, the terminal control unit 161 sets the content of the setting item based on the information read from the code information in subsequent step S541, and The process returns to step S53 while maintaining the standby state.
  • the terminal control unit 161 reads information by the reading process after the transition to the standby state at the start of activation of the wearable terminal 16 and before the upper limit time elapses, the terminal control unit 161 Based on this, the contents of the setting item are set. Similarly, when the terminal control unit 161 reads information by the reading process after the setting process in step S541 is executed and before the upper limit time elapses, the terminal control unit 161 is also based on the information. The contents of the setting item are set. Note that the terminal control unit 161 also performs processing after resetting the content of the setting item even when information for setting the setting item already set by the setting process is read by the reading process. The standby time is reset by returning to step S53, and the time measurement of the standby time is restarted from 0. Thereby, even if the setting item is set by mistake, the setting content can be easily changed.
  • the standby state continues even after the setting item is set based on the information read by the reading process. Accordingly, since the terminal control unit 161 can continuously set a plurality of the setting items in the setting process, even if the operator sets the contents of the plurality of setting items. There is no need to operate the wearable terminal 16.
  • the terminal control unit 161 determines the type of the setting item based on the information read from the code information, and sets the content of the setting item. For example, the terminal control unit 161 changes the display mode to the left-eye mode when information indicating that the setting item is the display mode and the content is the left-eye mode is read from the code information.
  • FIG. 30B is a display example when the display mode is set to the left-eye mode. As shown in FIG. 30B, the terminal control unit 161 sets the display mode to the left eye mode and displays a message indicating that the display mode is set to the left eye mode on the preview screen of the setting screen D3. Pop-up display on P2. The message is automatically deleted from the setting screen D3 after a preset time has elapsed.
  • the terminal control unit 161 sets the connection destination to the second machine when the information indicating that the setting item is the connection destination and the content is the second machine number is read from the code information. To do. Specifically, the terminal control unit 161 establishes a communication connection between the wearable terminal 16 and the mixed injection control unit 11 corresponding to the mixed injection support system 1 corresponding to the second machine.
  • the safety cabinet 100 in which the wearable terminal 16 is used is set by the unit number or the like, and the safety cabinet 100 Other components arranged correspondingly are associated with the wearable terminal 16.
  • FIG. 30C is a display example when the connection destination is set to the second machine. As shown in FIG.
  • the terminal control unit 161 sets the connection destination to No. 2 machine and displays a message to the effect that the connection destination is set to No. 2 machine on the preview screen P2 of the setting screen D3. Pop-up display. The message is automatically deleted from the setting screen D3 after a preset time has elapsed.
  • one piece of code information includes information on a plurality of the setting items
  • the terminal control unit 161 collects the contents of the plurality of setting items at once based on information read from the one piece of code information. It is possible to set. Specifically, when a total of four pieces of code information are prepared for the two types of setting items of the display mode and the connection destination, the display mode is based on information read from one piece of the code information. In addition, a total of four types of combinations of the machine number can be set. For example, it is conceivable that the display mode is set to the left-eye mode and the connection destination is set to No. 2 based on information read from one piece of code information.
  • the terminal control unit 161 may set the contents of each setting item for each worker who uses the wearable terminal 16.
  • the storage unit 173 stores in advance the content of each setting item corresponding to each worker, and the terminal control unit 161 can identify the worker from the code information. Is read, the contents of each of the setting items corresponding to the worker may be read from the storage unit 173 and set.
  • the terminal control unit 161 associates the contents of each of the latest setting items set in the setting process with the worker after a certain worker logs in to the wearable terminal 16 or the mixed injection control unit 11. It is conceivable that the data is stored in the storage unit 173.
  • the contents of the setting items corresponding to each worker are stored in the storage unit 113 of the mixed injection control unit 11, and the terminal control unit 161 stores the setting corresponding to each worker from the storage unit 113.
  • the content of the item may be read.
  • the contents of the setting items corresponding to each worker are stored in the storage unit 173 of any one of the wearable terminals 16.
  • the terminal control unit 161 may read the content of the setting item corresponding to each worker from the storage unit 173 of the other wearable terminal 16.
  • Step S56> If it is determined that the standby time is equal to or longer than the upper limit time, in the subsequent step S56, the terminal control unit 161 cancels the standby state in which the reading process can be performed. That is, if the terminal control unit 161 does not read information by the reading process until the upper limit time elapses after the wearable terminal 16 starts and transitions to the standby state, the terminal control unit 161 Is released. Similarly, the terminal control unit 161 also executes the above-described setting item setting process in step S541, and when the information is not read by the reading process until the upper limit time elapses. Release the standby state. Accordingly, the terminal control unit 161 can automatically end the setting process in the setting process on condition that no information is read from the code information within the upper limit time. Even if the contents of the setting items are not set, it is not necessary to operate the wearable terminal 16 by hand.
  • the terminal control unit 161 includes an unset item that is not set based on information read by the reading process in the standby state in one or a plurality of the set items that can be set for the wearable terminal 16. If it exists, the unset item is set based on the history stored in the storage unit 173. Specifically, the terminal control unit 161 sets the contents of the unset items to the latest history state stored in the storage unit 173. The terminal control unit 161 accumulates the history of the setting items set in the past in the wearable terminal 16 in the storage unit 173 and stores the history in the storage unit 173, or the latest information on each of the setting items. It can be considered that only the history is stored in the storage unit 173.
  • step S58 the terminal control unit 161 starts the display control process (see FIG. 7). Thereby, in the wearable terminal 16, the contents of each work process of the mixed injection work are sequentially displayed on the terminal display unit 162, and the mixed injection work by the worker is supported. At this time, in the display control process, the terminal control unit 161 causes the terminal display unit 162 to display the contents of each work process according to the setting contents of each of the setting items set in the setting process.
  • the wearable terminal 16 transitions to the standby state upon activation, and the contents of the setting items are set based on information read by the reading process. It is possible to set one or a plurality of the setting items without an operator performing an operation with his / her hand.
  • the terminal control unit 161 determines the type of the setting item corresponding to the information and sets the content of the setting item.
  • the configuration in which the plurality of setting items can be set in an arbitrary order has been described.
  • the terminal control unit 161 displays a screen for prompting reading of the code information for a plurality of preset setting items in a preset order, and indicates the contents of the setting items corresponding to the display.
  • Another embodiment is also conceivable in which the contents of each of the setting items are sequentially set by sequentially reading information from the code information.
  • the type of the setting item is not limited to the display mode and the connection destination, and may be various setting items related to the operation of the wearable terminal 16 or the mixed injection control unit 11.
  • the mixed injection support system 1 includes a plurality of imaging units
  • the imaging unit used in the imaging process such as the solution imaging process or the chemical imaging process included in the mixed injection operation is selected from the plurality of imaging units.
  • the setting for doing this is considered as an example of the setting item.
  • the mixed injection support system 1 is fixed together with the operation display unit 12 and the first reading unit 13 in addition to the photographing unit 163 of the wearable terminal 16, or is fixed to the safety cabinet 100 It may be possible to provide a fixed photographing unit used in the above.
  • the terminal control unit 161 selects either the photographing unit 163 or the fixed photographing unit as a photographing unit to be used in the photographing process based on information read from the code information. It is possible.
  • the display content of each work process included in the mixed injection work can be changed according to the skill level of the worker or the preference of the worker.
  • the terminal control unit 161 includes a simple mode for simply displaying the contents of the work process for the work process, and a detailed mode for displaying the details of the work process for the work process in detail. It is conceivable to switch between the simple mode and the detailed mode according to the information read in the reading process. In this case, the setting for switching between the simple mode and the detailed mode is considered as an example of the setting item.
  • the extraction step such as the dissolution solution extraction step or the chemical solution extraction step
  • the detailed mode when it is necessary to extract the dissolution solution or the chemical solution in a plurality of extraction steps with the syringe specified in the preparation data, the detailed mode Then, the extraction amount corresponding to each of the extraction steps is sequentially displayed on the terminal display screen D2, and the total extraction amount is displayed on the terminal display screen D2 in the simple mode.
  • a measurement process such as the dissolution liquid measurement process or the chemical liquid measurement process
  • a sampling display screen that prompts the syringe to extract the dissolution liquid or the chemical liquid to be measured in the measurement process with a syringe. It is conceivable that the weighing screen is displayed after the display, and in the simple mode, the weighing screen is displayed without displaying the sampling display screen.
  • the mixed injection control unit 11 can switch between enabling and disabling the medicine image display function according to the information read in the reading process in the setting process. That is, it can be considered that the setting for switching between valid and invalid of the medicine image display function is an example of the setting item.

Abstract

The purpose of the present invention is to provide a mixed injection assistance system with which the operation efficiency of a mixed injection operation can be increased. The mixed injection assistance system (1) is provided with: a terminal display unit (162); and a terminal control unit (161) which causes the terminal display unit (162) to successively display information about operation steps included in a drug mixed injection operation. The terminal control unit (161), when the information about a specific one of the operation steps that has been set in advance is displayed, causes the terminal display unit (162) to only display, as the information about the specific operation step, the content, operation amount, and object of operation of the operation step.

Description

混注支援システムMixed injection support system



本発明は、抗がん剤のような薬品の混注作業を支援する混注支援システムに関する。


The present invention relates to a mixed injection support system that supports mixed injection work of drugs such as anticancer agents.





病院又は薬局では、抗がん剤のような薬品を生理食塩液のような溶解液に混合する混注作業が薬剤師によって行われる。このとき、混注作業に必要な情報を表示装置に表示することにより、その混注作業を行う薬剤師を支援する混注支援システムが使用されることがある（例えば特許文献１参照）。


In hospitals or pharmacies, a pharmacist performs a mixed injection operation in which a drug such as an anticancer drug is mixed with a solution such as physiological saline. At this time, a mixed injection support system that supports a pharmacist performing the mixed injection work by displaying information necessary for the mixed injection work on a display device may be used (for example, see Patent Document 1).





特開２００７－２６０３９０号公報JP 2007-260390 A 特開２００６－１２２８１６号公報JP 2006-122816 A



ところで、混注支援システムにおいて、混注作業に必要な情報として多くの情報が表示装置に表示されると、薬剤師が混注作業における作業工程ごとに、必要な情報と不要な情報とを取捨選択しながら情報を整理する必要があり作業効率が低下する。


By the way, in a mixed injection support system, when a lot of information is displayed on the display device as information necessary for mixed injection work, the pharmacist selects information necessary and unnecessary information for each work process in the mixed injection work. It is necessary to sort out the work efficiency.





本発明の目的は、混注作業の作業効率を向上させることのできる混注支援システムを提供することにある。


An object of the present invention is to provide a mixed injection support system capable of improving the work efficiency of mixed injection work.





本発明に係る混注支援システムは、表示部と、薬品の混注作業に含まれる各作業工程の情報を前記表示部に順次表示させる制御部とを備える。そして、前記制御部が、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際に、前記特定の作業工程の情報として作業工程の内容、作業量、及び作業対象のみを前記表示部に表示させる。


The co-infusion support system according to the present invention includes a display unit and a control unit that sequentially displays information on each work process included in the co-infusion operation of medicine on the display unit. When the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are used as the information on the specific work process. Display on the display.





また、本発明の他の形態に係る混注支援システムは、表示部と、薬品の混注作業に含まれる各作業工程の情報を前記表示部に順次表示させる制御部とを備える。そして、前記制御部が、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際に、前記特定の作業工程の情報として作業工程の内容、作業量、及び作業対象のみを前記表示部に表示させると共に、現在の前記特定の作業工程に予め対応付けられた色を示すステータス領域を前記表示部に表示させる。


A mixed injection support system according to another embodiment of the present invention includes a display unit and a control unit that sequentially displays information on each work process included in the mixed injection operation of the medicine on the display unit. When the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are used as the information on the specific work process. While displaying on a display part, the status area | region which shows the color previously matched with the said specific said work process is displayed on the said display part.





また、本発明の他の形態に係る混注支援システムは、表示部と、薬品の混注作業に含まれる各作業工程の情報を前記表示部に順次表示させる制御部とを備える。そして、前記制御部が、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際に、前記特定の作業工程の情報として作業工程の内容、作業量、及び作業対象のみを前記表示部に表示させると共に、同一の前記特定の作業工程が繰り返し表示される場合には同一の前記特定の作業工程の実施予定数と実施済数とを示す薬品数表示領域を前記表示部に表示させる。


A mixed injection support system according to another embodiment of the present invention includes a display unit and a control unit that sequentially displays information on each work process included in the mixed injection operation of the medicine on the display unit. When the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are used as the information on the specific work process. When the same specific work process is repeatedly displayed, the medicine number display area indicating the number of scheduled executions and the number of completed same specific work processes is displayed on the display unit. Let





また、本発明の他の形態に係る混注支援システムは、表示部と、薬品の混注作業に含まれる各作業工程の情報を前記表示部に順次表示させる制御部とを備える。そして、前記制御部が、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際に、前記特定の作業工程の情報として作業工程の内容、作業量、及び作業対象のみを前記表示部に表示させると共に、前記特定の作業工程について少なくとも進行又は後退を操作するための操作表示領域を前記表示部に表示させる。


A mixed injection support system according to another embodiment of the present invention includes a display unit and a control unit that sequentially displays information on each work process included in the mixed injection operation of the medicine on the display unit. When the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are used as the information on the specific work process. While displaying on a display part, the operation display area | region for operating at least progress or reverse about the said specific work process is displayed on the said display part.





例えば、前記作業工程の内容が、前記作業工程の内容に対応して予め設定されたピクトグラムである。


For example, the content of the work process is a pictogram set in advance corresponding to the content of the work process.





また、前記混注支援システムは、前記表示部を第１表示部として、前記第１表示部よりも画面サイズが大きい第２表示部を更に備えてもよい。この場合、前記制御部が、前記作業工程の情報を前記第２表示部にも表示させるものであって、前記第１表示部に表示される前記作業工程の情報の情報量が前記第２表示部に表示される前記作業工程の情報の情報量よりも少ないことが考えられる。


The mixed injection support system may further include a second display unit having the display unit as a first display unit and a screen size larger than that of the first display unit. In this case, the control unit causes the second display unit to display information on the work process, and the information amount of the work process information displayed on the first display unit is the second display. It is conceivable that the amount of information of the work process displayed on the section is smaller.





また、前記混注支援システムが、前記混注作業の作業者が装着可能なウェアラブル端末を更に備えており、前記第１表示部が、前記ウェアラブル端末に設けられていることが考えられる。さらに、前記混注支援システムは、前記作業工程の情報を音声で読み上げる読上処理部を更に備えてもよい。


Further, it is conceivable that the mixed injection support system further includes a wearable terminal that can be worn by an operator of the mixed injection operation, and the first display unit is provided in the wearable terminal. Furthermore, the mixed injection support system may further include a reading processing unit that reads out the information of the work process by voice.





前記制御部が、前記作業対象が薬品名称である場合、前記薬品名称の規格を除く略称を表示させることが考えられる。特に、前記制御部が、前記作業工程のうち前記薬品を認証する薬品認証工程では前記表示部に前記薬品名称を省略せずに表示させ、前記薬品認証工程の終了後の他の前記作業工程について前記薬品名称を表示する際には前記薬品名称の略称を前記表示部に表示させることが考えられる。


When the said operation target is a chemical | medical agent name, it is possible for the said control part to display the abbreviation except the specification of the said chemical | medical agent name. In particular, the control unit displays the medicine name in the display unit without omitting the medicine name in the medicine authentication process for authenticating the medicine in the work process, and the other work process after the medicine authentication process is finished. When displaying the medicine name, it is conceivable to display the abbreviation of the medicine name on the display unit.





また、前記制御部が、前記作業対象が薬品名称である場合、前記作業対象として薬品画像を表示可能であることが考えられる。また、前記制御部が、前記作業工程の内容、前記作業量、及び前記作業対象が表示される状態と前記薬品画像が表示される状態とを交互に切り替えて表示可能であることが考えられる。さらに、前記混注支援システムが、予め設定された薬品データベースに基づいて前記薬品画像を更新する薬品更新処理部を備えることが考えられる。


Moreover, when the said operation target is a chemical | medical agent name, it is possible that the said control part can display a chemical | medical agent image as said work target. Moreover, it is possible that the said control part can switch and display the state where the content of the said work process, the said work amount, and the said work object are displayed, and the state where the said chemical | medical agent image is displayed alternately. Furthermore, it is conceivable that the mixed injection support system includes a medicine update processing unit that updates the medicine image based on a medicine database set in advance.





また、前記混注支援システムが、前記混注作業の作業者が装着可能であって前記表示部及び撮影部を備えるウェアラブル端末と、前記撮影部で捉えられるコード情報から情報を読み取る読取処理部と、前記読取処理部によって読み取られる情報に基づいて前記ウェアラブル端末に関する設定項目の内容を設定する設定処理部とを備えることが考えられる。


In addition, the mixed injection support system is a wearable terminal that can be worn by an operator of the mixed injection work and includes the display unit and the imaging unit, a reading processing unit that reads information from code information captured by the imaging unit, It is conceivable to include a setting processing unit that sets the contents of the setting items related to the wearable terminal based on information read by the reading processing unit.





特に、前記設定処理部は、前記ウェアラブル端末の起動に伴って、前記読取処理部を前記情報の読み取りが可能な待機状態に遷移させた後、予め設定された第１上限時間の経過前に前記読取処理部によって情報が読み取られた場合は当該情報に基づいて前記ウェアラブル端末に関する設定項目の内容を設定し、前記第１上限時間の経過前に前記読取処理部によって情報が読み取られなかった場合は前記待機状態を解除することが考えられる。


In particular, the setting processing unit transitions the reading processing unit to a standby state in which the information can be read with activation of the wearable terminal, and then before the elapse of a preset first upper limit time. When information is read by the reading processing unit, the contents of the setting items related to the wearable terminal are set based on the information, and when the information is not read by the reading processing unit before the first upper limit time elapses It is conceivable to cancel the standby state.





また、本発明に係る他の形態の混注支援システムは、薬品の混注作業の作業者が装着可能であって表示部及び撮影部を備えるウェアラブル端末と、前記混注作業に含まれる各作業工程の情報を前記表示部に表示させる制御部と、前記撮影部で捉えられるコード情報から情報を読み取る読取処理部と、前記ウェアラブル端末の起動に伴って、前記読取処理部を前記情報の読み取りが可能な待機状態に遷移させた後、予め設定された第１上限時間の経過前に前記読取処理部によって情報が読み取られた場合は当該情報に基づいて前記ウェアラブル端末に関する設定項目の内容を設定し、前記第１上限時間の経過前に前記読取処理部によって情報が読み取られなかった場合は前記待機状態を解除する設定処理部とを備える。


In addition, the mixed injection support system according to another aspect of the present invention includes a wearable terminal that can be worn by a chemical mixed injection worker and includes a display unit and a photographing unit, and information on each work process included in the mixed injection operation. On the display unit, a reading processing unit that reads information from code information captured by the photographing unit, and a standby that enables the reading processing unit to read the information when the wearable terminal is activated. After the transition to the state, when information is read by the reading processing unit before the elapse of a preset first upper limit time, the contents of the setting items related to the wearable terminal are set based on the information, and the first And a setting processing unit for canceling the standby state when information is not read by the reading processing unit before the elapse of one upper limit time.





また、前記設定処理部が、前記第１上限時間内に前記読取処理部によって読み取られた前記情報に基づく前記設定項目の設定後に前記待機状態を維持し、その後、予め設定された第２上限時間以内の間隔で前記読取処理部によって情報が読み取られた場合は当該情報に基づいて前記設定項目の内容を設定して前記待機状態を維持し、前記第２上限時間の経過前に前記読取処理部によって情報が読み取られなかった場合は前記待機状態を解除することが考えられる。


The setting processing unit maintains the standby state after setting the setting item based on the information read by the reading processing unit within the first upper limit time, and then a preset second upper limit time. If the information is read by the reading processing unit at an interval of within, the content of the setting item is set based on the information to maintain the standby state, and the reading processing unit is set before the second upper limit time has elapsed. If the information is not read by this, it is possible to cancel the standby state.





また、前記設定項目の一つに、前記表示部による表示モード及び前記ウェアラブル端末の接続先のいずれか一方又は両方が含まれることが考えられる。また、前記表示モードが、前記作業者が右目で前記表示部を見る右目モードと前記作業者が左目で前記表示部を見る左目モードとを含むことが考えられる。


One of the setting items may include one or both of a display mode by the display unit and a connection destination of the wearable terminal. Further, the display modes may include a right eye mode in which the worker views the display unit with a right eye and a left eye mode in which the worker views the display unit with a left eye.





また、一つの前記コード情報に、複数の前記設定項目の設定内容についての情報が含まれており、前記設定処理部が、前記読取処理部によって読み取られる情報に基づいて複数の前記設定項目を一挙に設定可能であることが考えられる。


Further, one piece of code information includes information about the setting contents of a plurality of setting items, and the setting processing unit adds a plurality of the setting items at a time based on information read by the reading processing unit. It is conceivable that it can be set.





また、前記混注支援システムが、前記設定処理部によって設定された前記設定項目の履歴を記憶する記憶部を備え、前記設定処理部が、前記設定項目のうち前記待機状態で前記読取処理部によって読み取られる情報に基づいて設定されなかった未設定項目は、前記記憶部に記憶されている前記履歴に基づいて設定することが考えられる。


The mixed injection support system includes a storage unit that stores a history of the setting items set by the setting processing unit, and the setting processing unit reads the setting items in the standby state by the reading processing unit. It is conceivable that an unset item that has not been set based on the information to be set is set based on the history stored in the storage unit.





また、前記混注支援システムが、前記作業者ごとに対応する前記設定項目を記憶する記憶部を備え、前記設定処理部が、前記待機状態で前記読取処理部によって読み取られた情報に前記作業者を識別可能な情報が含まれる場合、当該作業者に対応する前記設定項目を前記記憶部から読み出して設定することが考えられる。


The mixed injection support system includes a storage unit that stores the setting item corresponding to each worker, and the setting processing unit assigns the worker to information read by the reading processing unit in the standby state. When identifiable information is included, the setting item corresponding to the worker may be read from the storage unit and set.



本発明によれば、混注作業の作業効率を向上させることのできる混注支援システムが提供される。


ADVANTAGE OF THE INVENTION According to this invention, the mixed injection assistance system which can improve the work efficiency of mixed injection work is provided.





図１は、本発明の実施形態に係る混注支援システムの一例を示すブロック図である。FIG. 1 is a block diagram showing an example of a mixed injection support system according to an embodiment of the present invention. 図２は、本発明の実施形態に係る混注支援システムの一例を示す外観模式図である。FIG. 2 is a schematic external view showing an example of the mixed injection support system according to the embodiment of the present invention. 図３は、本発明の実施形態に係る混注支援システムで用いられる安全キャビネットの使用状態を示す図である。FIG. 3 is a diagram illustrating a usage state of the safety cabinet used in the mixed injection support system according to the embodiment of the present invention. 図４は、本発明の実施形態に係る混注支援システムのウェアラブル端末の一例を示す外観模式図である。FIG. 4 is a schematic external view illustrating an example of a wearable terminal of the mixed injection support system according to the embodiment of the present invention. 図５は、本発明の実施形態に係る混注支援システムで実行される混注支援処理の手順の一例を説明するフローチャートである。FIG. 5 is a flowchart for explaining an example of the procedure of the mixed injection support process executed by the mixed injection support system according to the embodiment of the present invention. 図６Ａは、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 6A is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention. 図６Ｂは、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 6B is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention. 図７は、本発明の実施形態に係る混注支援システムで実行される表示制御処理の手順の一例を説明するフローチャートである。FIG. 7 is a flowchart for explaining an example of the procedure of the display control process executed in the mixed injection support system according to the embodiment of the present invention. 図８は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 8 is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention. 図９は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 9 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図１０は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 10 is a diagram illustrating an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図１１は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 11 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図１２は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 12 is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention. 図１３は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 13 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図１４は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 14 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図１５は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 15 is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention. 図１６は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 16 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図１７は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 17 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図１８は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 18 is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention. 図１９Ａは、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 19A is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention. 図１９Ｂは、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 19B is a diagram illustrating an example of a display screen displayed in the mixed injection support system according to the embodiment of the present invention. 図１９Ｃは、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 19C is a diagram illustrating an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２０は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 20 is a diagram illustrating an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２１は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 21 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２２は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 22 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２３は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 23 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２４は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 24 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２５Ａは、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 25A is a diagram illustrating an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２５Ｂは、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 25B is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２５Ｃは、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 25C is an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２６は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 26 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２７は、本発明の実施形態に係る混注支援システムで表示される表示画面の一例を図である。FIG. 27 is a diagram showing an example of a display screen displayed by the mixed injection support system according to the embodiment of the present invention. 図２８は、本発明の実施形態に係る混注支援システムで実行される薬品画像更新処理の一例を示すフローチャートである。FIG. 28 is a flowchart illustrating an example of a medicine image update process executed by the mixed injection support system according to the embodiment of the present invention. 図２９は、本発明の実施形態に係る混注支援システムで実行される設定処理の一例を示すフローチャートである。FIG. 29 is a flowchart showing an example of setting processing executed in the mixed injection support system according to the embodiment of the present invention. 図３０Ａは、本発明の実施形態に係る混注支援システムでウェアラブル端末に表示される表示画面の一例を図である。FIG. 30A is a diagram illustrating an example of a display screen displayed on the wearable terminal in the mixed injection support system according to the embodiment of the present invention. 図３０Ｂは、本発明の実施形態に係る混注支援システムでウェアラブル端末に表示される表示画面の一例を図である。FIG. 30B is a diagram showing an example of a display screen displayed on the wearable terminal in the mixed injection support system according to the embodiment of the present invention. 図３０Ｃは、本発明の実施形態に係る混注支援システムでウェアラブル端末に表示される表示画面の一例を図である。FIG. 30C is a diagram showing an example of a display screen displayed on the wearable terminal in the mixed injection support system according to the embodiment of the present invention.



以下添付図面を参照しながら、本発明の実施形態について説明し、本発明の理解に供する。なお、以下の実施形態は、本発明を具体化した一例であって、本発明の技術的範囲を限定する性格のものではない。


Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings for understanding of the present invention. In addition, the following embodiment is an example which actualized this invention, Comprising: The thing of the character which limits the technical scope of this invention is not.





［混注支援システム１］



まず、図１～図４を参照しつつ、前記混注支援システム１の構成について説明する。図１及び図２に示すように、本発明の実施の形態に係る混注支援システム１は、混注制御部１１、操作表示部１２、第１読取部１３、プリンター１４、フットスイッチ部１５、ウェアラブル端末１６、第２読取部２１、及び秤量部２２などを備える。そして、前記混注支援システム１は、医師又は薬剤師などの作業者によって実行される薬品の混注作業の効率化を図るために使用される。


[Mixed injection support system 1]



First, the configuration of the mixed injection support system 1 will be described with reference to FIGS. As shown in FIGS. 1 and 2, the mixed injection support system 1 according to the embodiment of the present invention includes a mixed injection control unit 11, an operation display unit 12, a first reading unit 13, a printer 14, a foot switch unit 15, and a wearable terminal. 16, a second reading unit 21, a weighing unit 22, and the like. The mixed injection support system 1 is used to increase the efficiency of the mixed injection work of medicines performed by an operator such as a doctor or a pharmacist.





具体的に、前記混注作業において、作業者は、薬品容器から注射器で薬液を吸引して、生理食塩液のような溶解液が収容されている輸液バッグに注入する作業を実行することがある。また、前記混注作業において、作業者が、輸液バッグから生理食塩液のような溶解液を注射器で吸引して、粉薬が収容されている薬品容器に注入してその粉薬を溶解させ、その溶解後の薬液を注射器で吸引して輸液バッグに注入する作業を実行することもある。


Specifically, in the mixed injection operation, an operator may perform an operation of sucking a drug solution from a drug container with a syringe and injecting the solution into an infusion bag containing a solution such as physiological saline. Further, in the mixed injection work, an operator sucks a solution such as a physiological saline solution from an infusion bag with a syringe, and injects the solution into a medicine container in which the powder is contained, dissolves the powder, and after the dissolution In some cases, the chemical solution is sucked with a syringe and injected into an infusion bag.





図２に示されるように、前記第２読取部２１及び前記秤量部２２は、作業者が混注作業を行う安全キャビネット１００の作業室１０１内に配置される。一方、前記混注制御部１１、前記操作表示部１２、前記第１読取部１３、前記プリンター１４、前記フットスイッチ部１５、及び前記ウェアラブル端末１６は、前記安全キャビネット１００の作業室外に配置される。


As shown in FIG. 2, the second reading unit 21 and the weighing unit 22 are arranged in a work chamber 101 of a safety cabinet 100 where an operator performs a mixed injection operation. On the other hand, the mixed injection control unit 11, the operation display unit 12, the first reading unit 13, the printer 14, the foot switch unit 15, and the wearable terminal 16 are disposed outside a work room of the safety cabinet 100.





前記安全キャビネット１００は、前面が透明なガラス扉１０２で仕切られた作業室１０１を備える。また、前記ガラス扉１０２は、下方に開放部１０３が形成される位置で支持されており、作業者は前記開放部１０３から前記作業室１０１内にアクセス可能である。なお、前記安全キャビネット１００には、前記作業室１０１内の空気を清浄化して排気するためのＨＥＰＡフィルタを有する空気清浄装置１０４なども設けられている。


The safety cabinet 100 includes a work chamber 101 partitioned by a glass door 102 having a transparent front surface. The glass door 102 is supported at a position where an opening 103 is formed below, and an operator can access the work chamber 101 from the opening 103. The safety cabinet 100 is also provided with an air cleaning device 104 having a HEPA filter for purifying and exhausting the air in the work chamber 101.





そして、図３に示されるように、作業者は、前記開放部１０３から両手を前記作業室１０１内に差し込み、前記作業室１０１内を目視しながら薬品の混注作業を行う。なお、前記混注支援システム１では、高カロリー輸液などの毒性の無い薬品を混注作業する場合、前記安全キャビネット１００に代えて、クリーンベンチなどが用いられることも考えられる。


Then, as shown in FIG. 3, the operator inserts both hands into the work chamber 101 from the opening 103 and performs a chemical injection operation while visually observing the inside of the work chamber 101. In the mixed injection support system 1, when a non-toxic chemical such as a high calorie infusion is mixed, a clean bench or the like may be used instead of the safety cabinet 100.





前記安全キャビネット１００内に設けられる前記第２読取部２１は、前記混注作業で使用する薬品の薬品容器に付されている一次元コード又は二次元コードなどのコード情報を読み取り可能なコード読取装置である。前記二次元コードは、例えばＱＲコード（登録商標）である。前記コード情報には、前記薬品の種類を特定するための識別情報が含まれている。前記第２読取部２１で読み取られる前記コード情報は、前記混注制御部１１に入力される。


The second reading unit 21 provided in the safety cabinet 100 is a code reading device capable of reading code information such as a one-dimensional code or a two-dimensional code attached to a medicine container for a medicine used in the mixed injection operation. is there. The two-dimensional code is, for example, a QR code (registered trademark). The code information includes identification information for specifying the type of the medicine. The code information read by the second reading unit 21 is input to the mixed injection control unit 11.





同じく前記安全キャビネット１００内に設けられる前記秤量部２２は、前記混注作業における各種の計量に用いられる電子天秤である。前記秤量部２２による計量結果は、リアルタイムで前記混注制御部１１に入力される。また、前記秤量部２２は、計量結果が安定したか否かを示す安定情報を前記混注制御部１１に入力する。これにより、前記混注制御部１１では、前記秤量部２２による計量結果及び安定有無などの情報を取得することが可能である。なお、前記混注制御部１１が、前記秤量部２２による計量結果及び安定有無などの情報を能動的に読み出し可能な構成であってもよい。


Similarly, the weighing unit 22 provided in the safety cabinet 100 is an electronic balance used for various types of weighing in the mixed injection work. The measurement result by the weighing unit 22 is input to the mixed injection control unit 11 in real time. Further, the weighing unit 22 inputs stability information indicating whether or not the measurement result is stable to the mixed injection control unit 11. As a result, the mixed injection control unit 11 can acquire information such as the measurement result by the weighing unit 22 and the presence or absence of stability. The mixed injection control unit 11 may be configured to actively read information such as the measurement result by the weighing unit 22 and the presence or absence of stability.





前記混注制御部１１は、ＬＡＮ、ＷＡＮ、インターネット、又はイントラネットなどの通信網を介して無線又は有線で上位システムと通信可能に接続される。前記上位システムは、電子カルテシステム、オーダーリングシステム、又はレセプトシステムなどであり、前記混注制御部１１は、作業者が実行する混注作業の内容を示す調製データ（処方データ）を前記上位システムから取得可能である。


The mixed injection control unit 11 is communicably connected to a host system wirelessly or via a communication network such as a LAN, WAN, Internet, or intranet. The host system is an electronic medical record system, an ordering system, a receipt system, or the like, and the mixed injection control unit 11 acquires preparation data (prescription data) indicating the contents of mixed injection work performed by an operator from the upper system. Is possible.





例えば、前記調製データには、患者情報（患者ＩＤ、患者氏名、身長、体重、体表面積など）、調製日、薬品情報（薬品コード、薬品名など）、用量、レジメン識別情報などが含まれる。前記レジメン識別情報は、例えば療法名（レジメン名）、療法ＩＤ、又はレジメンＩＤなどのレジメン情報を識別可能な情報である。また、前記調製データには、医師情報、薬品容器の種類（薬液入りアンプル、薬液入りバイアル瓶、粉薬入りバイアル瓶、又は輸液バッグなど）、調製内容情報（混注作業に使用する薬品容器、注射器、注射針の種類及び本数等）、及び調製手順情報（作業内容、溶解薬、溶媒、溶解薬量、溶媒量、抜取量）、投薬日、処方箋区分、診療科、病棟などの情報が含まれていてもよい。


For example, the preparation data includes patient information (patient ID, patient name, height, weight, body surface area, etc.), preparation date, drug information (drug code, drug name, etc.), dose, regimen identification information, and the like. The regimen identification information is information that can identify regimen information such as a therapy name (regimen name), a therapy ID, or a regimen ID. In addition, the preparation data includes doctor information, types of chemical containers (such as ampoules with chemicals, vials with chemicals, vials with powders, or infusion bags), preparation information (chemical containers, syringes, Information such as type and number of injection needles) and preparation procedure information (work contents, dissolved drug, solvent, dissolved drug volume, solvent volume, sampling volume), medication date, prescription classification, clinical department, ward, etc. May be.





前記混注制御部１１は、ＣＰＵ１１１、ＲＡＭ１１２、及び記憶部１１３などを有するコンピューターである。前記ＣＰＵ１１１は、各種の演算処理を実行するプロセッサーである。前記ＲＡＭ１１２は揮発性の記憶部であり、前記ＣＰＵが実行する各種の処理の一時記憶メモリー（作業領域）として使用される。前記記憶部１１３は、前記ＣＰＵ１１１に各種の処理を実行させるための制御プログラムなどの情報が記憶されるＨＤＤ又はＳＳＤなどの不揮発性の記憶部である。前記混注制御部１１は、前記ＣＰＵ１１１及び前記ＲＡＭ１１２を用いて、前記記憶部１１３に予め記憶された各種の制御プログラムに従った各種の処理を実行する。


The mixed injection control unit 11 is a computer having a CPU 111, a RAM 112, a storage unit 113, and the like. The CPU 111 is a processor that executes various arithmetic processes. The RAM 112 is a volatile storage unit, and is used as a temporary storage memory (working area) for various processes executed by the CPU. The storage unit 113 is a non-volatile storage unit such as an HDD or an SSD that stores information such as a control program for causing the CPU 111 to execute various processes. The mixed injection control unit 11 uses the CPU 111 and the RAM 112 to execute various processes according to various control programs stored in the storage unit 113 in advance.





前記記憶部１１３には、データ領域、プログラム領域、及びマスター領域などの記憶領域が含まれる。なお、前記記憶部１１３が、ＨＤＤ及び半導体メモリーなどの複数の記憶媒体を備えており、前記データ領域、前記プログラム領域、及び前記マスター領域が複数の記憶媒体に分散して設けられていてもよい。


The storage unit 113 includes storage areas such as a data area, a program area, and a master area. The storage unit 113 may include a plurality of storage media such as an HDD and a semiconductor memory, and the data area, the program area, and the master area may be distributed over a plurality of storage media. .





前記データ領域には、前記上位システムから取得される前記調製データが蓄積して記憶される。なお、前記混注制御部１１では、ユーザー操作に応じて前記調製データを新規登録又は編集することも可能である。また、前記データ領域には、前記調製データに従って作業者によって実行された混注作業の内容を示す履歴データが前記調製データに対応付けて記憶される。例えば、前記履歴データには、前記混注作業の作業者、作業開始時間、作業終了時間、及び前記混注作業の途中で撮影される撮影画像などが含まれる。


In the data area, the preparation data acquired from the host system is accumulated and stored. The mixed injection control unit 11 can also newly register or edit the preparation data in accordance with a user operation. In the data area, history data indicating the contents of mixed injection work performed by an operator according to the preparation data is stored in association with the preparation data. For example, the history data includes a worker of the mixed injection work, a work start time, a work end time, and a photographed image taken during the mixed injection work.





前記プログラム領域には、前記混注制御部１１に後述の混注支援処理（図５参照）などを実行させるための制御プログラムが記憶される。なお、前記プログラム領域には、オペレーティングシステム（ＯＳ）及びブラウザソフトなどのアプリケーションプログラムも記憶されている。


The program area stores a control program for causing the mixed injection control unit 11 to execute a mixed injection support process (see FIG. 5) described later. Note that an application program such as an operating system (OS) and browser software is also stored in the program area.





前記マスター領域には、薬品マスター、患者マスター、病棟マスター、医師マスター、及び薬剤師マスターなどの各種のマスター情報が記憶される。例えば、前記薬品マスターには、薬品ＩＤ、薬品名、薬品コード、薬瓶コード、区分（剤形：散薬、錠剤、水剤、外用薬など）、比重、薬品種（普通薬、抗がん剤、毒薬、麻薬、劇薬、抗精神薬、治療薬など）、配合変化、賦形薬品、注意事項、薬品容器の種別（アンプル、バイアル瓶）、薬品容器単位の薬品の収容量（既定量）、及び薬品容器の重量などの情報が含まれる。なお、前記薬品ＩＤは、ＹＪコード、ＪＡＮコード、又はＲＳＳコードなどの識別コードである。


The master area stores various types of master information such as a medicine master, patient master, ward master, doctor master, and pharmacist master. For example, the medicine master includes a medicine ID, a medicine name, a medicine code, a medicine bottle code, a classification (dosage form: powder, tablet, liquid medicine, topical medicine, etc.), specific gravity, medicine type (ordinary medicine, anticancer agent). , Poisonous drugs, narcotics, powerful drugs, antipsychotics, therapeutic drugs, etc.), formulation changes, excipients, precautions, types of drug containers (ampoules, vials), drug capacity per drug container (predetermined amount), And information such as the weight of the chemical container. The medicine ID is an identification code such as a YJ code, JAN code, or RSS code.





前記操作表示部１２は、前記混注制御部１１からの制御指示に従って各種の情報を表示する液晶ディスプレイ又は有機ＥＬディスプレイなどの表示部と、前記混注制御部１１に各種の情報を入力するためにユーザーによって操作される操作部とを備える第２表示部の一例である。作業者から見て、前記操作表示部１２の前記表示部の表示画面のサイズは、後述の前記ウェアラブル端末１６の端末表示部１６２の表示画面のサイズよりも大きい。


The operation display unit 12 includes a display unit such as a liquid crystal display or an organic EL display that displays various information in accordance with a control instruction from the mixed injection control unit 11, and a user for inputting various information to the mixed injection control unit 11. It is an example of a 2nd display part provided with the operation part operated by. When viewed from the operator, the size of the display screen of the display unit of the operation display unit 12 is larger than the size of the display screen of the terminal display unit 162 of the wearable terminal 16 described later.





具体的に、前記操作表示部１２の前記操作部は、前記表示部に表示される各種の操作画面に対するタッチ操作を受け付けるタッチパネルである。なお、前記操作表示部１２は、タブレット端末などであってもよい。また、前記操作部は、前記表示部に表示される各種の操作画面における入力操作を受け付けるキーボード及びマウス（ポインティングデバイス）を含むものであってもよい。さらに、前記操作部は、音声認識により各種情報の入力を受け付ける音声入力装置を含むものであってもよい。


Specifically, the operation unit of the operation display unit 12 is a touch panel that receives touch operations on various operation screens displayed on the display unit. The operation display unit 12 may be a tablet terminal. The operation unit may include a keyboard and a mouse (pointing device) that accept input operations on various operation screens displayed on the display unit. Furthermore, the operation unit may include a voice input device that receives input of various types of information by voice recognition.





前記第１読取部１３は、前記調製データに対応する調製箋などに印刷されている一次元コード又は二次元コードなどのコード情報を読み取り可能なコード読取装置である。前記コード情報には、前記調製データを識別するための識別情報が含まれている。前記第１読取部１３で読み取られる前記コード情報は、前記混注制御部１１に入力される。そして、前記混注制御部１１は、前記第１読取部１３を用いて前記調製箋から読み取られる前記コード情報に基づいて、今回の混注作業の対象となる前記調製データを特定する。具体的に、前記混注制御部１１は、前記コード情報から前記調製データの識別情報を読み取り、前記識別情報に対応する前記調製データを前記記憶部１１３のデータ記憶部１１１から選択する。なお、前記混注制御部１１が、前記コード情報から前記調製データを取得するものであってもよい。


The first reading unit 13 is a code reading device capable of reading code information such as a one-dimensional code or a two-dimensional code printed on a preparation note corresponding to the preparation data. The code information includes identification information for identifying the preparation data. The code information read by the first reading unit 13 is input to the mixed injection control unit 11. And the said mixed injection control part 11 specifies the said preparation data used as the object of this mixed injection operation | work based on the said code information read from the said preparation note using the said 1st reading part 13. FIG. Specifically, the mixed injection control unit 11 reads the identification information of the preparation data from the code information, and selects the preparation data corresponding to the identification information from the data storage unit 111 of the storage unit 113. The mixed injection control unit 11 may acquire the preparation data from the code information.





前記プリンター１４は、前記混注制御部１１によって各種の情報を印刷するために用いられる。例えば、前記混注制御部１１によって実行される前記調製データに対応する前記調製箋の印刷、又は前記調製データに従って実行される前記混注作業の履歴の印刷などに用いられる。


The printer 14 is used by the mixed injection control unit 11 to print various information. For example, it is used for printing the preparation note corresponding to the preparation data executed by the mixed injection control unit 11 or printing the history of the mixed injection work executed according to the preparation data.





前記フットスイッチ部１５は、作業者が前記混注作業の実行中に前記混注制御部１１への操作入力を行うための操作部である。前記フットスイッチ部１５は、第１フットスイッチ１５１、第２フットスイッチ１５２、及び第３フットスイッチ１５３を備える。前記第１フットスイッチ１５１及び前記第２フットスイッチ１５２は、操作対象の項目の選択操作などに用いられ、前記第３フットスイッチ１５３は、操作対象の項目の決定操作などに用いられる。


The foot switch unit 15 is an operation unit for an operator to input an operation to the mixed injection control unit 11 during execution of the mixed injection operation. The foot switch unit 15 includes a first foot switch 151, a second foot switch 152, and a third foot switch 153. The first foot switch 151 and the second foot switch 152 are used for selecting an operation target item, and the third foot switch 153 is used for determining an operation target item.





図１及び図４に示されるように、前記ウェアラブル端末１６は、端末制御部１６１、端末表示部１６２、撮影部１６３、操作ボタン１６４、スピーカー１６５、及びマイク１６６などを備えている。例えば、前記ウェアラブル端末１６は、ウエストユニティス株式会社製の製品名「ＩｎｆｏＬｉｎｋｅｒ（登録商標）」、型番「ＷＵＺ－０１Ａ－ＮＢ０１」のウェアラブルグラスである。また、前記ウェアラブル端末１６は、Ｗｉ－Ｆｉ（登録商標）などの無線ＬＡＮ規格、又はＢｌｕｅｔｏｏｔｈ（登録商標）などの近距離無線通信規格に従って前記混注制御部１１と通信可能である。なお、前記ウェアラブル端末１６には、前記ウェアラブル端末１６に着脱可能であって充電可能な二次電池が設けられており、前記ウェアラブル端末１６は前記二次電池からの供給電力によって稼働する。


As shown in FIGS. 1 and 4, the wearable terminal 16 includes a terminal control unit 161, a terminal display unit 162, a photographing unit 163, operation buttons 164, a speaker 165, a microphone 166, and the like. For example, the wearable terminal 16 is a wearable glass having a product name “InfoLinker (registered trademark)” and a model number “WUZ-01A-NB01” manufactured by West Unitis Co., Ltd. The wearable terminal 16 can communicate with the mixed injection control unit 11 according to a wireless LAN standard such as Wi-Fi (registered trademark) or a short-range wireless communication standard such as Bluetooth (registered trademark). The wearable terminal 16 is provided with a rechargeable secondary battery that can be attached to and detached from the wearable terminal 16, and the wearable terminal 16 is operated by power supplied from the secondary battery.





前記ウェアラブル端末１６は、作業者が装着可能な端末である。具体的に、図４に示されるように、前記ウェアラブル端末１６は、不図示の着脱部材によって、作業者が装着するメガネに着脱可能であって、作業者が片眼で視認する片眼タイプのスマートグラスである。なお、前記ウェアラブル端末１６は、不図示のアタッチメントを介して直接作業者の頭部に装着可能な構成であってもよい。また、前記ウェアラブル端末１６は、メガネと一体構成された所謂ヘッドマウントディスプレイ等であってもよい。さらに、前記ウェアラブル端末１６は、スマートウォッチ又はスマートフォン等のように作業者によって容易に持ち運び可能であり、その作業者が必要に応じて表示情報を確認することが可能なデバイスであればよい。


The wearable terminal 16 is a terminal that can be worn by an operator. Specifically, as shown in FIG. 4, the wearable terminal 16 can be attached to and detached from glasses worn by an operator by a detachable member (not shown), and is a one-eye type that the worker can visually recognize with one eye. Smart glasses. Note that the wearable terminal 16 may be configured to be directly attached to the operator's head via an attachment (not shown). Further, the wearable terminal 16 may be a so-called head mounted display or the like integrally configured with glasses. Furthermore, the wearable terminal 16 may be any device that can be easily carried by an operator, such as a smart watch or a smartphone, and that allows the operator to check display information as necessary.





前記端末制御部１６１は、ＣＰＵ１７１、ＲＡＭ１７２、及び記憶部１７３などを有する。前記ＣＰＵ１７１は、各種の演算処理を実行するプロセッサーである。前記ＲＡＭ１７２は揮発性の記憶部であり、前記ＣＰＵが実行する各種の処理の一時記憶メモリー（作業領域）として使用される。前記記憶部１７３は、前記ＣＰＵ１７１に各種の処理を実行させるための制御プログラムなどの情報が記憶されるＥＥＰＲＯＭ（登録商標）などの不揮発性の記憶部である。前記端末制御部１６１は、前記ＣＰＵ１７１及び前記ＲＡＭ１７２を用いて、前記記憶部１７３に予め記憶された各種の制御プログラムに従って各種の処理を実行する。また、前記記憶部１７３には、後述の表示制御処理（図７参照）において、前記端末表示部１６２に表示される各種の表示画面のレイアウト情報及び画像データなどが記憶されている


The terminal control unit 161 includes a CPU 171, a RAM 172, a storage unit 173, and the like. The CPU 171 is a processor that executes various arithmetic processes. The RAM 172 is a volatile storage unit, and is used as a temporary storage memory (working area) for various processes executed by the CPU. The storage unit 173 is a nonvolatile storage unit such as an EEPROM (registered trademark) in which information such as a control program for causing the CPU 171 to execute various processes is stored. The terminal control unit 161 executes various processes according to various control programs stored in advance in the storage unit 173 using the CPU 171 and the RAM 172. The storage unit 173 stores layout information and image data of various display screens displayed on the terminal display unit 162 in a display control process (see FIG. 7) described later.





前記端末表示部１６２は、前記端末制御部１６１によって制御されることにより各種の情報を表示可能な小型ディスプレイを備える第１表示部の一例である。作業者は、前記端末表示部１６２を直接覗き込むことにより、前記端末表示部１６２による表示情報を視認することが可能である。例えば、前記端末表示部１６２は、数十ｃｍ先に数インチ相当の表示画面が表示されているような感覚を作業者に与えるように情報を表示する。また、前記ウェアラブル端末１６が眼鏡と共に用いられる場合には、前記端末表示部１６２が前記眼鏡のレンズ等に情報を投影させるマイクロディスプレイを有することも他の実施形態として考えられる。


The terminal display unit 162 is an example of a first display unit including a small display capable of displaying various types of information by being controlled by the terminal control unit 161. The operator can view the information displayed on the terminal display unit 162 by looking directly into the terminal display unit 162. For example, the terminal display unit 162 displays information so as to give the operator a feeling that a display screen corresponding to several inches is displayed several tens of centimeters away. Further, when the wearable terminal 16 is used together with glasses, it is also conceivable as another embodiment that the terminal display unit 162 includes a micro display that projects information on a lens or the like of the glasses.





前記撮影部１６３は、前記ウェアラブル端末１６を装着した作業者の視点と同様の画角で写真を撮影することが可能なデジタルカメラである。前記撮影部１６３で撮影される画像又は映像は、前記端末制御部１６１の記憶部１７３に一次記憶されると共に、前記混注制御部１１に送信される。


The photographing unit 163 is a digital camera capable of photographing a photograph at the same angle of view as the viewpoint of the worker wearing the wearable terminal 16. An image or video imaged by the imaging unit 163 is temporarily stored in the storage unit 173 of the terminal control unit 161 and transmitted to the mixed injection control unit 11.





なお、前記混注支援システム１では、前記第１読取部１３及び前記第２読取部２１に代えて、前記端末制御部１６１が、前記撮影部１６３を用いて薬品容器又は調製箋などのコード情報を読み取る機能を有することも考えられる。これにより、前記第１読取部１３及び前記第２読取部２１の一方又は両方を省略することが可能である。


In the mixed injection support system 1, instead of the first reading unit 13 and the second reading unit 21, the terminal control unit 161 uses the photographing unit 163 to provide code information such as a medicine container or a preparation note. It is conceivable to have a reading function. Thereby, one or both of the first reading unit 13 and the second reading unit 21 can be omitted.





前記端末操作部１６４は、作業者が前記ウェアラブル端末１６を直接操作するための電源ボタン等の各種の操作ボタンを含む。前記スピーカー１６５は、予め設定された案内メッセージデータに基づいて音声を再生するために用いられる。前記マイク１６６は、入力される音声を音声信号に変換して前記端末制御部１６１に入力する。なお、前記スピーカー１６５に代えてイヤホン又はスピーカーが装着可能なイヤホン端子が設けられていること、又は前記マイク１６６に代えてマイクが装着可能なマイク端子が設けられていることも考えられる。


The terminal operation unit 164 includes various operation buttons such as a power button for an operator to directly operate the wearable terminal 16. The speaker 165 is used to reproduce sound based on preset guidance message data. The microphone 166 converts input sound into a sound signal and inputs the sound signal to the terminal control unit 161. It is also conceivable that an earphone or an earphone terminal to which a speaker can be attached is provided instead of the speaker 165, or a microphone terminal to which a microphone can be attached instead of the microphone 166.





ところで、このように構成された前記混注支援システム１において、前記混注作業に必要な情報として多くの情報が前記操作表示部１２及び前記端末表示部１６２などの表示装置に表示されると、作業者が混注作業に含まれる作業工程ごとに、必要な情報と不要な情報とを取捨選択しながら情報を整理する必要があり作業効率が低下することがある。これに対し、本実施形態に係る前記混注支援システム１では、混注作業の作業効率を向上させることができる。


By the way, in the mixed injection support system 1 configured as described above, when a lot of information is displayed on the display device such as the operation display unit 12 and the terminal display unit 162 as information necessary for the mixed injection operation, the worker However, for each work process included in the mixed injection work, it is necessary to organize information while selecting necessary information and unnecessary information, which may reduce work efficiency. On the other hand, in the mixed injection support system 1 according to the present embodiment, the work efficiency of the mixed injection work can be improved.





なお、前記混注作業では、作業者によって、例えば薬品認証工程、風袋引き工程、溶解液抜取り工程、溶解液計量工程、溶解液撮影工程、溶解工程、薬液抜取り工程、薬液計量工程、薬液撮影工程、及び混注工程などから必要な作業工程が選択されて順次実行される。


Note that, in the mixed injection work, by an operator, for example, a chemical authentication process, a tare drawing process, a dissolution liquid extraction process, a dissolution liquid measurement process, a dissolution liquid imaging process, a dissolution process, a chemical extraction process, a chemical measurement process, a chemical imaging process, In addition, a necessary work process is selected from the mixed injection process and the like and sequentially executed.





前記薬品認証工程は、前記混注作業で使用する薬品を認証するための工程であり、例えば前記第２読取部２１を用いて薬品の識別情報を読み取る工程である。前記風袋引き工程は、前記混注作業で使用する注射器などの機材のみの重量を予め計量するための工程であり、例えば前記注射器を前記秤量部２２に載置する工程である。


The medicine authentication step is a step for authenticating a medicine used in the mixed injection operation, for example, a step of reading medicine identification information using the second reading unit 21. The taring step is a step for measuring in advance the weight of only the equipment such as a syringe used in the mixed injection operation, for example, a step of placing the syringe on the weighing unit 22.





前記溶解液抜取り工程は、輸液バッグから生理食塩液のような溶解液を注射器で必要量抜き取る工程である。前記溶解液計量工程は、前記溶解液を抜き取った前記注射器の重量を計量するための工程であり、前記注射器を前記秤量部２２に載置する工程である。なお、前記溶解液計量工程において、前記混注制御装置１１は、前記秤量部２２に載置された前記注射器の重量と前記風袋引きで設定された前記注射器の重量との差分を前記溶解液の重量として計量する。前記溶解工程は、薬品が粉薬である場合にその薬品を溶解するための工程であり、前記注射器で抜き取られた溶解液を薬品容器に注入する工程である。


The solution extraction step is a step of extracting a necessary amount of a solution such as physiological saline from an infusion bag with a syringe. The solution measuring step is a step for measuring the weight of the syringe from which the solution is extracted, and is a step of placing the syringe on the weighing unit 22. In the dissolution liquid measuring step, the mixed injection control device 11 calculates the difference between the weight of the syringe placed on the weighing unit 22 and the weight of the syringe set by the tare, and the weight of the dissolution liquid. Weigh as The dissolution step is a step for dissolving the drug when the drug is a powder drug, and is a step of injecting the solution extracted with the syringe into the drug container.





前記溶解液撮影工程は、前記溶解液が抜き取られた前記注射器を前記撮影部１６３で撮影するための工程である。前記薬液抜取り工程は、薬品容器から薬液を注射器で必要量抜き取る工程である。前記薬液計量工程は、前記薬液を抜き取った前記注射器の重量を計量するための工程であり、前記注射器を前記秤量部２２に載置する工程である。なお、前記薬液計量工程においても、前記混注制御装置１１は、前記秤量部２２に載置された前記注射器の重量と前記風袋引きで設定された前記注射器の重量との差分を前記薬液の重量として計量する。前記薬液撮影工程は、前記薬液が抜き取られた前記注射器を前記撮影部１６３で撮影するための工程である。前記混注工程は、前記注射器内の前記薬液を前記輸液バッグに注入する工程である。


The solution photographing step is a step for photographing the syringe from which the solution is extracted by the photographing unit 163. The said chemical | medical solution extraction process is a process of extracting a chemical | medical solution from a chemical | medical agent container with a syringe. The medicinal solution measuring step is a step for measuring the weight of the syringe from which the medicinal solution has been extracted, and is a step of placing the syringe on the weighing unit 22. In the medicinal solution measurement step, the mixed injection control device 11 uses the difference between the weight of the syringe placed on the weighing unit 22 and the weight of the syringe set by the tare as the weight of the medicinal solution. Weigh. The chemical solution photographing step is a step for photographing the syringe from which the chemical solution has been extracted by the photographing unit 163. The mixed injection step is a step of injecting the drug solution in the syringe into the infusion bag.





［混注支援処理］



以下、図５を参照しつつ、前記混注支援システム１において前記混注制御部１１によって実行される混注支援処理について説明する。なお、前記混注支援処理は、例えば前記操作表示部１２を用いて自己のＩＤ及びパスワードなどを入力して前記混注支援システム１にログインした後、前記混注作業を開始する旨の操作が行われた場合に実行される。


[Mixed injection support processing]



Hereinafter, the mixed injection support process executed by the mixed injection control unit 11 in the mixed injection support system 1 will be described with reference to FIG. In the mixed injection support process, for example, an operation for starting the mixed injection work is performed after logging in to the mixed injection support system 1 by inputting its own ID and password using the operation display unit 12. If executed.





＜ステップＳ１１＞



ステップＳ１１において、前記混注制御部１１は、前記混注作業の対象となる前記調製データが選択されたか否かが判断される。具体的に、前記混注制御部１１は、前記第１読取部１３により前記調製データの識別情報が読み取られた場合に、前記識別情報に対応する前記調製データが選択されたと判断する。なお、前記操作表示部１２に表示される調製データ選択画面において、未調整の前記調製データのいずれか一つが選択された場合に前記調製データが選択されたと判断されてもよい。ここで、前記調製データが選択されたと判断されると（Ｓ１１：Ｙｅｓ）、処理がステップＳ１２に移行し、前記調製データが選択されていなければ（Ｓ１１：Ｎｏ）、処理がステップＳ１１で待機する。なお、前記第１読取部１３によって読み取られた識別情報に対応する前記調製データが前記記憶部１１３に記憶されていない場合、又は既に調製済みである場合にはエラーが報知される。


<Step S11>



In step S11, the mixed injection control unit 11 determines whether or not the preparation data to be subjected to the mixed injection operation has been selected. Specifically, the mixed injection control unit 11 determines that the preparation data corresponding to the identification information is selected when the identification information of the preparation data is read by the first reading unit 13. In the preparation data selection screen displayed on the operation display unit 12, it may be determined that the preparation data is selected when any one of the unadjusted preparation data is selected. If it is determined that the preparation data is selected (S11: Yes), the process proceeds to step S12. If the preparation data is not selected (S11: No), the process waits in step S11. . An error is notified when the preparation data corresponding to the identification information read by the first reading unit 13 is not stored in the storage unit 113 or has already been prepared.





＜ステップＳ１２＞



ステップＳ１２において、前記混注制御部１１は、前記ステップＳ１１で選択された前記調製データを前記混注作業の対象として前記操作表示部１２に表示させる。ここに、図６Ａは、前記調製データの内容が表示される混注支援画面Ｄ１の一例を示す図である。図６Ａに示されるように、前記混注支援画面Ｄ１には、前記調製データについて、作業者名（薬剤師名）、鑑査者名、診療科、病棟、服用開始日、医師名、患者名（患者ＩＤ）、年齢、性別、処方内容などが表示されている。また、前記混注支援画面Ｄ１には、前記秤量部２２による計量結果が表示されている。そして、前記混注制御部１１は、前記秤量部２２による計量結果を前記ウェアラブル端末１６にも送信しており、前記計量結果は、前記端末制御部１６１によって必要に応じて前記端末表示部１６２に表示される。


<Step S12>



In step S12, the mixed injection control unit 11 displays the preparation data selected in step S11 on the operation display unit 12 as the target of the mixed injection operation. FIG. 6A is a diagram showing an example of the mixed injection support screen D1 on which the contents of the preparation data are displayed. As shown in FIG. 6A, the mixed injection support screen D1 includes an operator name (pharmacist name), an examiner name, a medical department, a ward, a start date of taking, a doctor name, and a patient name (patient ID) for the preparation data. ), Age, gender, prescription content, etc. are displayed. In addition, on the mixed injection support screen D1, the measurement result by the weighing unit 22 is displayed. The mixed injection control unit 11 also transmits the measurement result from the weighing unit 22 to the wearable terminal 16, and the measurement result is displayed on the terminal display unit 162 by the terminal control unit 161 as necessary. Is done.





＜ステップＳ１３＞



ステップＳ１３において、前記混注制御部１１は、前記調製データに基づいて実行されるべき薬品の混注作業に含まれる各作業工程の情報を前記操作表示部１２及び前記端末表示部１６２に順次表示させる。具体的に、前記混注制御部１１は、前記作業工程の情報を前記操作表示部１２に表示させると共に、前記作業工程の表示要求を前記ウェアラブル端末１６に送信する。前記作業工程の表示要求には、前記作業工程の内容、前記作業量、及び前記作業対象などの情報が含まれる。これにより、前記ウェアラブル端末１６では、前記端末制御部１６１によって、前記作業工程の情報が前記端末表示部１６２に表示される。なお、後述するように、前記端末制御部１６１によって前記端末表示部１６２に順次表示される前記作業工程の情報は、前記混注作業に含まれる複数の前記作業工程のうち次に行われるべき作業工程のみに必要な情報であって、前記作業工程の内容、作業量、作業対象が簡素化された情報である。また、前記ステップＳ１３に代えて、ステップＳ１５、Ｓ１７、Ｓ１９、Ｓ２１、及びＳ２３各々において、前記混注作業のうち現在の前記作業工程の情報が前記端末表示部１６２に表示されてもよい。


<Step S13>



In step S <b> 13, the co-infusion control unit 11 causes the operation display unit 12 and the terminal display unit 162 to sequentially display information on each work process included in the co-infusion operation of the medicine to be executed based on the preparation data. Specifically, the mixed injection control unit 11 displays information on the work process on the operation display unit 12 and transmits a display request for the work process to the wearable terminal 16. The work process display request includes information such as the contents of the work process, the work amount, and the work target. As a result, in the wearable terminal 16, the terminal control unit 161 displays the work process information on the terminal display unit 162. As will be described later, the information on the work process sequentially displayed on the terminal display unit 162 by the terminal control unit 161 is the work process to be performed next among the plurality of work processes included in the mixed injection work. This information is necessary only for the above-mentioned, and is information in which the contents of the work process, the work amount, and the work object are simplified. Moreover, instead of the step S13, in each of the steps S15, S17, S19, S21, and S23, information on the current work process among the mixed injection work may be displayed on the terminal display unit 162.





例えば、前記混注制御部１１は、前記ステップＳ１３が実行されるごとに、前記薬品認証工程、前記風袋引き工程、前記溶解液抜取り工程、前記溶解液計量工程、前記溶解液撮影工程、前記溶解工程、前記薬液抜取り工程、前記薬液計量工程、前記薬液撮影工程、及び前記混注工程などの各種の作業工程の情報を順次表示させる。前記作業工程の情報には、例えば前記作業工程の内容（作業工程の種別）、作業量（抜取り量、注入量）、作業対象（薬品、溶解液、注射器の識別情報）が含まれる。但し、前記混注支援システム１では、後述するように、前記端末表示部１６２に表示される前記作業工程の情報が、前記操作表示部１２に表示される前記作業工程の情報に比べて簡素化されている。


For example, each time the step S13 is executed, the mixed injection control unit 11 performs the medicine authentication step, the tare step, the solution extraction step, the solution measurement step, the solution photographing step, and the dissolution step. , Information on various work processes such as the chemical liquid extraction process, the chemical liquid measurement process, the chemical liquid photographing process, and the mixed injection process are sequentially displayed. The information on the work process includes, for example, the contents of the work process (type of work process), work amount (sampling amount, injection amount), and work target (chemical, solution, syringe identification information). However, in the mixed injection support system 1, as described later, the information on the work process displayed on the terminal display unit 162 is simplified compared to the information on the work process displayed on the operation display unit 12. ing.





なお、ここでは前記混注制御部１１が、前記ウェアラブル端末１６に表示要求を送信することにより、前記端末表示部１６２に前記作業工程の情報を表示させる場合について説明する。一方、前記混注制御部１１が、前記端末表示部１６２を直接制御して前記作業工程の情報を前記端末表示部１６２に表示させる構成であってもよい。


Here, a case will be described in which the mixed injection control unit 11 displays the work process information on the terminal display unit 162 by transmitting a display request to the wearable terminal 16. On the other hand, the mixed injection control unit 11 may directly control the terminal display unit 162 to display the work process information on the terminal display unit 162.





ここに、図６Ｂは、前記ステップＳ１３で操作表示部１２に表示される本体側表示画面Ｄ１１の一例を示す図である。なお、前記本体側表示画面Ｄ１１は、前記混注支援画面Ｄ１の一部として表示され、又は前記混注支援画面Ｄ１に重ねてポップアップ表示される。前記本体表示画面Ｄ１１では、前記混注作業における各作業工程の情報を示す領域として、作業工程領域Ａ１、作業量領域Ａ２、及び作業対象領域Ａ３が表示されている。また、前記本体表示画面Ｄ１１には、現在操作可能な操作項目が表示される操作表示領域Ａ４と、前記本体表示画面Ｄ１１に表示されている前記作業工程の内容のタイトルが文字列で表示されるステータス領域Ａ５とが表示されている。


FIG. 6B is a diagram showing an example of the main body side display screen D11 displayed on the operation display unit 12 in step S13. The main body side display screen D11 is displayed as a part of the mixed injection support screen D1, or is displayed as a pop-up on the mixed injection support screen D1. On the main body display screen D11, a work process area A1, a work amount area A2, and a work target area A3 are displayed as areas indicating information of each work process in the mixed injection work. Further, on the main body display screen D11, an operation display area A4 in which operation items that can be operated at present are displayed, and a title of the content of the work process displayed on the main body display screen D11 is displayed as a character string. A status area A5 is displayed.





前記作業工程領域Ａ１には、前記作業工程の内容が前記作業工程の内容を示す文字列で表示されている。前記作業量領域Ａ２には、前記作業工程における作業量として、薬品数、抜取り量、又は注入量などの数値及び単位が表示されている。前記作業対象領域Ａ３には、前記作業工程で作業の対象となる作業対象を特定するための名称又はコードなどの識別情報が表示される。なお、前記操作表示部１２では、前述したように前記混注支援画面Ｄ１に患者の情報及び前記調製データの詳細情報などが表示されている。そのため、作業者は、前記操作表示部１２の前記混注支援画面Ｄ１及び前記本体側表示画面Ｄ１１などを参照することにより前記混注作業の詳細を確認することも可能である。


In the work process area A1, the contents of the work process are displayed as character strings indicating the contents of the work process. In the work amount area A2, numerical values and units such as the number of medicines, sampling amount, or injection amount are displayed as work amounts in the work process. In the work target area A3, identification information such as a name or a code for specifying a work target to be worked in the work process is displayed. In the operation display unit 12, as described above, patient information, detailed information on the preparation data, and the like are displayed on the mixed injection support screen D1. Therefore, the worker can confirm the details of the mixed injection work by referring to the mixed injection support screen D1 and the main body side display screen D11 of the operation display unit 12.





＜ステップＳ１４＞



ステップＳ１４において、前記混注制御部１１は、現在の作業工程が前記薬品認証工程であるか否かが判断される。ここで、現在の作業工程が前記薬品認証工程であると判断されると（Ｓ１４：Ｙｅｓ）、処理がステップＳ１５に移行し、現在の作業工程が前記薬品認証工程でないと判断されると（Ｓ１４：Ｎｏ）、処理がステップＳ１６に移行する。


<Step S14>



In step S14, the mixed injection control unit 11 determines whether or not the current work process is the medicine authentication process. Here, if it is determined that the current work process is the medicine authentication process (S14: Yes), the process proceeds to step S15, and if it is determined that the current work process is not the medicine authentication process (S14). : No), the process proceeds to step S16.





＜ステップＳ１５＞



ステップＳ１５において、前記混注制御部１１は、前記混注作業で使用する薬品の適否を判定する薬品認証処理を実行する。具体的に、前記混注制御部１１は、前記第２読取部２１による薬品の識別情報の読み取りを待ち受けており、前記薬品の識別情報が読み取られた場合に、前記薬品の識別情報が現在の前記薬品認証工程で読み取られるべき前記調製データ内の薬品の識別情報と一致するか否かを照合する。そして、前記混注制御部１１は、前記薬品の識別情報の照合結果が一致である場合、処理をステップＳ１６に移行させる。なお、前記混注制御部１１は、前記薬品の識別情報の照合結果が不一致である場合、エラーを報知して当該ステップＳ１５を繰り返し実行する。


<Step S15>



In step S15, the mixed injection control unit 11 executes a chemical authentication process for determining whether or not the chemical used in the mixed injection work is appropriate. Specifically, the mixed injection control unit 11 waits for reading of the medicine identification information by the second reading unit 21. When the medicine identification information is read, the medicine identification information is displayed as the current medicine identification information. It is verified whether or not it matches the identification information of the medicine in the preparation data to be read in the medicine authentication process. And the said mixed injection control part 11 makes a process transfer to step S16, when the collation result of the identification information of the said medicine is in agreement. In addition, the said mixed injection control part 11 alert | reports an error and repeatedly performs the said step S15, when the collation result of the identification information of the said chemical | medical agent is inconsistent.





＜ステップＳ１６＞



ステップＳ１６において、前記混注制御部１１は、現在の作業工程が前記風袋引き工程あるか否かが判断される。ここで、現在の作業工程が前記風袋引き工程であると判断されると（Ｓ１６：Ｙｅｓ）、処理がステップＳ１７に移行し、現在の作業工程が前記風袋引き工程でないと判断されると（Ｓ１６：Ｎｏ）、処理がステップＳ１８に移行する。


<Step S16>



In step S <b> 16, the mixed injection control unit 11 determines whether the current work process is the tare process. Here, when it is determined that the current work process is the taring process (S16: Yes), the process proceeds to step S17, and when it is determined that the current work process is not the taring process (S16). : No), the process proceeds to step S18.





＜ステップＳ１７＞



ステップＳ１７において、前記混注制御部１１は、前記混注作業で使用する注射器の重量を設定する風袋引き処理を実行する。具体的に、前記混注制御部１１は、前記秤量部２２への注射器の載置、及び前記秤量部２２による計量値の安定を待ち受けており、前記計量値が安定した場合に前記計量値を前記注射器の風袋引きの重量として前記記憶部１１３に記憶し、処理をステップＳ１８に移行させる。


<Step S17>



In step S <b> 17, the mixed injection control unit 11 performs a taring process for setting the weight of the syringe used in the mixed injection operation. Specifically, the mixed injection control unit 11 waits for placement of the syringe on the weighing unit 22 and stabilization of the measurement value by the weighing unit 22, and when the measurement value is stabilized, the measurement value is The weight is stored in the storage unit 113 as the tare weight of the syringe, and the process proceeds to step S18.





＜ステップＳ１８＞



ステップＳ１８において、前記混注制御部１１は、現在の作業工程が前記溶解液計量工程又は前記薬液計量工程などの計量工程であるか否かが判断される。ここで、現在の作業工程が前記計量工程であると判断されると（Ｓ１８：Ｙｅｓ）、処理がステップＳ１９に移行し、現在の作業工程が前記計量工程でないと判断されると（Ｓ１８：Ｎｏ）、処理がステップＳ１９に移行する。


<Step S18>



In step S <b> 18, the mixed injection control unit 11 determines whether or not the current work process is a measurement process such as the solution measurement process or the chemical measurement process. If it is determined that the current work process is the weighing process (S18: Yes), the process proceeds to step S19, and if it is determined that the current work process is not the weighing process (S18: No). ), The process proceeds to step S19.





＜ステップＳ１９＞



ステップＳ１９において、前記混注制御部１１は、前記計量工程を支援するための処理を実行する。具体的に、前記混注制御部１１は、前記秤量部２２への計量対象物の載置、及び前記秤量部２２による計量値（以下、「実測計量値」と称する）の安定を待ち受けており、前記計量値が安定した場合は前記実測計量値と前記計量対象物の計量目標値との差が予め設定された誤差範囲内であるか否かを判定する。そして、前記混注制御部１１は、前記実測計量値と前記計量目標値との差が前記誤差範囲内であると判定した場合、前記実測計量値を計量結果として前記記憶部１１３に記憶し、処理をステップＳ２０に移行させる。なお、前記混注制御部１１は、前記実測計量値と前記計量目標値との差が前記誤差範囲内でない場合、エラーを報知して当該ステップＳ１９を繰り返し実行する。


<Step S19>



In step S19, the mixed injection control unit 11 executes a process for supporting the measurement process. Specifically, the mixed injection control unit 11 waits for the placement of the weighing object on the weighing unit 22 and the stabilization of the measurement value (hereinafter referred to as “actual measurement value”) by the weighing unit 22, When the measurement value is stable, it is determined whether or not the difference between the actual measurement measurement value and the measurement target value of the measurement object is within a preset error range. When the mixed injection control unit 11 determines that the difference between the measured measurement value and the measurement target value is within the error range, the measured measurement value is stored in the storage unit 113 as a measurement result, and processed. To step S20. If the difference between the measured measurement value and the measurement target value is not within the error range, the mixed injection control unit 11 notifies an error and repeatedly executes step S19.





＜ステップＳ２０＞



ステップＳ２０において、前記混注制御部１１は、現在の作業工程が前記溶解液撮影工程又は前記薬液撮影工程などの撮影工程であるか否かが判断される。ここで、現在の作業工程が前記撮影工程であると判断されると（Ｓ２０：Ｙｅｓ）、処理がステップＳ２１に移行し、現在の作業工程が前記撮影工程でないと判断されると（Ｓ２０：Ｎｏ）、処理がステップＳ２２に移行する。


<Step S20>



In step S20, the mixed injection control unit 11 determines whether the current work process is an imaging process such as the solution imaging process or the chemical imaging process. Here, if it is determined that the current work process is the shooting process (S20: Yes), the process proceeds to step S21, and if it is determined that the current work process is not the shooting process (S20: No). ), The process proceeds to step S22.





＜ステップＳ２１＞



ステップＳ２１において、前記混注制御部１１は、前記ウェアラブル端末１６の前記撮影部１６３に写真撮影を実行させるための処理を実行する。具体的に、前記混注制御部１１は、前記フットスイッチ部１５を用いた前記撮影部１６３による撮影操作を待ち受けており、前記撮影操作が行われた場合に前記ウェアラブル端末１６に撮影要求を送信する。これにより、前記ウェアラブル端末１６では、前記端末制御部１６１によって前記撮影部１６３が制御されて前記撮影部１６３による撮影が実行され、撮影画像が前記混注制御部１１に送信される。そして、前記混注制御部１１は、前記撮影画像を前記操作表示部１２に表示させた後、作業者による確認操作が行われた場合に、前記撮影画像を前記調製データに対応付けて前記記憶部１１３に履歴データとして記憶する。なお、前記混注制御部１１は、作業者により再撮影操作などが行われた場合には、前記撮影要求を再度前記ウェアラブル端末１６に送信することにより、前記撮影部１６３による撮影を再実行させることも可能である。


<Step S21>



In step S <b> 21, the mixed injection control unit 11 executes a process for causing the photographing unit 163 of the wearable terminal 16 to take a picture. Specifically, the mixed injection control unit 11 waits for a photographing operation by the photographing unit 163 using the foot switch unit 15 and transmits a photographing request to the wearable terminal 16 when the photographing operation is performed. . Thereby, in the wearable terminal 16, the photographing unit 163 is controlled by the terminal control unit 161 to perform photographing by the photographing unit 163, and a photographed image is transmitted to the mixed injection control unit 11. The mixed injection control unit 11 displays the photographed image on the operation display unit 12 and then associates the photographed image with the preparation data when the operator performs a confirmation operation. 113 is stored as history data. The mixed injection control unit 11 re-executes photographing by the photographing unit 163 by transmitting the photographing request to the wearable terminal 16 again when a re-photographing operation or the like is performed by an operator. Is also possible.





＜ステップＳ２２＞



ステップＳ２２において、前記混注制御部１１は、現在の作業工程が前記溶解液抜取り工程、前記溶解工程、前記薬液抜取り工程、及び前記混注工程などの他の作業工程であるか否かが判断される。ここで、現在の作業工程が前記他の作業工程であると判断されると（Ｓ２２：Ｙｅｓ）、処理がステップＳ２３に移行し、現在の作業工程が前記他の作業工程ではないと判断されると（Ｓ２２：Ｎｏ）、処理が前記ステップＳ１３に移行する。


<Step S22>



In step S22, the mixed injection control unit 11 determines whether the current operation process is another operation process such as the dissolution liquid extraction process, the dissolution process, the chemical extraction process, and the mixed injection process. . When it is determined that the current work process is the other work process (S22: Yes), the process proceeds to step S23, and it is determined that the current work process is not the other work process. (S22: No), the process proceeds to step S13.





＜ステップＳ２３＞



ステップＳ２３において、前記混注制御部１１は、前記他の作業工程の情報の確認操作を受け付ける確認処理を実行する。具体的に、前記混注制御部１１は、前記作業工程の確認操作を待ち受けており、前記確認操作が行われた場合に、処理をステップＳ２４に移行させる。なお、前記確認操作は、前記操作表示部１２又は前記フットスイッチ部１５を用いて作業者によって行われる。


<Step S23>



In step S23, the mixed injection control unit 11 executes a confirmation process for accepting a confirmation operation for information on the other work process. Specifically, the mixed injection control unit 11 waits for a confirmation operation of the work process, and when the confirmation operation is performed, the process shifts to step S24. The confirmation operation is performed by an operator using the operation display unit 12 or the foot switch unit 15.





＜ステップＳ２４＞



ステップＳ２４において、前記混注制御部１１は、前記調製データに基づく前記混注作業の全ての作業工程が終了したか否かを判断する。ここで、全ての前記作業工程が終了していないと判断されると（Ｓ２４：Ｎｏ）、処理が前記ステップＳ１３に移行して次の作業工程について同様の処理が実行される。なお、全ての前記作業工程が終了したと判断された場合には（Ｓ２４：Ｙｅｓ）、前記調製データについての一連の前記混注支援処理が終了し、処理が前記ステップＳ１１に戻される。


<Step S24>



In step S24, the co-infusion control unit 11 determines whether or not all work processes of the co-infusion work based on the preparation data have been completed. Here, if it is determined that all the work processes are not completed (S24: No), the process proceeds to step S13, and the same process is executed for the next work process. If it is determined that all the work steps have been completed (S24: Yes), the series of mixed injection support processing for the preparation data is completed, and the processing is returned to step S11.





このように、前記混注支援処理では、前記調製データに基づいて前記混注作業に必要な作業工程が順次表示されるため、作業者がその表示に従って順に前記作業工程を進めることが可能である。そして、前記混注制御システム１では、以下に説明するように、前記混注支援処理によって作業者による前記混注作業が支援される際に作業者が参照する前記ウェアラブル端末１６の前記端末表示部１６２の表示画面から不要な情報が排除されている。


In this way, in the mixed injection support process, work steps necessary for the mixed injection work are sequentially displayed based on the preparation data, so that an operator can proceed with the work steps in order according to the display. In the mixed injection control system 1, as described below, the display of the terminal display unit 162 of the wearable terminal 16 referred to by the worker when the mixed injection operation by the worker is supported by the mixed injection support process. Unnecessary information is excluded from the screen.





［表示制御処理］



続いて、図７を参照しつつ、前記ウェアラブル端末１６の前記端末制御部１６１によって実行される表示制御処理について説明する。なお、前記表示制御処理は、例えば前記ウェアラブル端末１６の電源が投入されており、前記混注制御部１１の電源が投入されている場合に実行される。なお、前記表示制御処理は、前記混注制御部１１によって実行されてもよい。


[Display control processing]



Next, a display control process executed by the terminal control unit 161 of the wearable terminal 16 will be described with reference to FIG. The display control process is executed when, for example, the wearable terminal 16 is turned on and the mixed injection control unit 11 is turned on. The display control process may be executed by the mixed injection control unit 11.





＜ステップＳ３１＞



ステップＳ３１において、前記端末制御部１６１は、前記混注制御部１１からの前記作業工程の表示要求（前記ステップＳ１３）が行われたか否かを判断する。ここで、前記作業工程の表示要求が行われたと判断した場合（Ｓ３１：Ｙｅｓ）、処理はステップＳ３２に移行し、前記作業工程の表示要求が行われていないと判断した場合（Ｓ３１：Ｎｏ）、処理はステップＳ３３に移行する。


<Step S31>



In step S31, the terminal control unit 161 determines whether or not the work process display request (the step S13) from the mixed injection control unit 11 has been made. If it is determined that a display request for the work process has been made (S31: Yes), the process proceeds to step S32, and if it is determined that a display request for the work process has not been made (S31: No). The process proceeds to step S33.





＜ステップＳ３２＞



ステップＳ３２において、前記端末制御部１６１は、前記作業工程の表示要求に応じて、前記混注作業に含まれる各作業工程の情報を示す端末表示画面Ｄ２を前記端末表示部１６２に順次表示させる。前記作業工程の表示要求には、前述したように前記作業工程の内容、前記作業量、及び前記作業対象などの情報が含まれる。ここで、前記端末制御部１６１は、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際には、前記特定の作業工程の情報として前記作業工程の内容（作業工程の種別）、前記作業量、及び前記作業対象のみを前記端末表示部１６２の前記端末表示画面Ｄ２に表示させる。本実施形態において、前記特定の作業工程は、前記薬品認証工程、前記溶解液抜取り工程、前記溶解工程、前記薬液抜取り工程である。


<Step S32>



In step S32, the terminal control unit 161 causes the terminal display unit 162 to sequentially display a terminal display screen D2 indicating information on each work process included in the mixed injection work in response to the work process display request. As described above, the work process display request includes information such as the contents of the work process, the work amount, and the work target. Here, when the terminal control unit 161 displays information on a specific work process set in advance among the work processes, the content of the work process (type of work process) as the information on the specific work process. ), Only the work amount and the work target are displayed on the terminal display screen D2 of the terminal display unit 162. In the present embodiment, the specific work steps are the chemical authentication step, the dissolved solution extraction step, the dissolution step, and the chemical solution extraction step.





また、前記端末制御部１６１は、前記端末表示画面Ｄ２を前記端末表示部１６２に表示させる際、前記端末表示画面Ｄ２に表示される前記作業工程の情報を音声で読み上げる。ここに、前記読み上げ処理を実行するときの前記端末制御部１６１が読上処理部の一例である。これにより、作業者は、視覚だけでなく聴覚によっても前記作業工程の情報を認識することができ、前記作業工程の人為的ミスが抑制される。なお、前記作業工程の情報の音声による読み上げは、前記作業工程の情報のうち前記作業工程の内容、前記作業量、及び前記作業対象のいずれか一つ又は複数であってよい。例えば、前記端末制御部１６１の記憶部１７３に、前記作業工程の内容ごとに対応して、前記作業工程の内容が読み上げられた音声データが予め記憶されており、前記端末制御部１６１は、前記作業工程の内容に対応する前記音声データを前記スピーカー１６５によって再生させる。なお、前記音声による前記作業工程の情報の読み上げは省略されてもよい。


In addition, when the terminal display screen D2 is displayed on the terminal display unit 162, the terminal control unit 161 reads out information on the work process displayed on the terminal display screen D2 by voice. Here, the terminal control unit 161 when executing the reading process is an example of the reading process unit. Thereby, the worker can recognize the information of the work process not only visually but also by hearing, and an artificial mistake in the work process is suppressed. Note that the voice reading of the information on the work process may be any one or more of the contents of the work process, the work amount, and the work target in the information on the work process. For example, in the storage unit 173 of the terminal control unit 161, voice data that reads out the content of the work process is stored in advance corresponding to the content of the work process, and the terminal control unit 161 The audio data corresponding to the content of the work process is reproduced by the speaker 165. It should be noted that the reading of information on the work process by the voice may be omitted.





ここに、図８は、前記作業工程が前記薬品認証工程である場合における前記端末表示画面Ｄ２の一例を示す図である。なお、前記薬品認証工程が本発明における特定の作業工程の一例である。図８に示されるように、前記端末表示画面Ｄ２には、前記混注作業における各作業工程の情報を示す領域として、作業工程領域Ａ１１、作業量領域Ａ１２、及び作業対象領域Ａ１３のみが表示されている。また、前記端末表示画面Ｄ２には、前記作業工程の情報とは別に操作表示領域Ａ１４及びステータス領域Ａ１５が表示されている。そして、図６Ａ及び図８に示されるように、前記端末表示部１６２に表示される前記作業工程の情報の情報量は、前記操作表示部１２に表示される前記作業工程の情報の情報量よりも少ない。


FIG. 8 is a diagram showing an example of the terminal display screen D2 when the work process is the medicine authentication process. In addition, the said chemical | medical agent certification | authentication process is an example of the specific work process in this invention. As shown in FIG. 8, only the work process area A11, the work amount area A12, and the work target area A13 are displayed on the terminal display screen D2 as areas indicating information of each work process in the mixed injection work. Yes. Further, an operation display area A14 and a status area A15 are displayed on the terminal display screen D2 separately from the work process information. 6A and 8, the information amount of the work process information displayed on the terminal display unit 162 is larger than the information amount of the work process information displayed on the operation display unit 12. There are few.





前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１及び前記作業量領域Ａ１２が上段において左右に並べて表示され、それらの下段に前記作業対象領域Ａ１３が表示されている。なお、前記作業工程領域Ａ１１、前記作業量領域Ａ１２、及び前記作業対象領域Ａ１３各々の背景色は、相互に異なる予め設定された色で表示されている。また、前記操作表示領域Ａ１４は、前記作業対象領域Ａ１３の下段に表示されており、前記ステータス領域Ａ１５は、前記作業工程領域Ａ１１及び前記作業対象領域Ａ１３の左側に表示されている。


In the terminal display screen D2, the work process area A11 and the work amount area A12 are displayed side by side in the upper stage, and the work target area A13 is displayed in the lower stage. The background colors of the work process area A11, the work amount area A12, and the work target area A13 are displayed in different preset colors. The operation display area A14 is displayed in the lower part of the work target area A13, and the status area A15 is displayed on the left side of the work process area A11 and the work target area A13.





前記作業工程領域Ａ１１には、前記作業工程の内容をイラストなどで示すピクトグラムが前記作業工程の内容として表示されている。具体的に、前記ウェアラブル端末１６の前記記憶部１７３には、前記作業工程の内容ごとに対応して予め設定されたピクトグラムの画像データが記憶されている。そして、前記端末制御部１６１は、前記作業工程の表示要求に応じて前記作業工程の内容に対応する前記ピクトグラムの画像データを前記記憶部１７３から読み出して前記ピクトグラムを前記作業工程領域Ａ１１に表示させる。これにより、作業者は、前記作業工程領域Ａ１１を参照することにより、前記作業工程の内容を直感的に認識することが可能である。


In the work process area A11, a pictogram showing the contents of the work process with an illustration or the like is displayed as the contents of the work process. Specifically, the storage unit 173 of the wearable terminal 16 stores pictogram image data set in advance corresponding to the contents of the work process. Then, the terminal control unit 161 reads the pictogram image data corresponding to the content of the work process from the storage unit 173 in response to the display request of the work process, and displays the pictogram in the work process area A11. . Thereby, the worker can intuitively recognize the contents of the work process by referring to the work process area A11.





また、前記作業量領域Ａ１２には、前記作業工程における作業量として、薬品数、抜取り量、又は注入量などの数値及び単位が表示される。具体的に、前記作業量は、前記薬品認証工程では認証の必要がある薬品数であり、前記溶解液抜取り工程又は前記薬液抜取り工程では抜き取り量であり、前記溶解工程では注入量である。


In the work amount area A12, numerical values and units such as the number of medicines, sampling amount, or injection amount are displayed as the work amount in the work process. Specifically, the work amount is the number of chemicals that need to be authenticated in the chemical certification process, is a withdrawal quantity in the dissolution liquid extraction process or the chemical extraction process, and is an injection quantity in the dissolution process.





前記作業対象領域Ａ１３には、前記作業工程で作業の対象となる作業対象を特定するための名称又はコードなどの識別情報が表示される。より具体的に、前記作業対象が薬品である場合には、その薬品の名称又は略称が前記識別情報として表示され、前記作業対象が注射器である場合には、その注射器の名称又は略称が前記識別情報として表示され、前記作業対象が溶解液である場合には、その溶解液の名称又は略称が前記識別情報として表示される。特に、前記ウェアラブル端末１６では、前記作業対象領域Ａ１３に表示される作業対象の識別情報は、予め設定された文字サイズ以上となる範囲で予め設定されている。なお、前記識別情報が、前記作業対象領域Ａ１３に前記文字サイズ以上で表示できない場合には、前記作業対象領域Ａ１３において前記識別情報がスクロール表示されることも考えられる。


In the work target area A13, identification information such as a name or a code for specifying a work target to be worked in the work process is displayed. More specifically, when the work target is a medicine, the name or abbreviation of the medicine is displayed as the identification information, and when the work target is a syringe, the name or abbreviation of the syringe is the identification. When the work target is a solution, the name or abbreviation of the solution is displayed as the identification information. In particular, in the wearable terminal 16, work target identification information displayed in the work target area A13 is set in advance in a range that is equal to or larger than a preset character size. If the identification information cannot be displayed in the work target area A13 with the character size or larger, the identification information may be scrolled in the work target area A13.





このように、前記端末表示画面Ｄ２では、前記作業工程の情報として、前記作業工程の内容、前記作業量、及び前記作業対象のみが表示され、前記作業工程の実施に必要な情報を取捨選択する必要がないため、作業者による前記混注作業の作業効率が向上する。


Thus, on the terminal display screen D2, only the contents of the work process, the work amount, and the work object are displayed as the work process information, and information necessary for the execution of the work process is selected. Since this is not necessary, the work efficiency of the mixed injection work by the worker is improved.





また、前記端末表示画面Ｄ２において、前記操作表示領域Ａ１４には、現在操作可能な操作項目が表示される。具体的に、前記操作表示領域Ａ１４には、前記第３フットスイッチ１５３が操作された場合に前記混注制御部１１で受け付けられる操作項目を示す操作領域Ａ１４１が表示されている。また、前記操作表示領域Ａ１４には、前記第１フットスイッチ１５１が操作された場合に前記操作領域Ａ１４１に移動して表示される操作項目を示す操作領域Ａ１４２と、前記第２フットスイッチ１５２が操作された場合に前記操作領域Ａ１４１に表示される操作項目を示す操作領域Ａ１４３とが表示されている。


In the terminal display screen D2, operation items that are currently operable are displayed in the operation display area A14. Specifically, in the operation display area A14, an operation area A141 indicating an operation item accepted by the mixed injection control unit 11 when the third foot switch 153 is operated is displayed. In the operation display area A14, an operation area A142 indicating operation items displayed by moving to the operation area A141 when the first foot switch 151 is operated, and the second foot switch 152 are operated. In this case, an operation area A143 indicating operation items displayed in the operation area A141 is displayed.





例えば、図８に示される例では、前記操作領域Ａ１４２に「戻る」、前記操作領域Ａ１４３に「スキップ」、前記操作領域Ａ１４１に「認証」の操作内容が割り当てられている状態が示されている。そして、前記混注制御部１１は、前記第１フットスイッチ１５１が操作された場合は前記操作領域Ａ１４１に「戻る」を表示させ、前記第２フットスイッチ１５２が操作された場合は前記操作領域Ａ１４１に「スキップ」を表示させる。一方、前記第３フットスイッチ１５３が操作された場合、前記混注制御部１１は、前記操作領域Ａ１４１に表示されている「認証」の操作内容に対応する処理を実行する。具体的に、前記薬品認証工程である場合、前記薬品認証処理（Ｓ１５）を開始する。


For example, the example shown in FIG. 8 shows a state in which the operation contents “return” to the operation area A142, “skip” to the operation area A143, and “authentication” to the operation area A141 are assigned. . The mixed injection control unit 11 displays “return” in the operation area A141 when the first foot switch 151 is operated, and displays the operation area A141 when the second foot switch 152 is operated. “Skip” is displayed. On the other hand, when the third foot switch 153 is operated, the mixed injection control unit 11 executes processing corresponding to the operation content of “authentication” displayed in the operation area A141. Specifically, in the case of the medicine authentication process, the medicine authentication process (S15) is started.





また、前記ステータス領域Ａ１５には、前記端末表示画面Ｄ２に表示されている前記作業工程の内容に対応して予め設定された色が表示されている。これにより、作業者は、前記ステータス領域Ａ１５を参照することにより、前記作業工程の内容を容易に認識することが可能である。なお、前記ステータス領域Ａ１５に表示される色は、前記作業工程の内容ごとに個別である場合に限らず、前記作業工程の内容について予め設定されたグループごとに異なる色であってもよい。例えば、前記作業工程の内容が、抜取り又は注入などを伴う作業工程のグループ、計量を伴う作業工程のグループ、撮影を伴う作業工程のグループなどに分類されていることが考えられる。


In the status area A15, a color set in advance corresponding to the contents of the work process displayed on the terminal display screen D2 is displayed. Thereby, the worker can easily recognize the contents of the work process by referring to the status area A15. The color displayed in the status area A15 is not limited to a case where the color is different for each content of the work process, but may be a color which is different for each group set in advance for the content of the work process. For example, it is conceivable that the contents of the work process are classified into a group of work processes involving sampling or injection, a group of work processes involving measurement, a group of work processes involving photographing, and the like.





また、前記ステップＳ３２において、前記端末制御部１６１は、前記端末表示画面Ｄ２を前記端末表示部１６２に表示させると共に、前記端末表示画面Ｄ２に表示される前記作業工程の情報を音声で読み上げてもよい。これにより、作業者は、視覚だけでなく聴覚によっても前記作業工程の情報を認識することができ、前記作業工程の人為的ミスが抑制される。なお、前記作業工程の情報の音声による読み上げは、前記作業工程の情報のうち前記作業工程の内容、前記作業量、及び前記作業対象のいずれか一つ又は複数であってよい。例えば、前記端末制御部１６１の記憶部１７３に、前記作業工程の内容ごとに対応して、前記作業工程の内容が読み上げられた音声データが予め記憶されており、前記端末制御部１６１は、前記作業工程の内容に対応する前記音声データを前記スピーカー１６５によって再生させる。なお、前記音声による前記作業工程の情報の読み上げは省略されてもよい。


In step S32, the terminal control unit 161 displays the terminal display screen D2 on the terminal display unit 162 and reads out the information on the work process displayed on the terminal display screen D2 by voice. Good. Thereby, the worker can recognize the information of the work process not only visually but also by hearing, and an artificial mistake in the work process is suppressed. Note that the voice reading of the information on the work process may be any one or more of the contents of the work process, the work amount, and the work target in the information on the work process. For example, in the storage unit 173 of the terminal control unit 161, voice data that reads out the content of the work process is stored in advance corresponding to the content of the work process, and the terminal control unit 161 The audio data corresponding to the content of the work process is reproduced by the speaker 165. It should be noted that the reading of information on the work process by the voice may be omitted.





＜ステップＳ３３＞



ステップＳ３３において、前記端末制御部１６１は、前記撮影部１６３の撮影要求が行われたか否かが判断される。例えば、前記混注制御部１１は、前記端末表示画面Ｄ２の前記操作領域Ａ１４１に「撮影」が表示されている状態で前記フットスイッチ部１５の前記第３フットスイッチ１５３が操作された場合に、前記端末制御部１６１に前記撮影要求を送信する。


<Step S33>



In step S <b> 33, the terminal control unit 161 determines whether a shooting request from the shooting unit 163 has been made. For example, when the third foot switch 153 of the foot switch unit 15 is operated while the “shooting” is displayed in the operation area A 141 of the terminal display screen D2, the mixed injection control unit 11 The imaging request is transmitted to the terminal control unit 161.





＜ステップＳ３４＞



ステップＳ３４において、前記端末制御部１６１は、前記撮影部１６３による撮影を実行し、前記撮影部１６３で撮影された撮影画像を前記混注制御部１１に送信する。これにより、前記混注制御部１１では、前記混注作業に対応する前記調製データに対応付けて前記撮影画像を履歴データとして前記記憶部１１３に記憶させることが可能である。


<Step S34>



In step S <b> 34, the terminal control unit 161 executes photographing by the photographing unit 163, and transmits a photographed image photographed by the photographing unit 163 to the mixed injection control unit 11. Accordingly, the mixed injection control unit 11 can store the captured image in the storage unit 113 as history data in association with the preparation data corresponding to the mixed injection operation.





以上、説明したように、前記混注支援システム１では、作業者が前記ウェアラブル端末１６の端末表示部１６２に表示される前記端末表示画面Ｄ２を参照することで、前記混注作業の各作業工程を実行することが可能である。特に、前記端末表示画面Ｄ２では、前記混注作業の作業工程各々の情報として、前記作業工程の内容、前記作業量、前記作業対象のみが抽出して表示されている。従って、作業者が前記混注作業に含まれる作業工程ごとに、必要な情報と不要な情報とを取捨選択しながら情報を整理する必要がないため、前記混注作業の作業効率が向上する。


As described above, in the mixed injection support system 1, an operator executes each work process of the mixed injection work by referring to the terminal display screen D <b> 2 displayed on the terminal display unit 162 of the wearable terminal 16. Is possible. In particular, on the terminal display screen D2, only the contents of the work process, the work amount, and the work object are extracted and displayed as information on each work process of the mixed injection work. Therefore, since it is not necessary for the worker to sort out necessary information and unnecessary information for each work process included in the mixed injection work, the work efficiency of the mixed injection work is improved.





［作業工程各々に対応する表示例］



以下、図９～図２４を参照しつつ、前記混注作業に含まれる各作業工程が実行される場合の前記端末表示画面Ｄ２の表示例について説明する。図９～図２４では、右側に前記端末表示部１６２に表示される前記端末表示画面Ｄ２が示されている。また、図９～図２４では、左側には前記端末表示画面Ｄ２が表示されているときに前記操作表示部１２において前記混注支援画面Ｄ１にポップアップ表示される本体表示画面Ｄ１１が示されている。なお、図９～図２４における前記本体表示画面Ｄ１１及び前記端末表示画面Ｄ２の大小関係は図９～図２４に示す比率に限らない。


[Display example corresponding to each work process]



Hereinafter, a display example of the terminal display screen D2 when each work process included in the mixed injection work is executed will be described with reference to FIGS. 9 to 24. FIG. 9 to 24, the terminal display screen D2 displayed on the terminal display unit 162 is shown on the right side. 9 to 24 show a main body display screen D11 pop-up displayed on the mixed injection support screen D1 on the operation display unit 12 when the terminal display screen D2 is displayed on the left side. The size relationship between the main body display screen D11 and the terminal display screen D2 in FIGS. 9 to 24 is not limited to the ratio shown in FIGS.





＜薬品認証工程＞



ここに、図９及び図１０は、前記薬品認証工程に対応する表示例を示す図である。


<Chemical certification process>



9 and 10 are diagrams showing display examples corresponding to the medicine authentication process.





図９に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「認証を行ってください。」の文字列が表示されている。また、前記作業量領域Ａ２には、前記作業量として「本数：０／１」の文字列が表示されている。さらに、前記作業対象領域Ａ３には、前記作業対象として「アリムタ（登録商標）」注射用５００ｍｇ」の文字列が表示されている。


As shown in FIG. 9, on the main body side display screen D11, a character string “Please authenticate” is displayed as the content of the work process in the work process area A1. In the work amount area A2, a character string of “number: 0/1” is displayed as the work amount. Furthermore, in the work target area A3, a character string “Alimta (registered trademark)” 500 mg for injection ”is displayed as the work target.





一方、図９に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記薬品認証工程に対応して予め設定され、前記第２読取部２１を用いて薬品の識別情報をバーコードから読み取る動作を示唆するピクトグラムが表示されている。また、前記作業量領域Ａ１２には、前記作業量として「０／１」の文字列が表示されている。さらに、前記作業対象領域Ａ１３には、前記作業対象である薬品「アリムタ注射用５００ｍｇ」の略称である「５００ｍｇアリム」の文字列が表示されている。


On the other hand, as shown in FIG. 9, in the terminal display screen D <b> 2, the work process area A <b> 11 is set in advance corresponding to the medicine authentication process, and medicine identification information is displayed using the second reading unit 21. A pictogram suggesting reading from the bar code is displayed. In the work amount area A12, a character string “0/1” is displayed as the work amount. Further, the character string “500 mg alim”, which is an abbreviation for the drug “500 mg for alimta injection”, is displayed in the work target area A13.





なお、前記混注作業で他の薬品も使用される場合には、続けて前記他の薬品についても同様に前記本体表示画面Ｄ１１及び前記端末表示画面Ｄ２に前記薬品認証工程に対応する情報が表示される。例えば、図１０では、前記本体表示画面Ｄ１１及び前記端末表示画面Ｄ２において、前記他の薬品についての前記薬品認証工程の情報として、前記作業工程の内容が薬品認証工程であり、前記作業対象がアリムタ注射用１００ｍｇであり、前記作業量が３本である旨が表示されている。


In addition, when other medicines are used in the mixed injection operation, information corresponding to the medicine authentication process is displayed on the main body display screen D11 and the terminal display screen D2 in the same manner for the other medicines. The For example, in FIG. 10, in the main body display screen D11 and the terminal display screen D2, the content of the work process is a medicine authentication process as information of the medicine authentication process for the other medicine, and the work target is an alimta. The fact that the amount is 100 mg for injection and the work amount is 3 is displayed.





＜風袋引き工程＞



ここに、図１１は、前記風袋引き工程に対応する表示例を示す図である。


<Tare process>



FIG. 11 is a diagram showing a display example corresponding to the tare subtraction process.





図１１に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「空シリンジの風袋引きをしてください。」の文字列が表示されている。また、前記作業対象領域Ａ３には、前記作業対象として「５０ｍＬシリンジ－１」の文字列が表示されている。


As shown in FIG. 11, on the main body side display screen D11, a character string “Please tare an empty syringe” is displayed in the work process area A1 as the contents of the work process. In the work target area A3, a character string “50 mL syringe-1” is displayed as the work target.





一方、図１１に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記風袋引き工程に対応して予め設定され、前記風袋引き工程に含まれる計量動作を示唆する天秤の針の動きを示すピクトグラムが表示されている。また、前記端末表示画面Ｄ２では、前記作業対象領域Ａ１３に代えて、前記風袋引き工程の作業対象の識別情報が示される作業対象領域Ａ１３１と、前記秤量部２２による実測の計量値が表示される実測領域Ａ１３２とを含む計量領域Ａ１３０が表示されている。さらに、前記計量領域Ａ１３０には、前記秤量部２２による計量状態が安定したか否かが示される安定表示領域Ａ１６が表示されている。例えば、前記秤量部２２による計量状態が安定していない場合に前記安定表示領域Ａ１６が赤色で表示され、安定した場合には前記安定表示領域Ａ１６が青色で表示させる。


On the other hand, as shown in FIG. 11, in the terminal display screen D2, a balance of the work process area A11 that is set in advance corresponding to the taring process and suggests a weighing operation included in the taring process. A pictogram showing the movement of the needle is displayed. In addition, in the terminal display screen D2, instead of the work target area A13, a work target area A131 in which identification information of the work target of the taring process is shown, and a measured value measured by the weighing unit 22 are displayed. A measurement area A130 including the actual measurement area A132 is displayed. Further, in the weighing area A130, a stable display area A16 is displayed in which whether or not the weighing state by the weighing unit 22 is stabilized is displayed. For example, when the weighing state by the weighing unit 22 is not stable, the stable display area A16 is displayed in red, and when stable, the stable display area A16 is displayed in blue.





＜溶解液抜取り工程＞



ここに、図１２は、前記溶解液抜取り工程に対応する表示例を示す図である。


<Dissolved liquid extraction process>



Here, FIG. 12 is a diagram showing a display example corresponding to the solution extraction step.





図１２に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「溶解液を抜き取ってください。」の文字列が表示されている。また、前記作業量領域Ａ２には、前記作業量として「用量：３２．６ｍＬ」の文字列が表示されている。さらに、前記作業対象領域Ａ３には、前記作業対象として「生理食塩液５００ｍｌ」の文字列が表示されている。


As shown in FIG. 12, on the main body side display screen D11, a character string “please remove the solution” is displayed as the content of the work process in the work process area A1. In the work amount area A2, a character string “Dose: 32.6 mL” is displayed as the work amount. Furthermore, a character string “physiological saline 500 ml” is displayed as the work target in the work target area A3.





一方、図１２に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記溶解液抜取り工程に対応して予め設定され、前記溶解液抜取り工程に含まれる前記注射器のピストンを引いて前記溶解液を抜き取る動作を示唆するピクトグラムが表示されている。また、前記作業量領域Ａ１２には、前記作業量として「抜　３２．６ｍＬ」の文字列が表示されている。さらに、前記作業対象領域Ａ１３には、前記作業対象である薬品「生理食塩液５００ｍｌ」の略称である「５００ｍｌ生食」の文字列が表示されている。


On the other hand, as shown in FIG. 12, in the terminal display screen D2, the piston of the syringe set in advance in the work process area A11 corresponding to the solution extraction process and included in the solution extraction process is displayed. A pictogram suggesting an action of pulling out the solution is displayed. In the work amount area A12, a character string “32.6 mL” is displayed as the work amount. Furthermore, in the work target area A13, a character string “500 ml saline” which is an abbreviation of the drug “physiological saline 500 ml” as the work target is displayed.





＜溶解液計量工程＞



ここに、図１３は、前記溶解液計量工程に対応する表示例を示す図である。


<Dissolution measurement process>



FIG. 13 is a view showing a display example corresponding to the dissolving liquid measuring step.





図１３に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「溶解液を計量してください。」の文字列が表示されている。また、前記作業量領域Ａ２には、前記作業量として「用量：３２．６ｍＬ」の文字列が表示されている。さらに、前記作業対象領域Ａ３には、前記作業対象として「生理食塩液５００ｍｌ」の文字列が表示されている。


As shown in FIG. 13, on the main body side display screen D11, a character string “Please measure the dissolved solution” is displayed in the work process area A1 as the content of the work process. In the work amount area A2, a character string “Dose: 32.6 mL” is displayed as the work amount. Furthermore, a character string “physiological saline 500 ml” is displayed as the work target in the work target area A3.





一方、図１３に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記溶解液計量工程に対応して予め設定され、前記溶解液計量工程に含まれる前記溶解液が吸入された前記注射器の計量動作を示唆するピクトグラムが表示されている。また、前記端末表示画面Ｄ２では、前記作業量領域Ａ１２に代えて、前記前記目標計量値と前記実測計量値とが視覚的に認識可能な態様で示される天秤領域Ａ１２１が表示されている。さらに、前記端末表示画面Ｄ２では、前記作業対象領域Ａ１３に代えて、前記溶解液計量工程の作業対象の目標計量値が示される目標領域Ａ１３３と、前記秤量部２２による実測計量値が表示される実測領域Ａ１３２とを含む計量領域Ａ１３０が表示されている。なお、前記計量領域Ａ１３０には、前記秤量部２２による計量状態が安定したか否かが示される前記安定表示領域Ａ１６も表示されている。


On the other hand, as shown in FIG. 13, in the terminal display screen D2, the work solution area A11 is preset in correspondence with the solution measurement step, and the solution included in the solution measurement step is inhaled. A pictogram indicating the weighing operation of the syringe is displayed. Further, on the terminal display screen D2, instead of the work amount area A12, a balance area A121 is displayed in which the target measurement value and the actual measurement value can be visually recognized. Further, on the terminal display screen D2, instead of the work target area A13, a target area A133 where the target measurement value of the work target of the dissolving liquid measuring step is shown, and the actually measured weight value by the weighing unit 22 are displayed. A measurement area A130 including the actual measurement area A132 is displayed. In the weighing area A130, the stable display area A16 is also displayed, which indicates whether or not the weighing state by the weighing unit 22 is stable.





ここで、図１３に示されるように、前記天秤領域Ａ１２１には、予め設定された間隔で右肩上がりに形成された複数の目盛りが表示されると共に、複数の前記目盛りの中央には前記目標計量値に対応する目盛りが表示されている。なお、前記目盛り各々の間に割り当てられる重量の範囲は中央に近づくほど小さくなっていてもよい。


Here, as shown in FIG. 13, in the balance area A <b> 121, a plurality of scales formed to rise right at predetermined intervals are displayed, and at the center of the plurality of scales, the target The scale corresponding to the measured value is displayed. In addition, the range of the weight allocated between each said scales may become so small that it approaches the center.





前記目標計量値に対応する目盛りは、他の目盛りとは異なる色などの態様で他の目盛りとは区別可能に表示されている。また、前記端末制御部１６１は、前記混注制御部１１から前記秤量部２２による実測計量値をリアルタイムで取得しており、前記天秤領域Ａ１２１において、前記実測計量値を識別可能な色などの態様で表示させる。具体的に、前記天秤領域Ａ１２１では、左側の短い目盛りほど計量値が小さく、右側の長い目盛りほど計量値が大きいことを示している。これにより、作業者は、前記天秤領域Ａ１２１において直感的に前記目標計量値と前記実測計量値とが一致しているか否かを認識することができると共に、一致していない場合にその誤差量を直感的に把握することが可能である。


The scale corresponding to the target measurement value is displayed so as to be distinguishable from the other scales in a form such as a color different from the other scales. In addition, the terminal control unit 161 acquires the actual measurement value obtained by the weighing unit 22 from the mixed injection control unit 11 in real time, and in the balance area A121, the actual measurement value can be identified in a color or the like. Display. Specifically, in the balance area A121, the shorter the left scale, the smaller the measured value, and the longer the right scale, the larger the measured value. Thus, the operator can intuitively recognize whether or not the target measurement value and the actually measured measurement value match in the balance area A121. It is possible to grasp intuitively.





また、前記端末制御部１６１は、前記計量領域Ａ１３１において、前記実測計量値と前記目標計量値との差が予め設定された誤差範囲内であるか否かに応じて前記実測領域Ａ１３２の背景色などの表示態様を変更することが考えられる。具体的に、前記端末制御部１６１は、前記差が前記誤差範囲内でない場合は、前記実測領域Ａ１３２の背景色を赤色などの第１特定色で表示し、前記差が前記誤差範囲内である場合は、前記実測領域Ａ１３２の背景色を前記第１特定色とは異なる白又は青などの第２特定色で表示させる。


In addition, the terminal control unit 161 determines whether the difference between the actual measurement value and the target measurement value is within a preset error range in the measurement area A131. It is conceivable to change the display mode. Specifically, when the difference is not within the error range, the terminal control unit 161 displays the background color of the actual measurement area A132 in a first specific color such as red, and the difference is within the error range. In this case, the background color of the actual measurement area A132 is displayed in a second specific color such as white or blue different from the first specific color.





＜溶解液撮影工程＞



ここに、図１４は、前記溶解液撮影工程に対応する表示例を示す図である。


<Solution photography process>



FIG. 14 is a view showing a display example corresponding to the solution photographing step.





図１４に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「画像を撮影してください。」の文字列が表示されている。また、前記作業対象領域Ａ３には、前記作業対象として「生理食塩液５００ｍｌ」の文字列が表示されている。


As shown in FIG. 14, on the main body side display screen D11, a character string “Please shoot an image” is displayed as the content of the work process in the work process area A1. In the work target area A3, a character string “physiological saline 500 ml” is displayed as the work target.





一方、図１４に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記溶解液撮影工程に対応して予め設定され、前記溶解液撮影工程に含まれる前記撮影部１６３による撮影動作を示唆するカメラ画像を示すピクトグラムが表示されている。また、前記作業対象領域Ａ１３には、前記作業対象である薬品「生理食塩液５００ｍｌ」の略称である「５００ｍｌ生食」の文字列が表示されている。


On the other hand, as shown in FIG. 14, in the terminal display screen D <b> 2, the photographing unit 163 is preset in the work process area A <b> 11 corresponding to the solution photographing process and included in the solution photographing process. A pictogram showing a camera image suggesting a shooting operation is displayed. In the work target area A13, a character string “500 ml saline” which is an abbreviation of the chemical “physiological saline 500 ml” as the work target is displayed.





＜溶解工程＞



ここに、図１５～図１８は、前記溶解工程に対応する表示例を示す図である。


<Dissolution process>



Here, FIG. 15 to FIG. 18 are diagrams showing display examples corresponding to the melting step.





図１５に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「溶解してください。」の文字列が表示されている。また、前記作業量領域Ａ２には、前記作業量として「溶解量：２０ｍＬ」の文字列が表示されている。さらに、前記作業対象領域Ａ３には、前記作業対象として「アリムタ注射用５００ｍｇ」の文字列が表示されている。


As shown in FIG. 15, on the main body side display screen D11, a character string “Please dissolve” is displayed as the content of the work process in the work process area A1. In the work amount area A2, a character string “dissolution amount: 20 mL” is displayed as the work amount. Further, a character string “500 mg for Alimta injection” is displayed as the work target in the work target area A3.





一方、図１５に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記溶解工程に対応して予め設定され、前記溶解工程に含まれる前記注射器内の溶解液を前記薬品容器に注入する動作を示唆するピクトグラムが表示されている。また、前記作業量領域Ａ１２には、前記作業量として「入　２０ｍＬ」の文字列が表示されている。さらに、前記作業対象領域Ａ１３には、前記作業対象である薬品「アリムタ注射用５００ｍｇ」の略称である「５００ｍｇアリム」の文字列が表示されている。


On the other hand, as shown in FIG. 15, in the terminal display screen D <b> 2, the working solution region A <b> 11 is set in advance corresponding to the dissolving step, and the dissolved solution in the syringe included in the dissolving step is used as the medicine. A pictogram suggesting the action of pouring into the container is displayed. In the work volume area A12, a character string “input 20 mL” is displayed as the work volume. Further, the character string “500 mg alim”, which is an abbreviation for the drug “500 mg for alimta injection”, is displayed in the work target area A13.





なお、前記混注作業で他の薬品も使用される場合には、続けて前記他の薬品についても同様に前記本体表示画面Ｄ１１及び前記端末表示画面Ｄ２に前記溶解工程に対応する情報が表示される。例えば、図１６～図１８では、前記本体表示画面Ｄ１１及び前記端末表示画面Ｄ２において、前記他の薬品についての前記溶解工程の情報として、前記作業工程の内容が溶解工程であり、前記作業対象がアリムタ注射用１００ｍｇであり、前記作業量が４．２ｍＬである旨が表示されている。


In addition, when other chemicals are used in the mixed injection operation, information corresponding to the dissolution process is displayed on the main body display screen D11 and the terminal display screen D2 in the same manner for the other chemicals. . For example, in FIGS. 16 to 18, in the main body display screen D11 and the terminal display screen D2, the content of the work process is the dissolution process as information on the dissolution process for the other medicine, and the work target is Alimta injection is 100 mg, and the work volume is displayed as 4.2 mL.





ところで、図１６～図１８に示されるように、同一の薬品が収容されている複数の薬品容器を対象として前記溶解工程が複数回連続して実行される場合には、同一の前記端末表示画面Ｄ２が複数回連続して表示されることになる。具体的に、図１６～図１８に示す例では、「１００ｍｇアリム」に対応する３本の薬品容器に、前記注射器内の溶解液を４．２ｍｌずつ注入して溶解する状況が示されている。これに対し、図１６～図１８に示されるように、同一の薬品について前記溶解工程などの同一の作業工程が複数回繰り返し実行される場合、前記端末制御部１６１は、その作業工程の進捗状況を示すプログレスバーＡ１７を前記端末表示画面Ｄ２に表示させる。前記プログレスバーＡ１７では、長手方向を繰り返し実行される前記作業工程の数で分割した部分領域各々の色などの表示態様が、前記作業工程の終了ごとに順次変更される。これにより、作業者は、前記プログレスバーＡ１７を参照することにより、同一の薬品に対応する同一の作業工程について現在の作業工程の進捗状況を容易に認識することが可能である。なお、前記プログレスバーＡ１７の表示は省略されてもよい。


By the way, as shown in FIGS. 16 to 18, when the dissolution process is continuously performed a plurality of times for a plurality of medicine containers containing the same medicine, the same terminal display screen is displayed. D2 is continuously displayed a plurality of times. Specifically, in the examples shown in FIGS. 16 to 18, the situation is shown in which 4.2 ml of the solution in the syringe is injected into three drug containers corresponding to “100 mg Alim” and dissolved. . On the other hand, as shown in FIG. 16 to FIG. 18, when the same work process such as the dissolution process is repeatedly performed for the same medicine a plurality of times, the terminal control unit 161 determines the progress of the work process. Is displayed on the terminal display screen D2. In the progress bar A17, the display mode such as the color of each partial area divided by the number of the work processes repeatedly executed in the longitudinal direction is sequentially changed at the end of the work process. Thereby, the worker can easily recognize the progress status of the current work process for the same work process corresponding to the same medicine by referring to the progress bar A17. The display of the progress bar A17 may be omitted.





さらに、前記端末制御部１６１は、図１６～図１８に示されるプログレスバーＡ１７に代えて、図１９Ａ～図１９Ｃに示されるように、前記作業工程の数で分割した部分領域各々を明示することが考えられる。例えば、図１９Ａ～図１９Ｃに示されている例では、前記部分領域各々の境界に線分が形成されている。これにより、作業者は、前記部分領域の数及び進捗状況をより正確に把握することが可能である。


Further, the terminal control unit 161 specifies each of the partial areas divided by the number of the work steps as shown in FIGS. 19A to 19C, instead of the progress bar A17 shown in FIGS. Can be considered. For example, in the example shown in FIGS. 19A to 19C, a line segment is formed at the boundary of each of the partial regions. Thereby, the operator can grasp | ascertain the number of the said partial area | regions, and a progress condition more correctly.





＜薬液抜取り工程＞



ここに、図２０及び図２１は、前記薬液抜取り工程に対応する表示例を示す図である。


<Drug removal process>



20 and 21 are diagrams showing display examples corresponding to the chemical liquid extraction step.





図２０に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「抜き取ってください。」の文字列が表示されている。また、前記作業量領域Ａ２には、前記作業量として「用量：２０ｍＬ」の文字列が表示されている。さらに、前記作業対象領域Ａ３には、前記作業対象として「アリムタ注射用５００ｍｇ」の文字列が表示されている。


As shown in FIG. 20, on the main body side display screen D11, a character string “Please extract” is displayed as the content of the work process in the work process area A1. In the work amount area A2, a character string “Dose: 20 mL” is displayed as the work amount. Further, a character string “500 mg for Alimta injection” is displayed as the work target in the work target area A3.





一方、図２０に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記薬液抜取り工程に対応して予め設定され、前記薬液抜取り工程に含まれる前記注射器のピストンを引いて前記薬品容器から薬液を抜き取る動作を示唆するピクトグラムが表示されている。また、前記作業量領域Ａ１２には、前記作業量として「抜　２０ｍＬ」の文字列が表示されている。さらに、前記作業対象領域Ａ１３には、前記作業対象である薬品「アリムタ注射用５００ｍｇ」の略称である「５００ｍｇアリム」の文字列が表示されている。


On the other hand, as shown in FIG. 20, in the terminal display screen D2, the work process area A11 is set in advance corresponding to the chemical solution extraction step, and the piston of the syringe included in the chemical solution extraction step is pulled. A pictogram suggesting the action of extracting the chemical solution from the chemical container is displayed. In the work volume area A12, a character string “20 mL” is displayed as the work volume. Further, the character string “500 mg alim”, which is an abbreviation for the drug “500 mg for alimta injection”, is displayed in the work target area A13.





また、前記混注作業で他の薬品も使用される場合には、続けて前記他の薬品についても同様に前記本体表示画面Ｄ１１及び前記端末表示画面Ｄ２に前記薬液抜取り工程に対応する情報が表示される。例えば、図２１では、前記本体表示画面Ｄ１１及び前記端末表示画面Ｄ２において、前記他の薬品についての前記溶解工程の情報として、前記作業工程の内容が溶解工程であり、前記作業対象がアリムタ注射用１００ｍｇであり、前記作業量が１２ｍＬである旨が表示されている。なお、図２０に示す例では、前記薬液抜取り工程の対象物である「アリムタ注射用１００ｍｇ」については、３本の前記薬品容器から抜き取られることになるが、図２１に示されるように、前記端末表示画面Ｄ２では、３本の前記薬品容器からの薬液抜取り量の合計量が前記作業量領域Ａ１２に表示されている。


In addition, when other chemicals are used in the mixed injection operation, information corresponding to the chemical extraction process is displayed on the main body display screen D11 and the terminal display screen D2 for the other chemicals. The For example, in FIG. 21, in the main body display screen D11 and the terminal display screen D2, the content of the work process is the dissolution process as information on the dissolution process for the other medicine, and the work target is for alimta injection. 100 mg, indicating that the working volume is 12 mL. In the example shown in FIG. 20, “100 mg for Alimta injection”, which is an object of the chemical extraction process, will be extracted from the three chemical containers, but as shown in FIG. On the terminal display screen D2, the total amount of the chemical liquid extracted from the three chemical containers is displayed in the work amount area A12.





＜薬液計量工程＞



ここに、図２２は、前記薬液計量工程に対応する表示例を示す図である。


<Chemical liquid measurement process>



FIG. 22 is a diagram showing a display example corresponding to the chemical liquid measurement step.





図２２に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「計量してください。」の文字列が表示されている。また、前記作業量領域Ａ２には、前記作業量として「用量：３２ｍＬ」の文字列が表示されている。さらに、前記作業対象領域Ａ３には、前記作業対象として「アリムタ注射用」の文字列が表示されている。


As shown in FIG. 22, on the main body side display screen D11, a character string “Please measure” is displayed as the content of the work process in the work process area A1. In the work amount area A2, a character string “Dose: 32 mL” is displayed as the work amount. Further, a character string “Alimta injection” is displayed as the work target in the work target area A3.





一方、図２２に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記薬液計量工程に対応して予め設定され、前記薬液計量工程に含まれる前記薬液が吸入された前記注射器の計量動作を示唆するピクトグラムが表示されている。また、前記端末表示画面Ｄ２では、前記溶解液計量工程と同様に、前記作業量領域Ａ１２に代えて前記天秤領域Ａ１２１が表示されている。さらに、前記端末表示画面Ｄ２では、前記溶解液計量工程と同様に、前記作業対象領域Ａ１３に代えて、前記計量領域Ａ１３０が表示されている。なお、前記計量領域Ａ１３０には、前記秤量部２２による計量状態が安定したか否かが示される前記安定表示領域Ａ１６も表示されている。また、前述したように、前記端末制御部１６１は、前記計量領域Ａ１３１において、前記実測計量値と前記目標計量値との差が予め設定された誤差範囲内であるか否かに応じて前記実測領域Ａ１３２の背景色などの表示態様を変更することが考えられる。


On the other hand, as shown in FIG. 22, in the terminal display screen D2, the work process area A11 is set in advance corresponding to the chemical liquid measurement process, and the chemical liquid included in the chemical liquid measurement process is inhaled. A pictogram indicating the metering action of the syringe is displayed. In the terminal display screen D2, the balance area A121 is displayed instead of the work amount area A12, as in the dissolution liquid measuring step. Further, in the terminal display screen D2, the measurement area A130 is displayed in place of the work target area A13, as in the dissolution liquid measurement step. In the weighing area A130, the stable display area A16 is also displayed, which indicates whether or not the weighing state by the weighing unit 22 is stable. Further, as described above, the terminal control unit 161 determines whether the difference between the actual measurement value and the target measurement value is within a preset error range in the measurement area A131. It is conceivable to change the display mode such as the background color of the area A132.





＜薬液撮影工程＞



ここに、図２３は、前記薬液撮影工程に対応する表示例を示す図である。


<Chemical solution photography process>



FIG. 23 is a diagram showing a display example corresponding to the chemical liquid photographing process.





図２３に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「画像を撮影してください。」の文字列が表示されている。また、前記作業対象領域Ａ３には、前記作業対象として「５０ｍＬシリンジ－１」の文字列が表示されている。


As shown in FIG. 23, on the main body side display screen D11, a character string “Please shoot an image” is displayed in the work process area A1 as the content of the work process. In the work target area A3, a character string “50 mL syringe-1” is displayed as the work target.





一方、図２３に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記薬液撮影工程に対応して予め設定され、前記薬液撮影工程に含まれる前記撮影部１６３による撮影動作を示唆するカメラ画像を示すピクトグラムが表示されている。また、前記作業対象領域Ａ１３には、前記作業対象である薬品「５０ｍＬシリンジ－１」の文字列が表示されている。


On the other hand, as shown in FIG. 23, in the terminal display screen D2, a photographing operation by the photographing unit 163 that is preset in the work process area A11 corresponding to the chemical photographing process and is included in the chemical photographing process. A pictogram showing a camera image suggesting that is displayed. In the work target area A13, the character string “50 mL syringe-1”, which is the work target, is displayed.





＜混注工程＞



ここに、図２４は、前記混注工程に対応する表示例を示す図である。


<Mixed injection process>



FIG. 24 is a view showing a display example corresponding to the mixed injection process.





図２４に示されるように、前記本体側表示画面Ｄ１１では、前記作業工程領域Ａ１に、前記作業工程の内容として「混注してください。」の文字列が表示されている。一方、図２４に示されるように、前記端末表示画面Ｄ２では、前記作業工程領域Ａ１１に、前記混注工程に対応して予め設定され、前記混注工程に含まれる前記注射器内の薬液を前記輸液バッグに注入する動作を示唆するピクトグラムが表示されている。


As shown in FIG. 24, on the main body side display screen D11, a character string “Please mix” is displayed as the content of the work process in the work process area A1. On the other hand, as shown in FIG. 24, in the terminal display screen D2, the medicinal solution in the syringe set in advance in the work process area A11 corresponding to the mixed injection process and included in the mixed injection process is transferred to the infusion bag. A pictogram suggesting the action of injecting is displayed.





以上、説明したように、本実施形態に係る前記混注支援システム１では、前記ウェアラブル端末１６の端末表示部１６２の端末表示画面Ｄ２に、前記混注作業に必要な情報だけが集約されて表示される。そのため、作業者は、前記端末表示画面Ｄ２を参照して前記混注作業を効率的に進めることが可能である。


As described above, in the mixed injection support system 1 according to the present embodiment, only the information necessary for the mixed injection work is displayed on the terminal display screen D2 of the terminal display unit 162 of the wearable terminal 16 in an aggregated manner. . Therefore, the worker can efficiently proceed with the mixed injection work with reference to the terminal display screen D2.





なお、本実施形態では、前記本体側表示画面Ｄ１１と前記端末表示画面Ｄ２とにおいて前記作業工程各々の情報が異なる態様で表示される場合について説明した。一方、前記本体側表示画面Ｄ１１が前記端末表示画面Ｄ２と同一であることも他の実施形態として考えられる。


In addition, in this embodiment, the case where the information of each said work process was displayed on the said main body side display screen D11 and the said terminal display screen D2 in a different aspect was demonstrated. On the other hand, it is also conceivable as another embodiment that the main body display screen D11 is the same as the terminal display screen D2.





また、本実施形態では、前記端末表示画面Ｄ２において、前記混注作業の作業工程の情報として、前記作業工程の内容、前記作業量、及び前記作業対象のみが表示されている。一方、前記端末表示画面Ｄ２では、前記操作表示領域Ａ１４及び前記ステータス領域Ａ１５なども表示されている。


In the present embodiment, only the content of the work process, the work amount, and the work target are displayed as the work process information of the mixed injection work on the terminal display screen D2. On the other hand, on the terminal display screen D2, the operation display area A14, the status area A15, and the like are also displayed.





これに対し、図２５Ａ～図２５Ｃに示されるように、前記端末制御部１６１が、前記操作表示領域Ａ１４及び前記ステータス領域Ａ１５の一方又は両方が省略された前記端末表示画面Ｄ２を表示することも他の実施形態として考えられる。即ち、前記作業工程領域Ａ１１、前記作業量領域Ａ１２、及び前記作業対象領域Ａ１３のみが前記端末表示画面Ｄ２に表示されること、前記作業工程領域Ａ１１、前記作業量領域Ａ１２、前記作業対象領域Ａ１３、及び前記操作表示領域Ａ１４のみが前記端末表示画面Ｄ２に表示されること、前記作業工程領域Ａ１１、前記作業量領域Ａ１２、前記作業対象領域Ａ１３、及び前記ステータス領域Ａ１５のみが前記端末表示画面Ｄ２に表示されることが考えられる。


On the other hand, as shown in FIGS. 25A to 25C, the terminal control unit 161 may display the terminal display screen D2 in which one or both of the operation display area A14 and the status area A15 are omitted. Other embodiments are possible. That is, only the work process area A11, the work quantity area A12, and the work target area A13 are displayed on the terminal display screen D2, the work process area A11, the work quantity area A12, and the work target area A13. Only the operation display area A14 is displayed on the terminal display screen D2, and only the work process area A11, the work amount area A12, the work target area A13, and the status area A15 are displayed on the terminal display screen D2. May be displayed.





さらに、前記端末制御部１６１が、少なくとも前記作業工程領域Ａ１１、前記作業量領域Ａ１２、及び前記作業対象領域Ａ１３を予め設定された一定期間ごとに順次個別に前記端末表示画面Ｄ２に表示させることも考えられる。これにより、前記作業工程領域Ａ１１、前記作業量領域Ａ１２、及び前記作業対象領域Ａ１３各々を前記端末表示画面Ｄ２で大きく表示させることが可能である。


Furthermore, the terminal control unit 161 may cause the terminal display screen D2 to display at least the work process area A11, the work amount area A12, and the work target area A13 individually on the terminal display screen D2 in a predetermined period. Conceivable. Thereby, each of the work process area A11, the work amount area A12, and the work target area A13 can be displayed largely on the terminal display screen D2.





また、前記端末制御部１６１が、前記端末表示画面Ｄ２を表示する際には、前記操作表示領域Ａ１４の表示を省略しておき、前記混注制御部１１が前記フットスイッチ部１５の操作を受け付けた場合に前記混注制御部１１からの入力信号に従って前記操作表示領域Ａ１４を一時的に表示させることも考えられる。さらに、前記端末制御部１６１が、前記端末表示画面Ｄ２を表示してから予め設定された時間が経過するまでの間だけ前記ステータス領域Ａ１５を表示させて、その後に前記ステータス領域Ａ１５の表示を省略させることも考えられる。


Further, when the terminal control unit 161 displays the terminal display screen D2, the operation display area A14 is omitted, and the mixed injection control unit 11 receives an operation of the foot switch unit 15. In some cases, the operation display area A14 may be temporarily displayed in accordance with an input signal from the mixed injection control unit 11. Further, the terminal control unit 161 displays the status area A15 only after the preset time has elapsed after displaying the terminal display screen D2, and thereafter omits the display of the status area A15. It is possible to make it.





また、前記端末制御部１６１が、前記作業対象領域Ａ１３に薬品名称などの識別情報を前記作業対象として表示する場合には、少なくとも前記識別情報から規格が除かれた略称の文字列を表示させることが考えられる。例えば、前記識別情報が「アリムタ注射用５００ｍｇ」である場合に、「アリムタ」又は「アリムタ注射用」などの略称の文字列が表示されることが考えられる。特に、前記端末制御部１６１は、前記作業工程のうち薬品を認証する前記薬品認証工程では前記端末表示部１６２に前記薬品名称を省略せずに表示させ、前記薬品認証工程の終了後の他の前記作業工程について前記薬品名称を表示する際には前記薬品名称の略称を前記端末表示部１６２に表示させることが考えられる。前記作業量領域Ａ１２に前記作業量が表示される前記端末表示画面Ｄ２を表示する際にのみ、前記作業対象領域Ａ１３において前記省略文字が表示されることが考えられる。これにより、前記識別情報に規格として含まれる数字と前記作業量とを誤って認識することが防止される。


Further, when the terminal control unit 161 displays identification information such as a medicine name as the work target in the work target area A13, at least an abbreviated character string from which the standard is removed from the identification information is displayed. Can be considered. For example, when the identification information is “500 mg for Alimta injection”, an abbreviated character string such as “Alimta” or “Alimta injection” may be displayed. In particular, the terminal control unit 161 causes the terminal display unit 162 to display the medicine name without omitting the medicine in the medicine authentication process for authenticating the medicine among the work processes. When displaying the medicine name for the work process, it is conceivable to display the abbreviation of the medicine name on the terminal display unit 162. It is conceivable that the abbreviated characters are displayed in the work target area A13 only when the terminal display screen D2 in which the work quantity is displayed in the work quantity area A12 is displayed. This prevents erroneous recognition of the numbers included in the identification information as standards and the work amount.





［他の機能］



以下、前記混注支援システム１が備える他の機能について説明する。なお、ここで説明する各種の機能は、前記混注支援システム１において、前記混注制御部１１又は前記ウェアラブル端末１６の初期設定などにおいて有効及び無効を切り替え可能である。


[Other functions]



Hereinafter, other functions provided in the mixed injection support system 1 will be described. The various functions described here can be switched between valid and invalid in the mixed injection support system 1 in the initial setting of the mixed injection control unit 11 or the wearable terminal 16.





［薬品画像表示機能］



前記実施形態では、前記端末表示画面Ｄ２において前記薬品名称などの識別情報の文字列が前記作業対象として表示される場合について説明した。一方、前記ウェアラブル端末１６において、前記端末制御部１６１が、前記作業対象として、前記薬品の外観写真又は外観イラストなどの薬品画像Ｐ１を前記端末表示画面Ｄ２に表示する薬品画像表示機能を有することが考えられる。なお、前記薬品画像Ｐ１には、少なくとも前記薬品の種類を識別可能な識別情報が含まれていることが望ましい。


[Chemical image display function]



The said embodiment demonstrated the case where the character string of identification information, such as the said chemical | medical agent name, was displayed on the said terminal display screen D2 as said work object. On the other hand, in the wearable terminal 16, the terminal control unit 161 has a medicine image display function for displaying a medicine image P1 such as an appearance photograph or an appearance illustration of the medicine on the terminal display screen D2 as the work target. Conceivable. In addition, it is desirable that the medicine image P1 includes at least identification information that can identify the kind of the medicine.





具体的に、前記ウェアラブル端末１６では、前記記憶部１７３に、前記ウェアラブル端末１６で表示される薬品各々に対応する前記薬品画像Ｐ１を含む薬品画像マスターが記憶される。なお、前記薬品画像マスターでは、前記薬品各々の識別情報（薬品名、薬品コードなど）と前記薬品画像Ｐ１とが対応付けて記憶されている。これにより、前記端末制御部１６１は、前記作業対象となっている薬品の識別情報に基づいて、前記薬品画像マスターから前記薬品に対応する前記薬品画像Ｐ１を特定することが可能である。


Specifically, in the wearable terminal 16, a medicine image master including the medicine image P1 corresponding to each medicine displayed on the wearable terminal 16 is stored in the storage unit 173. In the medicine image master, identification information (medicine name, medicine code, etc.) of each medicine and the medicine image P1 are stored in association with each other. Thereby, the terminal control unit 161 can specify the medicine image P1 corresponding to the medicine from the medicine image master based on the identification information of the medicine that is the work target.





そして、前記薬品画像表示機能が有効に設定されている場合、前記端末制御部１６１は、前記作業対象領域Ａ１３に表示される前記作業対象が薬品名称である場合、前記端末表示画面Ｄ２（例えば図８など参照）に、前記薬品名称と前記薬品画像Ｐ１とを予め設定された所定時間間隔で交互に表示させる。なお、前記端末制御部１６１が、前記端末表示画面Ｄ２の全体を、前記作業工程の内容、前記作業量、及び前記作業対象が表示される状態と前記薬品画像が表示される状態と、前記薬品画像Ｐ１が表示される状態とを切り替えることも考えられる。即ち、前記薬品画像Ｐ１が前記端末表示画面Ｄ２全体に表示されることが考えられる。また、前記端末制御部１６１が、前記作業対象領域Ａ１３において、前記薬品名称と前記薬品画像Ｐ１とを前記端末表示画面Ｄ２に同時に表示させることも考えられる。


When the medicine image display function is set to be effective, the terminal control unit 161, when the work target displayed in the work target area A13 is a medicine name, the terminal display screen D2 (for example, FIG. 8), the medicine name and the medicine image P1 are alternately displayed at predetermined time intervals. The terminal control unit 161 is configured to display the entire terminal display screen D2 in a state where the contents of the work process, the work amount, and the work target are displayed, and a state where the medicine image is displayed, and the medicine. It is also conceivable to switch the state in which the image P1 is displayed. That is, it is conceivable that the medicine image P1 is displayed on the entire terminal display screen D2. In addition, the terminal control unit 161 may simultaneously display the medicine name and the medicine image P1 on the terminal display screen D2 in the work target area A13.





このように、当該薬品画像表示機能によれば、作業者は、前記作業工程における作業対象の薬品を前記薬品画像Ｐ１によって直感的に認識することが可能となり、前記混注作業の作業効率を高めると共に、前記混注作業の人為的ミスを抑制することが可能である。


As described above, according to the medicine image display function, the operator can intuitively recognize the medicine to be worked in the work process by the medicine image P1, and improve the work efficiency of the mixed injection work. It is possible to suppress human errors in the mixed injection work.





［薬品画像自動更新機能］



ところで、前記混注作業の対象となる薬品として新薬の発売が開始された場合には、その新薬に対応する前記薬品画像Ｐ１を前記薬品画像マスターに登録する必要がある。また、薬品が収容される薬品容器のデザインが変更された場合にも、その薬品に対応する前記薬品画像Ｐ１を変更する必要がある。


[Drug image automatic update function]



By the way, when the sale of a new drug is started as a drug to be subjected to the mixed injection work, it is necessary to register the drug image P1 corresponding to the new drug in the drug image master. Further, even when the design of the medicine container in which the medicine is accommodated is changed, it is necessary to change the medicine image P1 corresponding to the medicine.





これに対し、前記混注制御部１１は、予め設定された薬品データベースに基づいて前記薬品画像Ｐ１を自動的に更新する薬品画像自動更新機能を有することが考えられる。前記薬品データベースは、前記混注制御部１１が前記通信網を介して無線又は有線で通信可能なサーバー装置などに予め記憶されており、前記混注制御部１１は、前記サーバー装置から前記薬品データベースを取得可能である。前記サーバー装置は、例えばインターネット上に設けられたクラウドサーバーなどである。なお、前記薬品データベースは、前記混注制御部１１が備える不図示の読取装置によってＣＤ又はＤＶＤなどの記録媒体から読み取られることも考えられる。


On the other hand, it is conceivable that the mixed injection control unit 11 has a medicine image automatic update function for automatically updating the medicine image P1 based on a medicine database set in advance. The medicine database is stored in advance in a server device or the like that the mixed injection control unit 11 can communicate wirelessly or by wire through the communication network, and the mixed injection control unit 11 acquires the medicine database from the server device. Is possible. The server device is, for example, a cloud server provided on the Internet. The medicine database may be read from a recording medium such as a CD or a DVD by a reading device (not shown) provided in the mixed injection control unit 11.





そして、前記混注制御部１１は、前記薬品データベースに基づいて下記の薬品画像更新処理（図２８参照）を実行することにより、前記薬品画像自動更新機能を実現する。ここに、前記薬品画像更新処理を実行するときの前記混注制御部１１が薬品更新処理部の一例である。なお、前記薬品更新処理は、前記端末制御部１６１によって実行されてもよい。前記混注制御部１１は、例えば前記混注制御部１１の電源投入時、省電力モードからの復帰時、任意の更新開始操作時などに前記薬品画像更新処理を実行する。以下、図２８を参照しつつ、前記薬品画像更新処理の手順の一例について説明する。


And the said mixed injection control part 11 implement | achieves the said medicine image automatic update function by performing the following medicine image update process (refer FIG. 28) based on the said medicine database. Here, the mixed injection control unit 11 when executing the medicine image update process is an example of a medicine update processing part. The medicine update process may be executed by the terminal control unit 161. The mixed injection control unit 11 executes the medicine image update process, for example, when the mixed injection control unit 11 is turned on, when returning from the power saving mode, or when an arbitrary update start operation is performed. Hereinafter, an example of the procedure of the medicine image update process will be described with reference to FIG.





＜ステップＳ４１＞



ステップＳ４１において、前記混注制御部１１は、前記記憶部１１３に記憶されている前記薬品マスターに含まれる薬品各々の識別情報に基づいて、前記薬品データベースにおける前記薬品各々に対応する前記薬品画像Ｐ１の更新日時を取得する。例えば、前記更新日時は、タイムスタンプ情報として前記薬品画像Ｐ１のデータに含まれ、又は、前記薬品データベースに記憶されている。


<Step S41>



In step S41, the co-infusion control unit 11 sets the medicine image P1 corresponding to each medicine in the medicine database based on the identification information of each medicine contained in the medicine master stored in the storage unit 113. Get the update date and time. For example, the update date / time is included in the data of the medicine image P1 as time stamp information or stored in the medicine database.





＜ステップＳ４２＞



ステップＳ４２において、前記混注制御部１１は、前記ウェアラブル端末１６に記憶されている前記薬品画像マスターにおける前記薬品各々に対応する前記薬品画像Ｐ１の更新日時を取得する。例えば、前記更新日時は、タイムスタンプ情報として前記薬品画像Ｐ１のデータに含まれ、又は、前記薬品画像マスターに記憶されている。なお、前記薬品画像マスターは、前記混注制御部１１の記憶部１１３に記憶されていてもよい。


<Step S42>



In step S <b> 42, the mixed injection control unit 11 acquires the update date and time of the medicine image P <b> 1 corresponding to each medicine in the medicine image master stored in the wearable terminal 16. For example, the update date and time is included in the data of the medicine image P1 as time stamp information or stored in the medicine image master. The medicine image master may be stored in the storage unit 113 of the mixed injection control unit 11.





＜ステップＳ４３＞



ステップＳ４３において、前記混注制御部１１は、前記薬品マスターに含まれている前記薬品各々について、前記薬品データベースにおける前記薬品画像Ｐ１の更新日時と前記薬品画像マスターにおける前記薬品画像Ｐ１の更新日時とを比較して差分を検出する。


<Step S43>



In step S43, for each of the medicines included in the medicine master, the mixed injection control unit 11 calculates the update date and time of the medicine image P1 in the medicine database and the update date and time of the medicine image P1 in the medicine image master. The difference is detected by comparison.





＜ステップＳ４４＞



そして、ステップＳ４４において、前記混注制御部１１は、前記ステップＳ４３で検出される差分に基づいて、前記ウェアラブル端末１６の記憶部１７３に記憶されている前記薬品画像マスターを更新する。


<Step S44>



In step S44, the mixed injection control unit 11 updates the medicine image master stored in the storage unit 173 of the wearable terminal 16 based on the difference detected in step S43.





具体的に、前記混注制御部１１は、前記薬品画像マスターに存在しない薬品が前記薬品データベースに存在する場合には、その薬品の前記薬品画像Ｐ１を前記薬品データベースから取得して前記ウェアラブル端末１６に送信する。これにより、前記ウェアラブル端末１６では、前記端末制御部１６１が、前記記憶部１７３の前記薬品画像マスターに前記薬品の識別情報と前記薬品画像Ｐ１とを対応付けて登録する。なお、前記混注制御部１１が、前記ウェアラブル端末１６の記憶部１７３に前記薬品画像Ｐ１を登録可能な構成であってもよい。これにより、前記混注支援システム１では、新薬などに自動的に対応することが可能である。


Specifically, when there is a medicine that does not exist in the medicine image master in the medicine database, the mixed injection control unit 11 acquires the medicine image P1 of the medicine from the medicine database and stores it in the wearable terminal 16. Send. Thereby, in the wearable terminal 16, the terminal control unit 161 registers the medicine identification information and the medicine image P1 in association with the medicine image master of the storage unit 173. The mixed injection control unit 11 may be configured to register the medicine image P1 in the storage unit 173 of the wearable terminal 16. Thereby, in the said mixed injection support system 1, it is possible to respond | correspond automatically to a new medicine.





また、前記混注制御部１１は、前記薬品画像マスターに存在する薬品の前記薬品画像Ｐ１の更新日時が前記薬品データベースにおける同じ薬品の前記薬品画像Ｐ１の更新日時以前である場合にも、その薬品の前記薬品画像Ｐ１を前記薬品データベースから取得して前記ウェアラブル端末１６に送信する。これにより、前記ウェアラブル端末１６では、前記端末制御部１６１が、前記記憶部１７３の前記薬品画像マスターにおいて、前記混注制御部１１から送信された前記薬品画像Ｐ１を前記薬品に対応する前記薬品画像Ｐ１として更新する。これにより、前記混注制御部１１では、既に登録されている薬品について前記薬品画像Ｐ１が変更された場合に自動的に対応することが可能である。


In addition, the mixed injection control unit 11 also includes the medicine when the update date of the medicine image P1 of the medicine existing in the medicine image master is before the update date of the medicine image P1 of the same medicine in the medicine database. The medicine image P1 is acquired from the medicine database and transmitted to the wearable terminal 16. Thereby, in the wearable terminal 16, the terminal control unit 161 uses the medicine image P1 transmitted from the mixed injection control unit 11 in the medicine image master of the storage unit 173, and the medicine image P1 corresponding to the medicine. Update as. Thereby, in the said mixed injection control part 11, when the said medicine image P1 is changed about the medicine already registered, it is possible to respond automatically.





さらに、前記混注制御部１１は、前記薬品画像マスターに存在する薬品が前記薬品データベースに存在しない場合には、その薬品の前記薬品画像Ｐ１を前記ウェアラブル端末１６の記憶部１７３から消去させる。これにより、前記ウェアラブル端末１６では、不要な前記薬品画像Ｐ１が自動的に削除されて記憶容量の圧迫が抑制される。


Furthermore, the mixed injection control unit 11 deletes the medicine image P1 of the medicine from the storage unit 173 of the wearable terminal 16 when the medicine existing in the medicine image master does not exist in the medicine database. Thereby, in the wearable terminal 16, the unnecessary medicine image P1 is automatically deleted, and the compression of the storage capacity is suppressed.





［設定機能］



前記ウェアラブル端末１６では、前記ウェアラブル端末１６に関する一又は複数の設定項目について任意に設定可能であることが考えられる。前記設定項目には、例えば前記端末表示部１６２の表示モード、及び前記ウェアラブル端末１６の接続先などが含まれる。このような各種の前記設定項目の設定は、例えば作業者が前記ウェアラブル端末１６の前記端末操作部１６４の操作に応じて行われることが考えられるが、その場合には作業者が手を使って操作を行う必要がある。これに対し、前記ウェアラブル端末１６では、作業者が手を使うことなく前記設定項目の設定を行うことができる設定機能を有することが考えられ、以下、前記設定機能について説明する。


[Setting function]



It is conceivable that the wearable terminal 16 can arbitrarily set one or a plurality of setting items related to the wearable terminal 16. The setting items include, for example, the display mode of the terminal display unit 162 and the connection destination of the wearable terminal 16. Such setting of the various setting items may be performed by an operator according to the operation of the terminal operation unit 164 of the wearable terminal 16, for example. In this case, the operator uses his / her hand. It is necessary to perform an operation. On the other hand, the wearable terminal 16 may have a setting function that allows the operator to set the setting items without using a hand. The setting function will be described below.





ここで、前記設定項目の一例である前記表示モードについて説明する。まず、前記ウェアラブル端末１６は、予め定められた右目又は左目のいずれか一方のみで前記端末表示部１６２を視認可能な状態で作業者に装着可能であることも考えられるが、この場合には、作業者が自由に右目又は左目を選択することができない。これに対し、前記ウェアラブル端末１６が、作業者が右目で前記端末表示部１６２を見る右目モードと、作業者が左目で前記端末表示部１６２を見る左目モードとを備え、前記端末制御部１６１が前記端末表示部１６２の表示モードを前記右目モードと前記左目モードとを任意に切替可能であることが考えられる。具体的に、作業者が左目で前記端末表示部１６２を見る場合には、作業者は図４に示される状態で前記端末表示部１６２が装着され、作業者が右目で前記端末表示部１６２を見る場合には、図４に示される状態から前記ウェアラブル端末１６の上下を反転させた状態で装着されることになる。そのため、前記端末制御部１６１は、前記右目モードと前記左目モードとにおいて前記端末表示部１６２の表示画面の上下を反転させる。


Here, the display mode, which is an example of the setting item, will be described. First, the wearable terminal 16 can be attached to an operator in a state in which the terminal display unit 162 is visible with only one of the predetermined right eye or left eye. In this case, The operator cannot freely select the right eye or the left eye. On the other hand, the wearable terminal 16 includes a right eye mode in which an operator looks at the terminal display unit 162 with a right eye and a left eye mode in which an operator looks at the terminal display unit 162 with a left eye, and the terminal control unit 161 has It is conceivable that the display mode of the terminal display unit 162 can be arbitrarily switched between the right eye mode and the left eye mode. Specifically, when the operator views the terminal display unit 162 with the left eye, the worker wears the terminal display unit 162 in the state shown in FIG. 4, and the operator uses the right eye to display the terminal display unit 162. For viewing, the wearable terminal 16 is mounted upside down from the state shown in FIG. Therefore, the terminal control unit 161 inverts the display screen of the terminal display unit 162 in the right eye mode and the left eye mode.





続いて、前記設定項目の一例である前記接続先について説明する。まず、前記混注支援システム１が使用される病院又は薬局には、複数の前記混注支援システム１が設けられることがある。この場合、前記ウェアラブル端末１６をいずれの前記混注支援システム１で使用するかが予め固定されていることも考えられるが、前記ウェアラブル端末１６を使用する前記混注支援システム１を任意に切替可能であることが望ましい。そのため、前記端末制御部１６１は、前記ウェアラブル端末１６の接続先を任意に設定可能であることが考えられる。具体的には、複数の前記混注支援システム１に対応する号機番号が予め設定されており、前記号機番号が設定されることによって前記接続先が設定される。なお、複数の前記混注支援システム１では、前記混注制御部１１が共通であることも考えられ、この場合には、例えば前記ウェアラブル端末１６の接続先に代えて、前記混注制御部１１を除く前記フットスイッチ部１５、前記第２読取部２１、及び前記秤量部２２などの構成要素との関連付けが設定項目として設定される。


Next, the connection destination that is an example of the setting item will be described. First, a plurality of the mixed injection support systems 1 may be provided in a hospital or pharmacy where the mixed injection support system 1 is used. In this case, it is conceivable that the mixed injection support system 1 in which the wearable terminal 16 is used is fixed in advance, but the mixed injection support system 1 using the wearable terminal 16 can be arbitrarily switched. It is desirable. Therefore, it is conceivable that the terminal control unit 161 can arbitrarily set the connection destination of the wearable terminal 16. Specifically, the number corresponding to a plurality of the mixed injection support systems 1 is set in advance, and the connection destination is set by setting the number. In the plurality of mixed injection support systems 1, the mixed injection control unit 11 may be shared. In this case, for example, instead of the connection destination of the wearable terminal 16, the mixed injection control unit 11 is excluded. Association with components such as the foot switch unit 15, the second reading unit 21, and the weighing unit 22 is set as a setting item.





そして、前記端末制御部１６１は、後述の設定処理（図２９参照）を実行することにより、前記設定機能を実現する。ここに、前記設定処理を実行するときの前記端末制御部１６１が設定処理部の一例である。ここで、前記端末制御部１６１は、前記ウェアラブル端末１６の電源投入又は省電力モードからの復帰などによる前記ウェアラブル端末１６の起動に伴って前記設定処理を実行する。


And the said terminal control part 161 implement | achieves the said setting function by performing the below-mentioned setting process (refer FIG. 29). Here, the terminal control unit 161 when executing the setting processing is an example of a setting processing unit. Here, the terminal control unit 161 executes the setting process as the wearable terminal 16 is activated by turning on the power of the wearable terminal 16 or returning from the power saving mode.





また、前記設定処理の一部又は全部が、前記混注制御部１１によって実行されてもよい。この場合、前記混注制御部１１は、前記ウェアラブル端末１６の電源が投入されて起動した後、前記ウェアラブル端末１６から送信される起動信号に基づいて、前記ウェアラブル端末１６の起動を認識する。


Moreover, a part or all of the setting process may be executed by the mixed injection control unit 11. In this case, the mixed injection control unit 11 recognizes activation of the wearable terminal 16 based on an activation signal transmitted from the wearable terminal 16 after the wearable terminal 16 is powered on and activated.





以下、図２９を参照しつつ、前記設定処理の手順の一例について説明する。


Hereinafter, an example of the procedure of the setting process will be described with reference to FIG.





＜ステップＳ５１＞



まず、前記ウェアラブル端末１６の起動に伴って、前記端末制御部１６１は、ステップＳ５１において、前記設定項目の内容を設定するために用いられる設定画面Ｄ３を前記端末表示部１６１に表示させる。なお、前記設定画面Ｄ３のレイアウト情報及び画像データなどは前記記憶部１７３に記憶されている。ここに、図３０Ａ～図３０Ｃは、前記設定画面Ｄ３の一例を示す図である。


<Step S51>



First, as the wearable terminal 16 is activated, the terminal control unit 161 causes the terminal display unit 161 to display a setting screen D3 used for setting the contents of the setting items in step S51. Note that layout information, image data, and the like of the setting screen D3 are stored in the storage unit 173. 30A to 30C are diagrams showing an example of the setting screen D3.





図３０Ａに示されるように、前記端末制御部１６１は、前記設定画面Ｄ３において、前記撮影部１６３で捉えられる映像をプレビュー画面Ｐ２に表示させる。また、前記端末制御部１６１は、前記プレビュー画面Ｐ２に一次元コード又は二次元コードなどのコード情報を写すことを促すメッセージも前記設定画面Ｄ３に表示させる。さらに、前記端末制御部１６１は、前記ウェアラブル端末１６で過去に設定された前記設定項目の履歴が前記記憶部１７３に記憶されている場合には、最も新しい履歴を現在の前記設定項目の設定内容として前記設定画面Ｄ３に表示させる。なお、前記設定項目の履歴は前記混注制御部１１の記憶部１１３に記憶されており、前記端末制御部１６１が前記記憶部１１３から読み出してもよい。図３０Ａに示される例では、現在の前記設定項目の設定内容として、前記表示モードが右目モードであり、前記接続先が１号機である旨が表示されている。


As shown in FIG. 30A, the terminal control unit 161 displays a video captured by the photographing unit 163 on the preview screen P2 in the setting screen D3. In addition, the terminal control unit 161 also displays a message on the setting screen D3 prompting to copy code information such as a one-dimensional code or a two-dimensional code on the preview screen P2. Further, when the history of the setting item set in the past in the wearable terminal 16 is stored in the storage unit 173, the terminal control unit 161 sets the latest setting history to the current setting item setting content. Is displayed on the setting screen D3. The history of the setting items may be stored in the storage unit 113 of the mixed injection control unit 11, and the terminal control unit 161 may read out from the storage unit 113. In the example shown in FIG. 30A, as the setting contents of the current setting item, it is displayed that the display mode is the right eye mode and the connection destination is the first machine.





＜ステップＳ５２＞



ステップＳ５２において、前記端末制御部１６１は、前記撮影部１６３で捉えられる一次元コード又は二次元コードなどのコード情報から情報を読み取る読取処理が実行可能な待機状態に遷移させる。ここで、前記コード情報は、例えば不図示の紙媒体に印刷されていること、前記安全キャビネット１００に貼付されていること、又は不図示のタブレット端末などに表示されること等が考えられる。なお、前記一次元コードは、例えばバーコードであり、前記二次元コードは、例えばＱＲコード（登録商標）である。ここに、前記読取処理を実行するときの前記端末制御部１６１が読取処理部の一例である。具体的に、前記端末制御部１６１は、前記撮影部１６３による撮影範囲内に前記コード情報が存在する場合に、前記コード情報から情報を読み取る。即ち、前記端末制御部１６１は、作業者による撮影操作を要することなく、前記コード情報から情報を読み取ることが可能である。


<Step S52>



In step S52, the terminal control unit 161 makes a transition to a standby state in which a reading process of reading information from code information such as a one-dimensional code or a two-dimensional code captured by the photographing unit 163 can be performed. Here, for example, the code information may be printed on a paper medium (not shown), affixed to the safety cabinet 100, or displayed on a tablet terminal (not shown). The one-dimensional code is, for example, a bar code, and the two-dimensional code is, for example, a QR code (registered trademark). Here, the terminal control unit 161 when executing the reading process is an example of a reading processing unit. Specifically, the terminal control unit 161 reads information from the code information when the code information exists within the shooting range of the shooting unit 163. That is, the terminal control unit 161 can read information from the code information without requiring a shooting operation by an operator.





＜ステップＳ５３＞



ステップＳ５３において、前記端末制御部１６１は、前記待機状態の継続時間を示す待機時間の計時を開始する。具体的に、前記端末制御部１６１は、前記ステップＳ５３が実行されるタイミングで前記待機時間を０にリセットして前記待機時間の計時を開始する。


<Step S53>



In step S53, the terminal control unit 161 starts measuring a standby time indicating the duration of the standby state. Specifically, the terminal control unit 161 resets the standby time to 0 at the timing when the step S53 is executed, and starts measuring the standby time.





＜ステップＳ５４＞



ステップＳ５４において、前記端末制御部１６１は、前記待機状態において前記読取処理によって前記コード情報から情報が読み取られたか否かを判断する。ここで、前記コード情報から情報が読み取られたと判断された場合（Ｓ５４：Ｙｅｓ）、処理はステップＳ５４１に移行する。一方、前記コード情報から情報が読み取られていないと判断された場合（Ｓ５４：Ｎｏ）、処理はステップＳ５５に移行する。なお、前記端末制御部１６１は、前記読取処理で読み取られた情報が前記設定項目の設定に用いられる予め定められた特定の情報を含む場合にのみ情報が読み取られたと判断し、前記特定の情報が含まれていない場合には前記読取処理で読み取られた情報を無視することも考えられる。


<Step S54>



In step S54, the terminal control unit 161 determines whether information is read from the code information by the reading process in the standby state. If it is determined that the information has been read from the code information (S54: Yes), the process proceeds to step S541. On the other hand, when it is determined that the information is not read from the code information (S54: No), the process proceeds to step S55. The terminal control unit 161 determines that the information is read only when the information read in the reading process includes predetermined specific information used for setting the setting item, and the specific information If the information is not included, the information read in the reading process may be ignored.





＜ステップＳ５５＞



ステップＳ５５において、前記端末制御部１６１は、前記ステップＳ５３で計時が開始された前記待機時間が予め設定された上限時間（例えば５秒又は１０秒）以上であるか否かを判断する。ここで、前記待機時間が前記上限時間以上であると判断された場合（Ｓ５５：Ｙｅｓ）、処理はステップＳ５６に移行する。なお、前記待機時間が前記上限時間以上でないと判断された場合（Ｓ５５：Ｎｏ）、処理は前記ステップＳ５４に戻る。


<Step S55>



In step S55, the terminal control unit 161 determines whether or not the standby time from which time measurement was started in step S53 is a preset upper limit time (for example, 5 seconds or 10 seconds). Here, when it is determined that the standby time is equal to or longer than the upper limit time (S55: Yes), the process proceeds to step S56. When it is determined that the standby time is not equal to or longer than the upper limit time (S55: No), the process returns to step S54.





なお、本実施形態では、前記ウェアラブル端末１６の起動後、最初に実行される前記ステップＳ５５で判断指標として用いられる上限時間（第１上限時間に相当）と、２回目以降に実行される前記ステップＳ５５で判断指標として用いられる上限時間（第２上限時間に相当）とが同じ時間である場合について説明するが、前記上限時間（第１上限時間、第２上限時間）各々は異なる時間であってもよい。即ち、前記端末制御部１６１は、前記ウェアラブル端末１６が起動してから前記第１上限時間内に前記読取処理によって情報が読み取られ、その情報に基づいて前記設定項目を設定した後も前記待機状態を維持する。そして、その後、前記端末制御部１６１は、予め設定された第２上限時間以内の間隔で前記読取処理によって情報が読み取られた場合は当該情報に基づいて前記設定項目の内容を設定して前記待機状態を維持する。即ち、前記ウェアラブル端末１６が起動後、２回目だけでなく３回目以降も、前記第２上限時間以内の間隔で前記読取処理によって情報が読み取られる場合にはその情報に基づく前記設定項目の内容の設定が実行されることになる。一方、前記端末制御部１６１は、前回の前記読取処理による情報の読み取り後から前記第２上限時間の経過前に前記読取処理によって情報が読み取られなかった場合は前記待機状態を解除する。例えば、前記第１上限時間が前記第２上限時間よりも長く設定されていれば、作業者が前記ウェアラブル端末１６の電源投入後に最初の前記コード情報を読み取るまでの間に余裕ができると共に、その後は無駄な待ち時間が短縮される。


In the present embodiment, the upper limit time (corresponding to the first upper limit time) used as a determination index in step S55 executed first after the wearable terminal 16 is started, and the step executed after the second time. The case where the upper limit time (corresponding to the second upper limit time) used as a determination index in S55 is the same time will be described, but the upper limit times (first upper limit time and second upper limit time) are different times. Also good. In other words, the terminal control unit 161 reads the information by the reading process within the first upper limit time after the wearable terminal 16 is activated, and sets the setting item based on the information. To maintain. After that, when information is read by the reading process at an interval within a preset second upper limit time, the terminal control unit 161 sets the content of the setting item based on the information and waits for the standby Maintain state. That is, when the information is read by the reading process at intervals within the second upper limit time after the wearable terminal 16 is activated not only at the second time but also after the third time, the content of the setting item based on the information is changed. Setting will be executed. On the other hand, the terminal control unit 161 cancels the standby state when information is not read by the reading process before the second upper limit time elapses after the information is read by the previous reading process. For example, if the first upper limit time is set longer than the second upper limit time, an operator can afford to read the first code information after turning on the wearable terminal 16, and thereafter Will reduce wasted waiting time.





また、前記端末制御部１６１は、前記ステップＳ５５において前記待機時間が前記上限時間以上に達していない場合であっても（Ｓ５５：Ｎｏ）、前記ウェアラブル端末１６で設定可能な全ての前記設定項目各々についての設定が一通り実行された場合は、処理をステップＳ５８に移行させることも他の実施形態として考えられる。


Further, the terminal control unit 161 sets each of all the setting items that can be set in the wearable terminal 16 even when the standby time does not reach the upper limit time or more in Step S55 (S55: No). In a case where the setting for is completed, it is also conceivable as another embodiment that the process proceeds to step S58.





＜ステップＳ５４１＞



一方、前記コード情報から情報が読み取られたと判断された場合は、続くステップＳ５４１において、前記端末制御部１６１は、前記コード情報から読み取られた情報に基づいて前記設定項目の内容を設定し、前記待機状態を維持したまま処理を前記ステップＳ５３に戻す。


<Step S541>



On the other hand, if it is determined that the information has been read from the code information, the terminal control unit 161 sets the content of the setting item based on the information read from the code information in subsequent step S541, and The process returns to step S53 while maintaining the standby state.





即ち、前記端末制御部１６１は、前記ウェアラブル端末１６の起動開始時に前記待機状態に遷移した後、前記上限時間が経過するまでの間に前記読取処理によって情報が読み取られた場合は、当該情報に基づいて前記設定項目の内容を設定する。同様に、前記端末制御部１６１は、前記ステップＳ５４１による設定処理が実行された後、前記上限時間が経過するまでの間に前記読取処理によって情報が読み取られた場合にも、当該情報に基づいて前記設定項目の内容を設定する。なお、前記端末制御部１６１は、前記設定処理によって既に設定された前記設定項目を設定するための情報が前記読取処理で読み取られた場合にも、前記設定項目の内容を再設定した後、処理をステップＳ５３に戻すことにより前記待機時間をリセットして前記待機時間の計時を０から再度開始する。これにより、誤って前記設定項目が設定された場合でも容易にその設定内容を変更することが可能である。


That is, if the terminal control unit 161 reads information by the reading process after the transition to the standby state at the start of activation of the wearable terminal 16 and before the upper limit time elapses, the terminal control unit 161 Based on this, the contents of the setting item are set. Similarly, when the terminal control unit 161 reads information by the reading process after the setting process in step S541 is executed and before the upper limit time elapses, the terminal control unit 161 is also based on the information. The contents of the setting item are set. Note that the terminal control unit 161 also performs processing after resetting the content of the setting item even when information for setting the setting item already set by the setting process is read by the reading process. The standby time is reset by returning to step S53, and the time measurement of the standby time is restarted from 0. Thereby, even if the setting item is set by mistake, the setting content can be easily changed.





また、前記読取処理によって読み取られた情報に基づいて前記設定項目が設定された後も前記待機状態が継続する。従って、前記端末制御部１６１は、前記設定処理において、複数の前記設定項目を連続的に設定することが可能であるため、作業者は複数の前記設定項目の内容を設定する場合であっても前記ウェアラブル端末１６の操作を行う必要がない。


Further, the standby state continues even after the setting item is set based on the information read by the reading process. Accordingly, since the terminal control unit 161 can continuously set a plurality of the setting items in the setting process, even if the operator sets the contents of the plurality of setting items. There is no need to operate the wearable terminal 16.





より具体的に、前記端末制御部１６１は、前記コード情報から読み取られた情報に基づいて、前記設定項目の種別を判断すると共に、その設定項目の内容を設定する。例えば、前記端末制御部１６１は、前記設定項目が前記表示モードであってその内容が前記左目モードであることを示す情報が前記コード情報から読み取られた場合に、前記表示モードを前記左目モードに設定する。ここに、図３０Ｂは、前記表示モードが前記左目モードに設定された場合の表示例である。図３０Ｂに示されるように、前記端末制御部１６１は、前記表示モードを前記左目モードに設定すると共に、前記表示モードが前記左目モードに設定された旨のメッセージを前記設定画面Ｄ３の前記プレビュー画面Ｐ２にポップアップ表示させる。なお、前記メッセージは、予め設定された時間が経過した後、自動的に前記設定画面Ｄ３から消去される。


More specifically, the terminal control unit 161 determines the type of the setting item based on the information read from the code information, and sets the content of the setting item. For example, the terminal control unit 161 changes the display mode to the left-eye mode when information indicating that the setting item is the display mode and the content is the left-eye mode is read from the code information. Set. Here, FIG. 30B is a display example when the display mode is set to the left-eye mode. As shown in FIG. 30B, the terminal control unit 161 sets the display mode to the left eye mode and displays a message indicating that the display mode is set to the left eye mode on the preview screen of the setting screen D3. Pop-up display on P2. The message is automatically deleted from the setting screen D3 after a preset time has elapsed.





また、前記端末制御部１６１は、前記設定項目が前記接続先であってその内容が２号機番号であることを示す情報が前記コード情報から読み取られた場合に、前記接続先を２号機に設定する。具体的に、前記端末制御部１６１は、前記ウェアラブル端末１６を、２号機に対応する前記混注支援システム１に対応する前記混注制御部１１との間で通信接続を確立する。また、複数の前記混注支援システム１に共通の前記混注制御部１１が用いられる場合には、前記ウェアラブル端末１６が使用される前記安全キャビネット１００が前記号機番号などによって設定され、前記安全キャビネット１００に対応して配置されたその他の構成要素が前記ウェアラブル端末１６と対応付けられる。ここに、図３０Ｃは、前記接続先が２号機に設定された場合の表示例である。図３０Ｃに示されるように、前記端末制御部１６１は、前記接続先を２号機に設定すると共に、前記接続先が２号機に設定された旨のメッセージを前記設定画面Ｄ３の前記プレビュー画面Ｐ２にポップアップ表示させる。なお、前記メッセージは、予め設定された時間が経過した後、自動的に前記設定画面Ｄ３から消去される。


Further, the terminal control unit 161 sets the connection destination to the second machine when the information indicating that the setting item is the connection destination and the content is the second machine number is read from the code information. To do. Specifically, the terminal control unit 161 establishes a communication connection between the wearable terminal 16 and the mixed injection control unit 11 corresponding to the mixed injection support system 1 corresponding to the second machine. When the mixed injection control unit 11 common to a plurality of the mixed injection support systems 1 is used, the safety cabinet 100 in which the wearable terminal 16 is used is set by the unit number or the like, and the safety cabinet 100 Other components arranged correspondingly are associated with the wearable terminal 16. Here, FIG. 30C is a display example when the connection destination is set to the second machine. As shown in FIG. 30C, the terminal control unit 161 sets the connection destination to No. 2 machine and displays a message to the effect that the connection destination is set to No. 2 machine on the preview screen P2 of the setting screen D3. Pop-up display. The message is automatically deleted from the setting screen D3 after a preset time has elapsed.





また、一つの前記コード情報に複数の前記設定項目に関する情報が含まれており、前記端末制御部１６１が、一つの前記コード情報から読み取られる情報に基づいて複数の前記設定項目の内容を一挙に設定することが考えられる。具体的に、前記表示モード及び前記接続先の２種類の前記設定項目について、合計４つの前記コード情報が用意されている場合には、一つの前記コード情報から読み取られる情報に基づいて前記表示モード及び前記号機番号の合計４種類の組み合わせが設定可能である。例えば、一つの前記コード情報から読み取られた情報に基づいて、前記表示モードが前記左目モードに設定され、前記接続先が２号機に設定されることが考えられる。


Further, one piece of code information includes information on a plurality of the setting items, and the terminal control unit 161 collects the contents of the plurality of setting items at once based on information read from the one piece of code information. It is possible to set. Specifically, when a total of four pieces of code information are prepared for the two types of setting items of the display mode and the connection destination, the display mode is based on information read from one piece of the code information. In addition, a total of four types of combinations of the machine number can be set. For example, it is conceivable that the display mode is set to the left-eye mode and the connection destination is set to No. 2 based on information read from one piece of code information.





また、同じ作業者であれば、前記ウェアラブル端末１６で設定する前記設定項目各々の内容が常に同じであることが考えられる。そこで、前記端末制御部１６１は、前記ウェアラブル端末１６を使用する作業者ごとに前記設定項目各々の内容を設定することも考えられる。具体的に、前記記憶部１７３には、前記作業者ごとに対応する前記設定項目各々の内容が予め記憶されており、前記端末制御部１６１が、前記コード情報から前記作業者を識別可能な情報が読み取られた場合に、前記作業者に対応する前記設定項目各々の内容を前記記憶部１７３から読み出して設定することが考えられる。例えば、前記端末制御部１６１は、ある作業者が前記ウェアラブル端末１６又は前記混注制御部１１にログインした後に、前記設定処理で設定された最新の前記設定項目各々の内容を当該作業者に対応付けて前記記憶部１７３に記憶させることが考えられる。なお、前記作業者ごとに対応する前記設定項目の内容は前記混注制御部１１の記憶部１１３に記憶されており、前記端末制御部１６１が前記記憶部１１３から前記作業者ごとに対応する前記設定項目の内容を読み出してもよい。また、前記混注支援システム１に複数の前記ウェアラブル端末１６が含まれる場合に、そのいずれかの前記ウェアラブル端末１６の前記記憶部１７３に前記作業者ごとに対応する前記設定項目の内容が記憶されており、前記端末制御部１６１が他の前記ウェアラブル端末１６の前記記憶部１７３から前記作業者ごとに対応する前記設定項目の内容を読み出してもよい。


Further, if the same worker, the contents of the setting items set on the wearable terminal 16 may be always the same. Therefore, the terminal control unit 161 may set the contents of each setting item for each worker who uses the wearable terminal 16. Specifically, the storage unit 173 stores in advance the content of each setting item corresponding to each worker, and the terminal control unit 161 can identify the worker from the code information. Is read, the contents of each of the setting items corresponding to the worker may be read from the storage unit 173 and set. For example, the terminal control unit 161 associates the contents of each of the latest setting items set in the setting process with the worker after a certain worker logs in to the wearable terminal 16 or the mixed injection control unit 11. It is conceivable that the data is stored in the storage unit 173. The contents of the setting items corresponding to each worker are stored in the storage unit 113 of the mixed injection control unit 11, and the terminal control unit 161 stores the setting corresponding to each worker from the storage unit 113. The content of the item may be read. Further, when a plurality of the wearable terminals 16 are included in the mixed injection support system 1, the contents of the setting items corresponding to each worker are stored in the storage unit 173 of any one of the wearable terminals 16. The terminal control unit 161 may read the content of the setting item corresponding to each worker from the storage unit 173 of the other wearable terminal 16.





＜ステップＳ５６＞



前記待機時間が前記上限時間以上であると判断されると、続くステップＳ５６において、前記端末制御部１６１は、前記読取処理が実行可能な前記待機状態を解除する。即ち、前記端末制御部１６１は、前記ウェアラブル端末１６が起動して前記待機状態に遷移した後、前記上限時間が経過するまでの間に前記読取処理によって情報が読み取られなかった場合は前記待機状態を解除する。同様に、前記端末制御部１６１は、前記ステップＳ５４１による前記設定項目の設定処理が実行された後、前記上限時間が経過するまでの間に前記読取処理によって情報が読み取られなかった場合にも前記待機状態を解除する。従って、前記端末制御部１６１は、前記設定処理において、前記上限時間内に前記コード情報から情報が読み取られないことを条件に自動的に前記設定処理を終了させることが可能であるため、作業者は前記設定項目の内容を設定しない場合であっても手で前記ウェアラブル端末１６の操作を行う必要がない。


<Step S56>



If it is determined that the standby time is equal to or longer than the upper limit time, in the subsequent step S56, the terminal control unit 161 cancels the standby state in which the reading process can be performed. That is, if the terminal control unit 161 does not read information by the reading process until the upper limit time elapses after the wearable terminal 16 starts and transitions to the standby state, the terminal control unit 161 Is released. Similarly, the terminal control unit 161 also executes the above-described setting item setting process in step S541, and when the information is not read by the reading process until the upper limit time elapses. Release the standby state. Accordingly, the terminal control unit 161 can automatically end the setting process in the setting process on condition that no information is read from the code information within the upper limit time. Even if the contents of the setting items are not set, it is not necessary to operate the wearable terminal 16 by hand.





＜ステップＳ５７＞



ステップＳ５７において、前記端末制御部１６１は、前記ウェアラブル端末１６について設定可能な一又は複数の前記設定項目に、前記待機状態で前記読取処理によって読み取られる情報に基づいて設定されなかった未設定項目が存在する場合は、当該未設定項目を前記記憶部１７３に記憶されている前記履歴に基づいて設定する。具体的に、前記端末制御部１６１は、前記未設定項目の内容を前記記憶部１７３に記憶されている最新の前記履歴の状態に設定する。なお、前記端末制御部１６１は、前記ウェアラブル端末１６で過去に設定された前記設定項目の履歴を前記記憶部１７３に蓄積して前記記憶部１７３に記憶すること、又は前記設定項目各々について最新の履歴のみを前記記憶部１７３に記憶することが考えられる。


<Step S57>



In step S57, the terminal control unit 161 includes an unset item that is not set based on information read by the reading process in the standby state in one or a plurality of the set items that can be set for the wearable terminal 16. If it exists, the unset item is set based on the history stored in the storage unit 173. Specifically, the terminal control unit 161 sets the contents of the unset items to the latest history state stored in the storage unit 173. The terminal control unit 161 accumulates the history of the setting items set in the past in the wearable terminal 16 in the storage unit 173 and stores the history in the storage unit 173, or the latest information on each of the setting items. It can be considered that only the history is stored in the storage unit 173.





＜ステップＳ５８＞



ステップＳ５８において、前記端末制御部１６１は、前記表示制御処理（図７参照）を開始する。これにより、前記ウェアラブル端末１６では、前記端末表示部１６２に前記混注作業の各作業工程の内容が順次表示され、作業者による前記混注作業が支援されることになる。このとき、前記表示制御処理において、前記端末制御部１６１は、前記設定処理で設定された前記設定項目各々の設定内容に従って前記作業工程各々の内容を前記端末表示部１６２に表示させる。


<Step S58>



In step S58, the terminal control unit 161 starts the display control process (see FIG. 7). Thereby, in the wearable terminal 16, the contents of each work process of the mixed injection work are sequentially displayed on the terminal display unit 162, and the mixed injection work by the worker is supported. At this time, in the display control process, the terminal control unit 161 causes the terminal display unit 162 to display the contents of each work process according to the setting contents of each of the setting items set in the setting process.





以上、説明したように、前記混注支援システム１では、前記ウェアラブル端末１６が起動に伴って前記待機状態に遷移し、前記読取処理で読み取られる情報に基づいて前記設定項目の内容が設定されるため、作業者が手を使って操作を行うことなく一又は複数の前記設定項目を設定することが可能である。


As described above, in the mixed injection support system 1, the wearable terminal 16 transitions to the standby state upon activation, and the contents of the setting items are set based on information read by the reading process. It is possible to set one or a plurality of the setting items without an operator performing an operation with his / her hand.





また、前記端末制御部１６１は、前記ステップＳ５４で前記コード情報から情報が読み取られた場合に、その情報に対応する設定項目の種別を判断すると共に、その設定項目の内容を設定すること、即ち複数の前記設定項目について任意の順序で設定可能な構成について説明した。一方、前記端末制御部１６１が、予め設定された複数の前記設定項目についての前記コード情報の読み取りを促す画面を予め設定された順序で表示させ、その表示に対応する前記設定項目の内容を示す情報が前記コード情報から順次読み取られることにより、前記設定項目各々の内容を順次設定することも他の実施形態として考えられる。


In addition, when the information is read from the code information in the step S54, the terminal control unit 161 determines the type of the setting item corresponding to the information and sets the content of the setting item. The configuration in which the plurality of setting items can be set in an arbitrary order has been described. On the other hand, the terminal control unit 161 displays a screen for prompting reading of the code information for a plurality of preset setting items in a preset order, and indicates the contents of the setting items corresponding to the display. Another embodiment is also conceivable in which the contents of each of the setting items are sequentially set by sequentially reading information from the code information.





なお、前記設定項目の種別は、前記表示モード及び前記接続先に限らず、前記ウェアラブル端末１６又は前記混注制御部１１の動作に関する各種の設定項目であればよい。例えば、前記混注支援システム１が複数の撮影部を備える場合に、その複数の撮影部から、前記混注作業に含まれる前記溶解液撮影工程又は前記薬液撮影工程などの撮影工程で用いる撮影部を選択するための設定が前記設定項目の一例として考えられる。例えば、前記混注支援システム１が、前記ウェアラブル端末１６の前記撮影部１６３の他に、前記操作表示部１２及び前記第１読取部１３などと共に固定され、或いは、前記安全キャビネット１００に固定された状態で用いられる固定撮影部を備えることが考えられる。この場合、前記端末制御部１６１は、前記設定処理において、前記コード情報から読み取られる情報に基づいて、前記撮影工程で使用する撮影部として前記撮影部１６３及び前記固定撮影部のいずれかを選択することが考えられる。


The type of the setting item is not limited to the display mode and the connection destination, and may be various setting items related to the operation of the wearable terminal 16 or the mixed injection control unit 11. For example, when the mixed injection support system 1 includes a plurality of imaging units, the imaging unit used in the imaging process such as the solution imaging process or the chemical imaging process included in the mixed injection operation is selected from the plurality of imaging units. The setting for doing this is considered as an example of the setting item. For example, the mixed injection support system 1 is fixed together with the operation display unit 12 and the first reading unit 13 in addition to the photographing unit 163 of the wearable terminal 16, or is fixed to the safety cabinet 100 It may be possible to provide a fixed photographing unit used in the above. In this case, in the setting process, the terminal control unit 161 selects either the photographing unit 163 or the fixed photographing unit as a photographing unit to be used in the photographing process based on information read from the code information. It is possible.





また、前記混注支援システム１では、前記混注作業に含まれる各作業工程の表示内容が作業者の技能レベル又は作業者の好みに応じて変更可能であることが考えられる。具体的に、前記端末制御部１６１は、前記作業工程について簡易的に作業工程の内容を表示する簡易モードと、前記作業工程について詳細に作業工程の内容を表示する詳細モードとを備え、前記設定処理における前記読取処理で読み取られた情報に応じて前記簡易モードと前記詳細モードとを切り替えることが考えられる。この場合、前記簡易モード及び前記詳細モードの切り替えの設定が前記設定項目の一例として考えられる。例えば、前記溶解液抜取り工程又は前記薬液抜取り工程などの抜取り工程において、前記調製データで指定されている注射器で複数回の抜取り工程に分けて溶解液又は薬液を抜き取る必要がある場合、前記詳細モードでは前記抜取り工程各々に対応する抜取り量が前記端末表示画面Ｄ２に順次表示され、前記簡易モードでは前記抜取り量の合計が前記端末表示画面Ｄ２に表示される。また、前記溶解液計量工程又は前記薬液計量工程などの計量工程が実行される場合に、前記詳細モードでは、前記計量工程による計量対象の溶解液又は薬液を注射器で抜き取ることを促す抜取り表示画面が表示された後に秤量画面を表示させ、前記簡易モードでは、前記抜取り表示画面が表示されずに前記秤量画面が表示されることが考えられる。


In the mixed injection support system 1, it is conceivable that the display content of each work process included in the mixed injection work can be changed according to the skill level of the worker or the preference of the worker. Specifically, the terminal control unit 161 includes a simple mode for simply displaying the contents of the work process for the work process, and a detailed mode for displaying the details of the work process for the work process in detail. It is conceivable to switch between the simple mode and the detailed mode according to the information read in the reading process. In this case, the setting for switching between the simple mode and the detailed mode is considered as an example of the setting item. For example, in the extraction step such as the dissolution solution extraction step or the chemical solution extraction step, when it is necessary to extract the dissolution solution or the chemical solution in a plurality of extraction steps with the syringe specified in the preparation data, the detailed mode Then, the extraction amount corresponding to each of the extraction steps is sequentially displayed on the terminal display screen D2, and the total extraction amount is displayed on the terminal display screen D2 in the simple mode. In addition, when a measurement process such as the dissolution liquid measurement process or the chemical liquid measurement process is executed, in the detailed mode, a sampling display screen that prompts the syringe to extract the dissolution liquid or the chemical liquid to be measured in the measurement process with a syringe. It is conceivable that the weighing screen is displayed after the display, and in the simple mode, the weighing screen is displayed without displaying the sampling display screen.





また、前記混注支援システム１では、前記混注制御部１１が、前記薬品画像表示機能の有効及び無効を、前記設定処理における前記読取処理で読み取られた情報に応じて切り替えることが考えられる。即ち、前記薬品画像表示機能の有効及び無効の切り替えの設定が前記設定項目の一例であることが考えられる。


In the mixed injection support system 1, the mixed injection control unit 11 can switch between enabling and disabling the medicine image display function according to the information read in the reading process in the setting process. That is, it can be considered that the setting for switching between valid and invalid of the medicine image display function is an example of the setting item.





１混注支援システム



１１混注制御部



１２操作表示部



１３第１読取部



１４プリンター



１５フットスイッチ部



１６ウェアラブル端末



１６１端末制御部



１６２端末表示部



１６３撮影部



１６４端末操作部



１６５スピーカー



１６６マイク



２１第２読取部



２２秤量部


1 mixed injection support system



11 mixed injection control unit



12 operation display



13 First reading unit



14 printer



15 foot switch



16 wearable terminals



161 terminal control unit



162 terminal display



163 shooting section



164 terminal operation unit



165 speakers



166 microphone



21 Second reading unit



22 weighing parts

Claims (22)




  1. 表示部と、薬品の混注作業に含まれる各作業工程の情報を前記表示部に順次表示させる制御部とを備え、



    前記制御部が、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際に、前記特定の作業工程の情報として作業工程の内容、作業量、及び作業対象のみを前記表示部に表示させる混注支援システム。


    A display unit, and a control unit that sequentially displays information on each work process included in the mixed injection work of medicine on the display unit,



    When the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are displayed on the display unit as the information on the specific work process. Mixed injection support system to be displayed.





  2. 表示部と、薬品の混注作業に含まれる各作業工程の情報を前記表示部に順次表示させる制御部とを備え、



    前記制御部が、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際に、前記特定の作業工程の情報として作業工程の内容、作業量、及び作業対象のみを前記表示部に表示させると共に、現在の前記特定の作業工程に予め対応付けられた色を示すステータス領域を前記表示部に表示させる混注支援システム。


    A display unit, and a control unit that sequentially displays information on each work process included in the mixed injection work of medicine on the display unit,



    When the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are displayed on the display unit as the information on the specific work process. In addition, the mixed injection support system displays a status area indicating a color previously associated with the current specific work process on the display unit.





  3. 表示部と、薬品の混注作業に含まれる各作業工程の情報を前記表示部に順次表示させる制御部とを備え、



    前記制御部が、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際に、前記特定の作業工程の情報として作業工程の内容、作業量、及び作業対象のみを前記表示部に表示させると共に、同一の前記特定の作業工程が繰り返し表示される場合には同一の前記特定の作業工程の実施予定数と実施済数とを示す薬品数表示領域を前記表示部に表示させる混注支援システム。


    A display unit, and a control unit that sequentially displays information on each work process included in the mixed injection work of medicine on the display unit,



    When the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are displayed on the display unit as the information on the specific work process. When the same specific work process is repeatedly displayed, a mixed injection for displaying a medicine number display area indicating the planned execution number and the completed number of the same specific work process on the display unit Support system.





  4. 表示部と、薬品の混注作業に含まれる各作業工程の情報を前記表示部に順次表示させる制御部とを備え、



    前記制御部が、前記作業工程のうち予め設定された特定の作業工程の情報を表示する際に、前記特定の作業工程の情報として作業工程の内容、作業量、及び作業対象のみを前記表示部に表示させると共に、前記特定の作業工程について少なくとも進行又は後退を操作するための操作表示領域を前記表示部に表示させる混注支援システム。


    A display unit, and a control unit that sequentially displays information on each work process included in the mixed injection work of medicine on the display unit,



    When the control unit displays information on a specific work process set in advance among the work processes, only the content of the work process, the work amount, and the work target are displayed on the display unit as the information on the specific work process. And a mixed injection support system that displays an operation display area for operating at least advancing or retreating on the specific work process on the display unit.





  5. 前記作業工程の内容が、前記作業工程の内容に対応して予め設定されたピクトグラムである請求項１～４のいずれかに記載の混注支援システム。


    The mixed injection support system according to any one of claims 1 to 4, wherein the content of the work process is a pictogram set in advance corresponding to the content of the work process.





  6. 前記表示部を第１表示部として、前記第１表示部よりも画面サイズが大きい第２表示部を更に備え、



    前記制御部が、前記作業工程の情報を前記第２表示部にも表示させるものであって、



    前記第１表示部に表示される前記作業工程の情報の情報量が前記第２表示部に表示される前記作業工程の情報の情報量よりも少ない請求項１～５のいずれかに記載の混注支援システム。


    The display unit as a first display unit, further comprising a second display unit having a larger screen size than the first display unit,



    The control unit displays information on the work process also on the second display unit,



    6. The mixed injection according to claim 1, wherein an information amount of the work process information displayed on the first display unit is smaller than an information amount of the work process information displayed on the second display unit. Support system.





  7. 前記混注作業の作業者が装着可能なウェアラブル端末を備え、



    前記第１表示部が、前記ウェアラブル端末に設けられている請求項６に記載の混注支援システム。


    A wearable terminal that can be worn by the worker of the mixed injection work,



    The mixed injection support system according to claim 6, wherein the first display unit is provided in the wearable terminal.





  8. 前記作業工程の情報を音声で読み上げる読上処理部を更に備える請求項１～７のいずれかに記載の混注支援システム。


    The mixed injection support system according to any one of claims 1 to 7, further comprising a reading processing unit that reads out information on the work process by voice.





  9. 前記制御部が、前記作業対象が薬品名称である場合、前記薬品名称の規格を除く略称を表示させる請求項１～８のいずれかに記載の混注支援システム。


    The mixed injection support system according to any one of claims 1 to 8, wherein, when the work target is a medicine name, the control unit displays an abbreviation excluding a standard of the medicine name.





  10. 前記制御部が、前記作業工程のうち前記薬品を認証する薬品認証工程では前記表示部に前記薬品名称を省略せずに表示させ、前記薬品認証工程の終了後の他の前記作業工程について前記薬品名称を表示する際には前記薬品名称の略称を前記表示部に表示させる請求項９に記載の混注支援システム。


    In the medicine authentication process for authenticating the medicine in the work process, the control unit displays the medicine name on the display unit without omitting the medicine, and the medicine is used for the other work processes after the medicine authentication process is finished. The mixed injection support system according to claim 9, wherein when the name is displayed, an abbreviation of the medicine name is displayed on the display unit.





  11. 前記制御部が、前記作業対象が薬品名称である場合、前記作業対象として薬品画像を表示可能である請求項１～１０のいずれかに記載の混注支援システム。


    The mixed injection support system according to any one of claims 1 to 10, wherein when the work target is a medicine name, the control unit can display a medicine image as the work target.





  12. 前記制御部が、前記作業工程の内容、前記作業量、及び前記作業対象が表示される状態と前記薬品画像が表示される状態とを交互に切り替えて表示可能である請求項１１に記載の混注支援システム。


    The mixed injection according to claim 11, wherein the control unit is capable of alternately switching and displaying a state in which the content of the work process, the work amount, and the work target are displayed and a state in which the medicine image is displayed. Support system.





  13. 予め設定された薬品データベースに基づいて前記薬品画像を更新する薬品更新処理部を更に備える請求項１１又は１２に記載の混注支援システム。


    The mixed injection support system according to claim 11 or 12, further comprising a medicine update processing unit that updates the medicine image based on a medicine database set in advance.





  14. 前記混注作業の作業者が装着可能であって前記表示部及び撮影部を備えるウェアラブル端末と、



    前記撮影部で捉えられるコード情報から情報を読み取る読取処理部と、



    前記読取処理部によって読み取られる情報に基づいて前記ウェアラブル端末に関する設定項目の内容を設定する設定処理部と、



    を備える請求項１～１３のいずれかに記載の混注支援システム。


    A wearable terminal that can be worn by a worker of the mixed injection work and includes the display unit and the photographing unit;



    A reading processing unit for reading information from code information captured by the photographing unit;



    A setting processing unit configured to set the content of setting items related to the wearable terminal based on information read by the reading processing unit;



    The mixed injection support system according to any one of claims 1 to 13, further comprising:





  15. 前記設定処理部が、前記ウェアラブル端末の起動に伴って、前記読取処理部を前記情報の読み取りが可能な待機状態に遷移させた後、予め設定された第１上限時間の経過前に前記読取処理部によって情報が読み取られた場合は当該情報に基づいて前記ウェアラブル端末に関する設定項目の内容を設定し、前記第１上限時間の経過前に前記読取処理部によって情報が読み取られなかった場合は前記待機状態を解除する請求項１４に記載の混注支援システム。


    After the setting processing unit transitions the reading processing unit to a standby state in which the information can be read in accordance with activation of the wearable terminal, the reading processing is performed before the elapse of a preset first upper limit time. If the information is read by the reading unit, the setting item for the wearable terminal is set based on the information. If the information is not read by the reading processing unit before the first upper limit time has elapsed, the standby is performed. The mixed injection support system according to claim 14, wherein the state is canceled.





  16. 薬品の混注作業の作業者が装着可能であって表示部及び撮影部を備えるウェアラブル端末と、



    前記混注作業に含まれる各作業工程の情報を前記表示部に表示させる制御部と、



    前記撮影部で捉えられるコード情報から情報を読み取る読取処理部と、



    前記ウェアラブル端末の起動に伴って、前記読取処理部を前記情報の読み取りが可能な待機状態に遷移させた後、予め設定された第１上限時間の経過前に前記読取処理部によって情報が読み取られた場合は当該情報に基づいて前記ウェアラブル端末に関する設定項目の内容を設定し、前記第１上限時間の経過前に前記読取処理部によって情報が読み取られなかった場合は前記待機状態を解除する設定処理部と、



    を備える混注支援システム。


    A wearable terminal equipped with a display unit and a photographing unit, which can be worn by an operator of the mixed injection work of medicine;



    A control unit for displaying information on each work process included in the mixed injection work on the display unit;



    A reading processing unit for reading information from code information captured by the photographing unit;



    With the activation of the wearable terminal, the information is read by the reading processing unit before the preset first upper limit time elapses after the reading processing unit is shifted to a standby state in which the information can be read. If the information is not read by the reading processing unit before the first upper limit time has elapsed, a setting process for canceling the standby state is set. And



    A mixed injection support system.





  17. 前記設定処理部が、前記第１上限時間内に前記読取処理部によって読み取られた前記情報に基づく前記設定項目の設定後に前記待機状態を維持し、その後、予め設定された第２上限時間以内の間隔で前記読取処理部によって情報が読み取られた場合は当該情報に基づいて前記設定項目の内容を設定して前記待機状態を維持し、前記第２上限時間の経過前に前記読取処理部によって情報が読み取られなかった場合は前記待機状態を解除する、



    請求項１６に記載の混注支援システム。


    The setting processing unit maintains the standby state after setting the setting item based on the information read by the reading processing unit within the first upper limit time, and then within a preset second upper limit time. When information is read by the reading processing unit at intervals, the setting item is set based on the information to maintain the standby state, and information is read by the reading processing unit before the second upper limit time elapses. When the is not read, the standby state is canceled.



    The mixed injection support system according to claim 16.





  18. 前記設定項目の一つに、前記表示部による表示モード及び前記ウェアラブル端末の接続先のいずれか一方又は両方が含まれる、



    請求項１６又は１７に記載の混注支援システム。


    One of the setting items includes one or both of a display mode by the display unit and a connection destination of the wearable terminal.



    The mixed injection support system according to claim 16 or 17.





  19. 前記表示モードが、前記作業者が右目で前記表示部を見る右目モードと前記作業者が左目で前記表示部を見る左目モードとを含む、



    請求項１８に記載の混注支援システム。


    The display mode includes a right eye mode in which the operator views the display unit with a right eye and a left eye mode in which the operator views the display unit with a left eye.



    The mixed injection support system according to claim 18.





  20. 一つの前記コード情報に、複数の前記設定項目の設定内容についての情報が含まれており、



    前記設定処理部が、前記読取処理部によって読み取られる情報に基づいて複数の前記設定項目を一挙に設定可能である、



    請求項１６～１９のいずれかに記載の混注支援システム。


    One piece of the code information includes information about the setting contents of the plurality of setting items,



    The setting processing unit can set a plurality of the setting items at once based on information read by the reading processing unit.



    The mixed injection support system according to any one of claims 16 to 19.





  21. 前記設定処理部によって設定された前記設定項目の履歴を記憶する記憶部を備え、



    前記設定処理部が、前記設定項目のうち前記待機状態で前記読取処理部によって読み取られる情報に基づいて設定されなかった未設定項目は、前記記憶部に記憶されている前記履歴に基づいて設定する、



    請求項１６～２０のいずれかに記載の混注支援システム。


    A storage unit for storing a history of the setting items set by the setting processing unit;



    The setting processing unit sets, based on the history stored in the storage unit, unset items that have not been set based on information read by the reading processing unit in the standby state among the setting items. ,



    The mixed injection support system according to any one of claims 16 to 20.





  22. 前記作業者ごとに対応する前記設定項目を記憶する記憶部を備え、



    前記設定処理部が、前記待機状態で前記読取処理部によって読み取られた情報に前記作業者を識別可能な情報が含まれる場合、当該作業者に対応する前記設定項目を前記記憶部から読み出して設定する請求項１６～２１のいずれかに記載の混注支援システム。


    A storage unit for storing the setting item corresponding to each worker;



    When the setting processing unit includes information that can identify the worker in the information read by the reading processing unit in the standby state, the setting item corresponding to the worker is read from the storage unit and set The mixed injection support system according to any one of claims 16 to 21.
PCT/JP2016/071692 2015-07-29 2016-07-25 Mixed injection assistance system WO2017018370A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2017530852A JP6809460B2 (en) 2015-07-29 2016-07-25 Mixed injection support system
KR1020177037191A KR20180035738A (en) 2015-07-29 2016-07-25 Self support system
CN201680043975.XA CN107920955B (en) 2015-07-29 2016-07-25 Hybrid injection assist system

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2015-149479 2015-07-29
JP2015149479 2015-07-29
JP2016-006119 2016-01-15
JP2016006119 2016-01-15

Publications (1)

Publication Number Publication Date
WO2017018370A1 true WO2017018370A1 (en) 2017-02-02

Family

ID=57884433

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/071692 WO2017018370A1 (en) 2015-07-29 2016-07-25 Mixed injection assistance system

Country Status (4)

Country Link
JP (3) JP6809460B2 (en)
KR (1) KR20180035738A (en)
CN (1) CN107920955B (en)
WO (1) WO2017018370A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10852548B2 (en) 2018-08-27 2020-12-01 Dynabook Inc. Electronic device, wearable device, and setting method
US11063822B2 (en) 2018-08-27 2021-07-13 Toshiba Client Solutions CO., LTD. Electronic apparatus and control method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005334056A (en) * 2004-05-24 2005-12-08 Tosho Inc Dispensing support system
JP2013135364A (en) * 2011-12-27 2013-07-08 Brother Ind Ltd Image processing device
JP2014057754A (en) * 2012-09-18 2014-04-03 Panasonic Corp Medicine preparation support device, medicine preparation support system and medicine preparation support method
WO2014145049A2 (en) * 2013-03-15 2014-09-18 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
JP2015013089A (en) * 2013-06-07 2015-01-22 株式会社Ｗｉｎｄｙ Picked medicine identifying system suitable for medicine picking examination and the like

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4553358B2 (en) * 2004-12-08 2010-09-29 株式会社トーショー Clean bench
JP2006280916A (en) * 2005-03-11 2006-10-19 Yuyama Manufacturing Co Ltd Medicine-weighing apparatus
JP2007102396A (en) * 2005-10-03 2007-04-19 Tosho Inc Medicine information management device
CN101627406A (en) * 2006-03-03 2010-01-13 株式会社汤山制作所 Mixed injection inspection system
WO2012033315A2 (en) * 2010-09-09 2012-03-15 (주)제이브이엠 Automatic prescription-medicine releasing system
CN203759721U (en) * 2010-10-08 2014-08-06 科朵尼克斯公司 Computer terminal and healthcare facility for label generation and label generated on demand for identifying material for medical application
JP5772071B2 (en) * 2011-03-07 2015-09-02 富士通株式会社 Work procedure display device
JP5891684B2 (en) * 2011-03-25 2016-03-23 株式会社湯山製作所 Mixed injection device
JP5743331B2 (en) * 2012-06-14 2015-07-01 株式会社トーショー Dispensing support system
JP2014038489A (en) * 2012-08-16 2014-02-27 Terumo Corp Prescription information management device, prescription information management system, and prescription information management device control method
JP5949501B2 (en) * 2012-11-29 2016-07-06 ブラザー工業株式会社 Work assistance system and program
JP5828832B2 (en) * 2012-11-30 2015-12-09 株式会社トーショー Dispensing support system
CN204515852U (en) * 2015-02-17 2015-07-29 杭州唐古信息科技有限公司 Formula based on radio hand-held equipment is boiled medicine intelligent management system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005334056A (en) * 2004-05-24 2005-12-08 Tosho Inc Dispensing support system
JP2013135364A (en) * 2011-12-27 2013-07-08 Brother Ind Ltd Image processing device
JP2014057754A (en) * 2012-09-18 2014-04-03 Panasonic Corp Medicine preparation support device, medicine preparation support system and medicine preparation support method
WO2014145049A2 (en) * 2013-03-15 2014-09-18 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
JP2015013089A (en) * 2013-06-07 2015-01-22 株式会社Ｗｉｎｄｙ Picked medicine identifying system suitable for medicine picking examination and the like

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10852548B2 (en) 2018-08-27 2020-12-01 Dynabook Inc. Electronic device, wearable device, and setting method
US11063822B2 (en) 2018-08-27 2021-07-13 Toshiba Client Solutions CO., LTD. Electronic apparatus and control method

Also Published As

Publication number Publication date
KR20180035738A (en) 2018-04-06
JP7255734B2 (en) 2023-04-11
JP2022116293A (en) 2022-08-09
JPWO2017018370A1 (en) 2018-05-17
JP7088274B2 (en) 2022-06-21
JP2021062213A (en) 2021-04-22
JP6809460B2 (en) 2021-01-06
CN107920955A (en) 2018-04-17
CN107920955B (en) 2021-06-11

Similar Documents

Publication Publication Date Title
JP7255734B2 (en) Mixed injection support system
JP2019036356A (en) Ward medicine business support system
KR102518941B1 (en) Dispensing management device, mixed infusion device
JP6027510B2 (en) Drug registration device and program
JP6307865B2 (en) Terminal device and program
JP5785961B2 (en) Drug registration apparatus, program, and drug registration method
JP2023054090A (en) Picking support system
JP6143700B2 (en) Drug registration device and program
JP6143701B2 (en) Drug registration device and program
JP2022107159A (en) Preparation support system and preparation support program
JP2015047362A (en) Medicine data input device and program
JP5944871B2 (en) Drug inspection device and program
JPWO2020243230A5 (en)
JP6117036B2 (en) Drug registration device and program
JP6283284B2 (en) Drug registration device and drug registration program
JP5852057B2 (en) Drug registration device and program
JP6193824B2 (en) Drug registration device and program
JPWO2017163777A1 (en) Medical pump management device and medical pump management system
JP6132781B2 (en) Drug registration device and program
JP6046564B2 (en) Drug registration device and program
JP2015153098A (en) Device and program for inspecting drug
JP6239452B2 (en) Drug registration device and program
JP2023085168A (en) Coinjection support system and coinjection support program
JP2018165867A (en) Medication management system, medication management program
JP6196565B2 (en) Drug registration device and program

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16830475

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017530852

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20177037191

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16830475

Country of ref document: EP

Kind code of ref document: A1